US20130244340A1 - Nanopore Based Molecular Detection and Sequencing - Google Patents

Nanopore Based Molecular Detection and Sequencing Download PDF

Info

Publication number
US20130244340A1
US20130244340A1 US13/745,688 US201313745688A US2013244340A1 US 20130244340 A1 US20130244340 A1 US 20130244340A1 US 201313745688 A US201313745688 A US 201313745688A US 2013244340 A1 US2013244340 A1 US 2013244340A1
Authority
US
United States
Prior art keywords
nanopore
molecule
polynucleotide
nucleic acid
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/745,688
Other languages
English (en)
Inventor
Randall Davis
Roger Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Sequencing Solutions Inc
Original Assignee
Genia Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genia Technologies Inc filed Critical Genia Technologies Inc
Priority to US13/745,688 priority Critical patent/US20130244340A1/en
Assigned to Genia Technologies, Inc. reassignment Genia Technologies, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, ROGER, DAVIS, RANDALL
Assigned to GLENVIEW CAPITAL PARTNERS LP, GLENVIEW INSTITUTIONAL PARTNERS, L.P., SHERMAN, LEN, DOBKIN, ROBERT, GLENVIEW CAPITAL OPPORTUNITY FUND, LP, GLENVIEW CAPITAL MASTER FUND LTD, Life Technologies Corporation, GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD. reassignment GLENVIEW CAPITAL PARTNERS LP SECURITY AGREEMENT Assignors: Genia Technologies, Inc.
Publication of US20130244340A1 publication Critical patent/US20130244340A1/en
Assigned to GLENVIEW CAPITAL OPPORTUNITY FUND, LP, GLENVIEW CAPITAL PARTNERS LP, GLENVIEW INSTITUTIONAL PARTNERS, L.P., GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD., GLENVIEW CAPITAL MASTER FUND LTD. reassignment GLENVIEW CAPITAL OPPORTUNITY FUND, LP SECURITY AGREEMENT Assignors: Genia Technologies, Inc.
Assigned to GENIA TECHNOLOGIES, INC reassignment GENIA TECHNOLOGIES, INC RELEASE OF SECURITY INTEREST Assignors: GLENVIEW CAPITAL MASTER FUND, LTD., GLENVIEW CAPITAL OPPORTUNITY FUND, L.P., GLENVIEW CAPITAL PARTNERS, L.P., GLENVIEW INSTITUTIONAL PARTNERS, L.P., GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD., Life Technologies Corporation
Assigned to GENIA TECHNOLOGIES, INC reassignment GENIA TECHNOLOGIES, INC RELEASE OF SECURITY INTEREST Assignors: GLENVIEW CAPITAL MASTER FUND, LTD., GLENVIEW CAPITAL OPPORTUNITY FUND, L.P., GLENVIEW CAPITAL PARTNERS, L.P., GLENVIEW INSTITUTIONAL PARTNERS, L.P., GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD
Priority to US15/703,909 priority patent/US10662471B2/en
Priority to US16/851,884 priority patent/US11965210B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores

Definitions

  • Nucleic acid sequencing is a process that may be used to provide sequence information for a nucleic acid sample. Such sequence information may be helpful in diagnosing and/or treating a subject. For example, the nucleic acid sequence of a subject may be used to identify, diagnose and potentially develop treatments for genetic diseases. As another example, research into pathogens may lead to treatment for contagious diseases.
  • Nanopores can be used to sequence polymers including nucleic acid molecules. Recognized herein is the need for improved methods for nucleic acid molecule identification and nucleic acid sequencing.
  • the polymer is passed through the nanopore and various subunits of the polymer (e.g., adenine (A), cytosine (C), guanine (G), thymine (T) and/or uracil (U) bases of the nucleic acid) may affect the current flowing through the nanopore.
  • various subunits can be identified by measuring the current at a plurality of voltages applied across the nanopore and/or membrane.
  • the polymerization of tagged nucleotides releases and/or presents tag molecules to the nanopore that can be identified by measuring the electric current at a plurality of voltages applied across the nanopore and/or membrane.
  • methods for sequencing both the sense and anti-sense strand of a double stranded nucleic acid molecule with a nanopore and methods for using ribonucleic acid (RNA) speed bump molecules to slow the passage of a nucleic acid molecule through a nanopore.
  • RNA ribonucleic acid
  • An aspect of the present disclosure provides a method for identifying a molecule or portion thereof, the method comprising (a) providing a chip comprising at least one nanopore in a membrane that is disposed adjacent or in proximity to an electrode, wherein the electrode is adapted to detect an electric current passing through the nanopore.
  • a molecule or portion thereof can be inserted into the nanopore.
  • a voltage can then be applied across the nanopore and/or across the membrane, and the voltage can be varied. The electric current at a plurality of voltages can be measured to identify the molecule or portion thereof.
  • Another aspect of the present disclosure provides a method for sequencing a nucleic acid molecule or portion thereof, the method comprising providing a double stranded nucleic acid molecule comprising a sense strand and an anti-sense strand, and ligating a first nucleic acid segment on a first end of the double stranded nucleic acid molecule.
  • the first nucleic acid segment links the sense strand with the anti-sense strand at the first end of the double stranded nucleic acid molecule.
  • the double stranded nucleic acid molecule can be dissociated to provide a single stranded nucleic acid molecule comprising a sense portion of the sense strand and an anti-sense portion of the anti-sense strand.
  • the single stranded nucleic acid molecule can then be passed or directed through or in proximity to a nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the electrode can be adapted to detect an electric current upon the single stranded nucleic molecule residing in, or passing through or in proximity to, the nanopore.
  • electric current also “current” herein
  • measurements can be obtained while the single stranded nucleic acid molecule resides I the nanopore, or passes through or in proximity to the nanopore.
  • the sequence of the double stranded nucleic acid can be determined from the electric current measurements.
  • Another aspect of the present disclosure provides a method for sequencing a nucleic acid molecule or portion thereof, the method comprising passing a single stranded nucleic acid molecule through or in proximity to a nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the single stranded nucleic molecule comprises a sense strand coupled to an anti-sense strand through a nucleic acid segment ligated on an end portion of each of the sense strand and anti-sense strand.
  • the electrode is adapted to detect an electric current upon the single stranded nucleic molecule passing through or in proximity to the nanopore. With the aid of the electrode, electric current measurements are obtained while passing the single stranded nucleic acid molecule through or in proximity to the nanopore.
  • a sequence of the single stranded nucleic acid molecule can be determined from the electric current measurements.
  • Another aspect of the present disclosure provides a method for sequencing a nucleic acid molecule, comprising providing a chip comprising at least one nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the electrode is adapted to detect the nucleic acid molecule or a portion thereof.
  • the nucleic acid molecule can be directed through or in proximity to the nanopore. Progression of the nucleic acid molecule through or in proximity to the nanopore is stopped or stalled with the aid of at least one ribonucleic acid (RNA) speed-bump molecule associated with the nucleic acid molecule.
  • RNA ribonucleic acid
  • the nucleic acid molecule or a portion thereof can be sequenced as the nucleic acid molecule passes through or in proximity to the nanopore.
  • Another aspect of the present disclosure provides a method for obtaining sequence information of a nucleic acid molecule, the method comprising forming a duplex segment comprising at least one ribonucleic acid (RNA) speed bump molecule associated with the nucleic acid molecule, and flowing the nucleic acid molecule through, adjacent to, or in proximity to a nanopore in a membrane.
  • the membrane is disposed adjacent to or in proximity to an electrode which may be coupled to, or be a part of, a sensing circuit.
  • the duplex segment is directed towards or across the nanopore.
  • electrical signals from the electrode are obtained upon the flow of the nucleic acid molecule through, adjacent to, or in proximity to the nanopore.
  • the electrical signals are associated with the interaction of one or more bases of the nucleic acid molecule and at least a portion of the nanopore.
  • the flow of the nucleic acid molecule can be reduced, in some cases stalled, with the aid of the duplex segment.
  • FIGS. 1A , 1 B and 1 C show examples of nanopore detectors.
  • the nanopore is disposed upon the electrode; in FIG. 1B , the nanopore is inserted in a membrane over a well; and in FIG. 1C ; the nanopore is disposed over a protruding electrode;
  • FIGS. 2A , 2 B, 2 C and 2 D show examples of molecules that can be detected with nanopores.
  • FIG. 2A shows the detection of a molecule
  • FIG. 2B shows the detection of portions of a polymer molecule
  • FIG. 2C shows the detection of tag molecules for nucleic acid sequencing
  • FIG. 2D shows the detection of the tag while the nucleotide is being incorporated;
  • FIG. 3 shows an example of a chip set-up comprising a nanopore and not a well
  • FIG. 4 shows an example of an ultra compact measurement circuit
  • FIG. 5 shows an example of cell analog circuitry
  • FIG. 6 shows an array of nanopore detectors
  • FIG. 7 shows an example of a test chip cell array configuration
  • FIG. 8 shows a computer system configured to control a sequencer
  • FIG. 9 shows a method for nucleic acid sequencing
  • FIG. 10 illustrates the passage of a single stranded (ss) test polynucleotide molecule through a nanopore
  • FIG. 11 illustrates a bulky structure formed at the trailing end of a ss test polynucleotide molecule to stall the passage of the ss test polynucleotide through a nanopore;
  • FIG. 12 illustrate multiple speed bumps bound to a ss test polynucleotide molecule, wherein the ss test polynucleotide is trapped in a nanopore by having bulky structures on both ends;
  • FIG. 13 illustrates different binding patterns achieved by contacting a ss test polynucleotide with a random speed bump pool
  • FIG. 14 illustrates different sequence information patterns achieved by randomly stalling a ss test polynucleotide in a nanopore to obtain sequence information
  • FIG. 15 illustrates a speed bump bound to a ss test polynucleotide having a bulky structure at a first end to stall its passage through a nanopore;
  • FIG. 16 illustrates multiple sets of electrical signals obtained by a nanopore detector according to the present invention
  • FIG. 17 illustrates detection of direction identifier in a ss test polynucleotide trapped in a nanopore bound by two bulky structures
  • FIG. 18 illustrates detection of an identifier by an identifier-specific speed bump
  • FIG. 19 illustrates an example of a ss test polynucleotide comprising a sample polynucleotide and multiple functional moieties
  • FIG. 20 illustrates an example of a ds test polynucleotide comprising a sample polynucleotide and multiple functional moieties
  • FIG. 21 illustrates a ss test polynucleotide trapped in a nanopore bound with multiple speed bumps on both sides of the nanopore;
  • FIG. 22 illustrates contacting a ss test polynucleotide with a speed bump train
  • FIG. 23 illustrates a flowchart of a process according to an embodiment of the present disclosure
  • FIG. 24 illustrates the relationship between working temperature and capture of a ss test polynucleotide having BS2-1 on one end and a BS1 on the other end in a nanopore;
  • FIG. 25 shows an example of a tag molecule attached to the phosphate of a nucleotide
  • FIG. 26 shows examples of alternate tag locations
  • FIG. 27 shows detectable TAG-polyphosphate and detectable TAG
  • FIG. 28 illustrates an example of a test polynucleotide comprising a sample polynucleotide, an antisense polynucleotide of the sample polynucleotide, a linker linking the sample polynucleotide and the antisense polynucleotide thereof, a first pre-bulky structure and a second pre-bulky structure;
  • FIG. 29 shows examples of waveforms
  • FIG. 30 shows a plot of extracted signal versus applied voltage for the four nucleic acid bases adenine (A), cytosine (C), guanine (G) and thymine (T);
  • FIG. 31 shows a plot of extracted signal versus applied voltage for multiple runs of the four nucleic acid bases adenine (A), cytosine (C), guanine (G) and thymine (T); and
  • FIG. 32 shows a plot of percent relative conductive difference (% RCD) versus applied voltage for multiple runs of the four nucleic acid bases adenine (A), cytosine (C), guanine (G) and thymine (T).
  • nanopore generally refers to a pore, channel or passage formed or otherwise provided in a membrane.
  • a membrane may be an organic membrane, such as a lipid bilayer, or a synthetic membrane, such as a membrane formed of a polymeric material.
  • the membrane may be a polymeric material.
  • the nanopore may be disposed adjacent or in proximity to a sensing circuit or an electrode coupled to a sensing circuit, such as, for example, a complementary metal-oxide semiconductor (CMOS) or field effect transistor (FET) circuit.
  • CMOS complementary metal-oxide semiconductor
  • FET field effect transistor
  • a nanopore has a characteristic width or diameter on the order of 0.1 nanometers (nm) to about 1000 nm.
  • Some nanopores are proteins. Alpha hemolysin is an example of a protein nanopore.
  • polymerase generally refers to any enzyme or other molecular catalyst that is capable of catalyzing a polymerization reaction.
  • examples of polymerases include, without limitation, a nucleic acid polymerase or a ligase.
  • a polymerase can be a polymerization enzyme.
  • nucleic acid generally refers to a molecule comprising one or more nucleic acid subunits.
  • a nucleic acid may include one or more subunits selected from adenosine (A), cytosine (C), guanine (G), thymine (T) and uracil (U), or variants thereof.
  • a nucleotide can include A, C, G, T or U, or variants thereof.
  • a nucleotide can include any subunit that can be incorporated into a growing nucleic acid strand.
  • Such subunit can be an A, C, G, T, or U, or any other subunit that is specific to one or more complementary A, C, G, T or U, or complementary to a purine (i.e., A or G, or variant thereof) or a pyrimidine (i.e., C, T or U, or variant thereof).
  • a subunit can enable individual nucleic acid bases or groups of bases (e.g., AA, TA, AT, GC, CG, CT, TC, GT, TG, AC, CA, or uracil-counterparts thereof) to be resolved.
  • a nucleic acid is deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), or derivatives thereof.
  • a nucleic acid may be single-stranded or double stranded.
  • polynucleotide or “oligonucleotide,” as used herein, generally refers to a polymer or oligomer comprising one or more nucleotides.
  • a polynucleotide or oligonucleotide may comprise a DNA polynucleotide or oligonucleotide, a RNA polynucleotide or oligonucleotide, or one or more sections of DNA polynucleotide or oligonucleotide and/or RNA polynucleotide or oligonucleotide.
  • a “nucleotide” or “base” can be a primary nucleotide or a nucleotide analog.
  • a primary nucleotide is deoxyadenosine mono-phosphate (dAMP), deoxycytidine mono-phosphate (dCMP), deoxyguanosine mono-phosphate (dGMP), deoxythymidine mono-phosphate (dTMP), adenosine mono-phosphate (AMP), cytidine mono-phosphate (CMP), guanosine mono-phosphate (GMP) or uridine mono-phosphate (UMP).
  • dAMP deoxyadenosine mono-phosphate
  • dCMP deoxycytidine mono-phosphate
  • dGMP deoxythymidine mono-phosphate
  • AMP adenosine mono-phosphate
  • CMP cytidine mono-phosphate
  • GMP guanosine mono-phosphate
  • UMP uridine mono-phosphate
  • a nucleotide analog is an analog or mimic of a primary nucleotide having modification on the primary nucleobase (A, C, G, T and U), the deoxyribose/ribose structure, the phosphate group of the primary nucleotide, or any combination thereof.
  • a nucleotide analog can have a modified base, either naturally existing or man-made.
  • modified bases include, without limitation, methylated nucleobases, modified purine bases (e.g. hypoxanthine, xanthine, 7-methylguanine, isodG), modified pyrimidine bases (e.g. 5,6-dihydrouracil and 5-methylcytosine, isodC), universal bases (e.g.
  • nucleotide analogs having modified deoxyribose e.g. dideoxynucleosides such as dideoxyguanosine, dideoxyadenosine, dideoxythymidine, and dideoxycytidine
  • phosphate structure (together referred to as the backbone structure) includes, without limitation, glycol nucleotides, morpholinos, and locked nucleotides.
  • test polymer generally refers to a polymer molecule that passes through or adjacent to a nanopore for detection purposes.
  • the test polymer may comprise multiple building blocks that have similar chemical structures.
  • test polymers include, without limitation, test polynucleotides, test peptides/proteins, and test carbohydrates.
  • a test polynucleotide can be a single-stranded test polynucleotide (i.e., ss test polynucleotide) or a double-stranded test polynucleotide (i.e., ds test polynucleotide).
  • building blocks include, without limitation, nucleotides, amino acids, and monosaccharides.
  • sample polynucleotide generally refers to a nucleic acid molecule which can comprise a polynucleotide of interest, such as, for example, a single-stranded (“ss”) sample polynucleotide (ss sample polynucleotide) or a double-stranded (“ds”) sample polynucleotide (i.e., ds sample polynucleotide, such as, e.g. ds sample DNA, ds sample RNA, and ds sample DNA-RNA hybrid).
  • ss sample polynucleotide such as, e.g. ds sample DNA, ds sample RNA, and ds sample DNA-RNA hybrid.
  • a sample polynucleotide can be a natural polynucleotide obtained from a biological sample or a synthetic polynucleotide.
  • the synthetic polynucleotide may be a polynucleotide obtained by modification of a natural polynucleotide, such as pre-processed polynucleotide intended for use in polynucleotide identification and/or sequencing.
  • pre-processings include, without limitation, enrichment of the sample polynucleotide for desired fragments, paired-end processing, mated pair read processing, epigenetic pre-processing including bisulfide treatment, focused fragment analysis via PCR, PCR fragment sequencing, and short polynucleotide fragment analysis.
  • test polynucleotide generally refers to a polynucleotide molecule that passes through or adjacent to a nanopore for detection purposes.
  • a test polynucleotide can be a single-stranded test polynucleotide (i.e., ss test polynucleotide) and a double-stranded test polynucleotide (i.e., ds test polynucleotide, such as, e.g. ds test DNA, ds test RNA, and ds test DNA-RNA hybrid).
  • a ss test polynucleotide as used herein, comprises a section of ss polynucleotide that is to be bound by a speed bump in a method described herein.
  • a ss test polynucleotide may further comprise a sample polynucleotide and other functional moieties (e.g., pre-bulky structure, identifiers and isolation tags).
  • pre-bulky structure generally refers to a molecular structure in a polynucleotide molecule which can form a bulky structure under certain conditions (e.g., at certain temperature, presence/absence of certain compound(s)).
  • pre-bulky structures include oligonucleotide structures.
  • a pre-bulky structure can be a ss polynucleotide or a ds polynucleotide.
  • the term “bulky structure”, as used herein, generally refers to a structure (e.g., nucleotide) formed from a pre-bulky structure in a ss test polynucleotide molecule.
  • the bulky structure can slow or stall the test polynucleotide molecule in a nanopore at a working condition until the working condition is changed to another condition wherein the bulky structure is converted to the pre-bulky structure or other structures that may stall the test polynucleotide molecule.
  • Examples of bulky structures include, without limitation, 2-D and 3-D structures such as polynucleotide duplex structures (RNA duplex, DNA duplex or RNA-DNA hybrid), polynucleotide hairpin structures, multi-hairpin structures and multi-arm structures.
  • the pre-bulky structure forms a bulky structure via interaction with a ligand specific to the pre-bulky structure. Examples of such pre-bulky structure/ligand pair include, without limitation, biotin/streptavidin, antigen/antibody, and carbohydrate/antibody.
  • the bulky structure is formed from an oligonucleotide pre-bulky structure, e.g., an oligonucleotide structure formed from a pre-bulky structure in a ss test polynucleotide molecule.
  • polynucleotide or oligonucleotide bulky structures include, without limitation, hairpin nucleic acid strands, hybridized antisense nucleic acid strands, multiple arms and three dimensional DNA or RNA molecules that are self-hybridized.
  • the bulky structure is formed via interactions of a pre-bulky structure/ligand pair as described herein.
  • duplex generally refers to a duplex structure, section, region or segment.
  • a duplex can include an RNA duplex, DNA duplex or a DNA-RNA duplex structure, section, region or segment.
  • speed bump generally refers to a molecule, such as an oligonucleotide, that forms a complex with a binding segment of a test polynucleotide molecule.
  • a test polynucleotide molecule travels through or adjacent to a nanopore under an applied electric potential
  • the complex formed between a speed bump and the binding segment slows or stalls the test polynucleotide molecule in or adjacent to the nanopore for a dwelling time long enough for the nanopore detector to obtain a signal from the test polynucleotide molecule, which signal can provide structure or sequence information for the test polynucleotide molecule.
  • the complex dissociates and the test polynucleotide molecule moves forward through the nanopore.
  • known speed bump generally refers to a speed bump that specifically binds to a known sequence in a ss test polynucleotide. Because the binding segment on the ss test polynucleotide (the known sequence) is known, the speed bump structure can also be known (e.g. complementary to the known sequence on the ss test polynucleotide).
  • random speed bump pool generally refers to a collection of speed bumps that can bind to all or substantially all sections of a test polynucleotide molecule or a fragment thereof.
  • An example of random speed bump pool comprises oligonucleotides having universal nucleobases which base-pair with all primary nucleobases (A, T, C, G and U).
  • Another example of random speed bump pool comprises oligonucleotides of a given length having all possible combinations of primary nucleobases.
  • Another example of random speed bump pool comprises oligonucleotides of a given length having every possible combination of primary nucleobases and universal nucleobases.
  • random speed bump pool comprises speed bumps having universal nucleobases at designated positions and all combinations of primary nucleobases at the other positions.
  • Another example of random speed bumps is a combination of ss speed bumps, which form duplex sections with ss test polynucleotide, and the duplex sections have about the same melting temperatures. These ss speed bumps may have the same or different lengths, and/or the same or different nucleotides.
  • stopper generally refers to a structure that can form a stopper-test polynucleotide complex with the test polynucleotide and stop the flow of the stopper-test polynucleotide complex before the constriction area of the nanopore for the dwelling time.
  • the stopper can be part of the test polynucleotide, or a separate structure (e.g. a speed bump described herein, and an antisense strand of the test polynucleotide formed in the presence of a nucleotide polymerase), or an enzyme that can bind to the test polynucleotide and optionally move the test polynucleotide through the nanopore.
  • identifier generally refers to a known sequence or structure in a test polynucleotide that can be detected or identified by the method described herein.
  • identifiers include, without limitation, direction identifiers, reference signal identifiers, sample source identifiers, and sample identifiers.
  • the identifiers may comprise one or more nucleotides or structures that provide distinctive electrical signals that are identifiable. Examples of such nucleotides and structures include, without limitation, isodG, isodC, methylated nucleotides, locked nucleic acids, universal nucleotides, and abasic nucleotides.
  • an abasic nucleotide provides a stronger signal than a primary nucleotide.
  • the electrical signal detected by a nanopore for a sequence comprising both abasic nucleotides and primary nucleotides may provide a signal more intense than the electrical signal obtained from primary nucleotide only sequences.
  • a 4 to 5 base sequence comprising about 25% abasic nucleotides may provide a signal more than twice as strong as a 4 to 5 base sequence comprising only primary nucleotides. The more abasic nucleotides the sequence have, the stronger electrical signal the sequence.
  • identifiers may provide electrical signals of a desired intensity (e.g., about twice, about 3, 4, 5, 6, 7, 8, 9, or about 10 times stronger than that of primary oligonucleotides having the same length) by changing the amount of abasic nucleotides in the identifier sequences.
  • a desired intensity e.g., about twice, about 3, 4, 5, 6, 7, 8, 9, or about 10 times stronger than that of primary oligonucleotides having the same length
  • direction identifier generally refers to a known sequence positioned at least 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 50 bases from a bulky structure formed from a pre-bulky structure (the shaded section in the ss test polynucleotide molecule as depicted in FIG. 17 ).
  • a bulky structure when a bulky structure is formed, it can stop a ss test polynucleotide molecule from flowing through a nanopore within which the ss test polynucleotide molecule is incorporated.
  • a set of electrical signals may be obtained, which can provide sequence information of the sequence that is in front of the bulky structure and the first base pair of the bulky structure, in the flow direction of the ss test polynucleotide molecule.
  • such electrical signals can, without limitation: (1) verify that the pre-bulky structure has properly formed into the bulky structure such that the bulky structure stops the ss test polynucleotide molecule from flowing through the nanopore; (2) indicate that the ss test polynucleotide molecule has reached one end of the single strand section of the ss test polynucleotide, and/or (3) serve as a reference or calibration read to base line other electrical signals obtained in the same nanopore.
  • the direction identifier comprises one or more nucleotides or structures that provide distinctive electrical signals that are readily identified. Examples of such nucleotides and structures include, without limitation, isodG, isodC and abasic nucleotides.
  • reference signal identifier generally refers to a known sequence in a test polynucleotide, which when detected or identified by the methods described herein, can serve as a reference or calibration read to base line other electrical signals obtained in the same nanopore.
  • sample source identifier generally refers to a known sequence in a test polynucleotide, which when detected or identified by the methods described herein, can be used to identify the source of the sample polynucleotide.
  • sample identifier generally refers to a known sequence in a test polynucleotide, which when detected or identified by the methods described herein, can be used to identify the individual sample polynucleotide.
  • linker identifier generally refers to a known sequence in a test polynucleotide, which when detected or identified by the methods described herein, can be used to indicate the transition between the sample polynucleotide section and the antisense polynucleotide section. In an example, when the linker identifier is detected or identified, the sample/antisense polynucleotide section has passed through the nanopore.
  • nucleic acid e.g., DNA, RNA
  • protein e.g., DNA, RNA
  • polymeric sequencing e.g., DNA or RNA
  • nucleic acid sequencing the nucleic acid base content of a nucleic acid molecule may be determined.
  • amino acid sequence of a protein may be determined.
  • a method for identifying a species, such as a molecule or portion thereof, with a nanopore can comprise providing a chip comprising at least one nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the electrode can be adapted to detect a current passing through the nanopore.
  • the method can further include inserting a molecule or portion thereof into the nanopore and varying a voltage applied across the nanopore and/or across the membrane.
  • the method includes measuring the current at a plurality of voltages to identify the molecule or portion thereof.
  • the current at a plurality of voltages comprises an electronic signature and further comprises comparing the electronic signature to a plurality of reference electronic signatures to identify the molecule or portion thereof.
  • the nanopore may be formed or otherwise embedded in a membrane disposed adjacent to a sensing electrode of a sensing circuit, such as an integrated circuit.
  • the integrated circuit may be an application specific integrated circuit (ASIC).
  • the integrated circuit is a field effect transistor or a complementary metal-oxide semiconductor (CMOS).
  • CMOS complementary metal-oxide semiconductor
  • the sensing circuit may be situated in a chip or other device having the nanopore, or off of the chip or device, such as in an off-chip configuration.
  • the semiconductor can be any semiconductor, including, without limitation, Group IV (e.g., silicon) and Group III-V semiconductors (e.g., gallium arsenide).
  • FIG. 1 shows an examples of a nanopore detector (or sensor) having temperature control, as may be prepared according to methods described in U.S. Patent Application Publication No. 2011/0193570, which is entirely incorporated herein by reference.
  • the nanopore detector comprises a top electrode 101 in contact with a conductive solution (e.g., salt solution) 107 .
  • a bottom conductive electrode 102 is near, adjacent, or in proximity to a nanopore 106 , which is inserted in a membrane 105 .
  • the bottom conductive electrode 102 is embedded in a semiconductor 103 in which is embedded electrical circuitry in a semiconductor substrate 104 .
  • a surface of the semiconductor 103 may be treated to be hydrophobic.
  • a sample being detected goes through the pore in the nanopore 106 .
  • the semiconductor chip sensor is placed in package 208 and this, in turn, is in the vicinity of a temperature control element 109 .
  • the temperature control element 109 may be a thermoelectric heating and/or cooling device (e.g., Peltier device).
  • a nanopore array can include one or more nanopore detectors. In some cases, a nanopore array includes at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 100, 1000, 10000, or 100,000 nanopore detectors.
  • An individual nanopore detector can include one or more nanopores adjacent to a sensing electrode (e.g., bottom conductive electrode 102 ). In some cases, an individual nanopore detector includes at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 100 nanopores adjacent to a sensing electrode.
  • the membrane 105 can be disposed over a well 110 , where the sensor 102 forms part of the surface of the well.
  • FIG. 1C shows an example in which the electrode 102 protrudes from the treated semiconductor surface 103 .
  • the membrane 105 forms on the bottom conductive electrode 102 and not on the semiconductor 103 .
  • the membrane 105 in such a case may form coupling interactions with the bottom conductive electrode 102 .
  • the membrane 105 forms on the bottom conductive electrode 102 and the semiconductor 103 .
  • the membrane 105 can form on the semiconductor 103 and not on the bottom conductive electrode 102 , but may extend over the bottom conductive electrode 102 .
  • FIG. 2 shows some examples of molecules that can be detected and methods for sequencing polymers including nucleic acids.
  • the molecule 201 passes through the nanopore 202 from the cis side 203 (away from the electrode) to the trans side 204 (toward to the electrode) of the membrane 205 .
  • the molecule can be a polymer molecule 206 and portions of the polymer molecule 207 can be identified as the polymer molecule passes through the nanopore.
  • the polymer molecule can be a biological molecule such as a nucleic acid or a protein.
  • the polymer molecule is a nucleic acid and the portions of the polymer molecule are nucleic acids or groups of nucleic acids (e.g., 2, 3, 4, 5, 6, 7, or 8 nucleic acids).
  • the polymer molecule is a polypeptide and the portions of the polypeptide are amino acids or groups of nucleic acids (e.g., 2, 3, 4, 5, 6, 7, or 8 amino acids).
  • the sensing circuit detects an electrical signal associated with the nucleic acid or tag.
  • the nucleic acid may be a subunit of a larger strand.
  • the tag may be a byproduct of a nucleotide incorporation event or other interaction between a tagged nucleic acid and the nanopore or a species adjacent to the nanopore, such as an enzyme that cleaves a tag from a nucleic acid.
  • the tag may remain attached to the nucleotide.
  • a detected signal may be collected and stored in a memory location, and later used to construct a sequence of the nucleic acid. The collected signal may be processed to account for any abnormalities in the detected signal, such as errors.
  • the molecule 208 (e.g., a “tag molecule”) is bound to a nucleotide 209 .
  • the molecule can be identified while the nucleotide is being incorporated into a growing nucleic acid chain 210 (e.g., by a polymerase 211 ).
  • the nucleotide can be incorporated according to base pair matching with a template nucleic acid 212 . If different tags are bound to each of the different nucleotides (e.g., A, C, T and G), the sequence of the template nucleic acid can be determined by detecting the tag molecules with the nanopore (e.g., without the template nucleic acid passing through the nanopore).
  • the molecule is released 213 from the nucleotide upon incorporation of the nucleotide into a growing nucleic acid chain. As shown in FIG. 2D , the molecule can be detected while the nucleotide is being incorporated into the growing strand and/or before being released from the nucleotide 214 .
  • FIG. 3 schematically illustrates a nanopore device 100 (or sensor) that may be used to detect a molecule (and/or sequence a nucleic acid) as described herein.
  • the nanopore containing lipid bilayer may be characterized by a resistance and capacitance.
  • the nanopore device 100 includes a lipid bilayer 102 formed on a lipid bilayer compatible surface 104 of a conductive solid substrate 106 , where the lipid bilayer compatible surface 104 may be isolated by lipid bilayer incompatible surfaces 105 and the conductive solid substrate 106 may be electrically isolated by insulating materials 107 , and where the lipid bilayer 102 may be surrounded by amorphous lipid 103 formed on the lipid bilayer incompatible surface 105 .
  • the lipid bilayer 102 may be embedded with a single nanopore structure 108 having a nanopore 110 large enough for passing of the molecules being detected and/or small ions (e.g., Na + , Ca 2+ , Cl ⁇ ′′ ) between the two sides of the lipid bilayer 102 .
  • a layer of water molecules 114 may be adsorbed on the lipid bilayer compatible surface 104 and sandwiched between the lipid bilayer 102 and the lipid bilayer compatible surface 104 .
  • the aqueous film 114 adsorbed on the hydrophilic lipid bilayer compatible surface 104 may promote the ordering of lipid molecules and facilitate the formation of lipid bilayer on the lipid bilayer compatible surface 104 .
  • a sample chamber 116 containing a solution of the molecule to be detected (e.g., nucleic acid molecule optionally with tagged nucleotides or other components as needed) 112 may be provided over the lipid bilayer 102 .
  • the solution may be an aqueous solution containing electrolytes and buffered to an optimum ion concentration and maintained at an optimum pH to keep the nanopore 110 open.
  • the device includes a pair of electrodes 118 (including a negative node 118 a and a positive node 118 b ) coupled to a variable voltage source 120 for providing electrical stimulus (e.g., voltage bias) across the lipid bilayer and for sensing electrical characteristics of the lipid bilayer (e.g., resistance, capacitance, and ionic current flow).
  • the surface of the positive electrode 118 b is or forms a part of the lipid bilayer compatible surface 104 .
  • the conductive solid substrate 106 may be coupled to or forms a part of one of the electrodes 118 .
  • the device 100 may also include an electrical circuit 122 for controlling electrical stimulation and for processing the signal detected.
  • the (e.g., variable) voltage source 120 is included as a part of the electrical circuit 122 .
  • the electrical circuitry 122 may include amplifier, integrator, noise filter, feedback control logic, and/or various other components.
  • the electrical circuitry 122 may be integrated electrical circuitry integrated within a silicon substrate 128 and may be further coupled to a computer processor 124 coupled to a memory 126 .
  • the lipid bilayer compatible surface 104 may be formed from various materials that are suitable for ion transduction and gas formation to facilitate lipid bilayer formation.
  • conductive or semi-conductive hydrophilic materials may be used because they may allow better detection of a change in the lipid bilayer electrical characteristics.
  • Example materials include Ag—AgCl, Au, Pt, or doped silicon or other semiconductor materials.
  • the electrode is not a sacrificial electrode.
  • the lipid bilayer incompatible surface 105 may be formed from various materials that are not suitable for lipid bilayer formation and they are typically hydrophobic. In some embodiments, non-conductive hydrophobic materials are preferred, since it electrically insulates the lipid bilayer regions in addition to separate the lipid bilayer regions from each other.
  • Example lipid bilayer incompatible materials include for example silicon nitride (e.g., Si 3 N 4 ) and Teflon, silicon oxide (e.g., SiO 2 ) silanized with hydrophobic molecules.
  • the nanopore device 100 of FIG. 3 is a alpha hemolysin (aHL) nanopore device having a single alpha hemolysin (aHL) protein 108 embedded in a diphytanoylphosphatidylcholine (DPhPC) lipid bilayer 102 formed over a lipid bilayer compatible silver (Ag) surface 104 coated on an aluminum material 106 .
  • the lipid bilayer compatible Ag surface 104 is isolated by lipid bilayer incompatible silicon nitride surfaces 105
  • the aluminum material 106 is electrically insulated by silicon nitride materials 107 .
  • the aluminum 106 is coupled to electrical circuitry 122 that is integrated in a silicon substrate 128 .
  • a silver-silver chloride electrode placed on-chip or extending down from a cover plate 128 contacts an aqueous solution containing (e.g., nucleic acid) molecules.
  • the aHL nanopore is an assembly of seven individual peptides.
  • the entrance or vestibule of the aHL nanopore is approximately 26 Angstroms in diameter, which is wide enough to accommodate a portion of a dsDNA molecule.
  • the aHL nanopore first widens and then narrows to a barrel having a diameter of approximately 15 Angstroms, which is wide enough to allow a single ssDNA molecule (or smaller tag molecules) to pass through but not wide enough to allow a dsDNA molecule (or larger tag molecules) to pass through.
  • the lipid bilayer of the nanopore device may be assembled from various other suitable amphiphilic materials, selected based on various considerations, such as the type of nanopore used, the type of molecule being characterized, and various physical, chemical and/or electrical characteristics of the lipid bilayer formed, such as stability and permeability, resistance, and capacitance of the lipid bilayer formed.
  • Example amphiphilic materials include various phospholipids such as palmitoyl-oleoyl-phosphatidyl-choline (POPC) and dioleoyl-phosphatidyl-methylester (DOPME), diphytanoylphosphatidylcholine (DPhPC) dipalmitoylphosphatidylcholine (DPPC), phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid, phosphatidylinositol, phosphatidylglycerol, and sphingomyelin.
  • POPC palmitoyl-oleoyl-phosphatidyl-choline
  • DOPME dioleoyl-phosphatidyl-methylester
  • DPhPC diphytanoylphosphatidylcholine
  • DPPC dipalmitoylphosphatidylcholine
  • the nanopore may be of various other types of nanopores. Examples include y-hemolysin, leukocidin, melittin, mycobacterium smegmatis porin A (MspA) and various other naturally occurring, modified natural, and synthetic nanopores.
  • a suitable nanopore may be selected based on various characteristics of the analyte molecule such as the size of the analyte molecule in relation to the pore size of the nanopore. For example, the aHL nanopore that has a restrictive pore size of approximately 15 Angstroms.
  • current may be measured at different applied voltages.
  • a desired potential may be applied to the electrode, and the applied potential may be subsequently maintained throughout the measurement.
  • an opamp integrator topology may be used for this purpose as described herein.
  • the integrator maintains the voltage potential at the electrode by means of capacitive feedback.
  • the integrator circuit may provide outstanding linearity, cell-to-cell matching, and offset characteristics.
  • the opamp integrator typically requires a large size in order to achieve the required performance. A more compact integrator topology is described herein.
  • a voltage potential “Vliquid” may be applied to the chamber which provides a common electrical potential (e.g., 350 mV) for all of the cells on the chip.
  • the integrator circuit may initialize the electrode (which is electrically the top plate of the integrating capacitor) to a potential greater than the common liquid potential. For example, biasing at 450 mV may give a positive 100 mV potential between electrode and liquid. This positive voltage potential may cause a current to flow from the electrode to the liquid chamber contact.
  • the carriers are: (a) K+ ions which flow through the pore from the electrode (trans) side of the bi-layer to the liquid reservoir (cis) side of the bi-layer and (b) chlorine (Cl ⁇ ) ions on the trans side which reacts with the silver electrode according to the following electro-chemical reaction: Ag+Cl ⁇ AgCl+e ⁇ .
  • K+ flows out of the enclosed cell (from trans to cis side of bi-layer) while Cl ⁇ is converted to silver chloride.
  • the electrode side of the bilayer may become desalinated as a result of the current flow.
  • a silver/silver-chloride liquid spongy material or matrix may serve as a reservoir to supply Cl ⁇ ions in the reverse reaction which occur at the electrical chamber contact to complete the circuit.
  • Electrodes ultimately flow onto the top side of the integrating capacitor which creates the electrical current that is measured.
  • the electrochemical reaction converts silver to silver chloride and current will continue to flow only as long as there is available silver to be converted.
  • the limited supply of silver leads to a current dependent electrode life in some cases.
  • electrode materials that are not depleted e.g., platinum are used.
  • the ability to re-charge the electrode during the detection cycle can be advantageous when using sacrificial electrodes or electrodes that change molecular character in the current-carrying reactions (e.g., electrodes comprising silver), or electrodes that change molecular character in current-carrying reactions.
  • An electrode may deplete during a detection cycle, though in some cases the electrode may not deplete during the detection cycle.
  • the re-charge can prevent the electrode from reaching a given depletion limit, such as becoming fully depleted, which can be a problem when the electrodes are small (e.g., when the electrodes are small enough to provide an array of electrodes having at least 500 electrodes per square millimeter).
  • Electrode lifetime in some cases scales and is at least partly dependent on the width of the electrode.
  • the need to maintain a voltage difference of conserved polarity across the nanopore during detection for long periods of time depletes the electrodes and can limit the duration of detection and/or size of the electrodes.
  • the devices and methods described herein allow for longer (e.g., infinite) detection times and/or electrodes that can be scaled down to an arbitrarily small size (e.g., as limited by considerations other than electrode depletion during detection).
  • the molecule e.g., tag molecule
  • the molecule or portion thereof is detected a plurality of times (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 100, 1000, 10,000, 100,000, 1,000,000 or more times in a 100 millisecond period).
  • the polarity of the voltage across the nanopore is reversed periodically.
  • the polarity of the voltage can be reversed after detection periods lasting any suitable amount of time (e.g., about 1 ms, about 5 ms, about 10 ms, about 15 ms, about 20 ms, about 25 ms, about 30 ms, about 40 ms, about 50 ms, about 60 ms, about 80 ms, about 100 ms, about 125 ms, about 150 ms, about 200 ms, and the like).
  • the period of time and strength of the electrical field during periods of recharging the electrodes is such that the electrode is restored to its state prior to detection (e.g., mass of electrode).
  • the net voltage across the nanopore is zero in some instances (e.g., periods of positive voltage cancel periods of negative voltage over a suitably long time scale such as 1 second, 1 minute or 5 minutes).
  • the voltage applied to a nanopore is balanced such that there is net zero current detected by a sensing electrode adjacent to or in proximity to the nanopore.
  • an alternating current (AC) waveform is applied to a nanopore in a membrane or an electrode adjacent to the membrane to draw a molecule through or in proximity to the nanopore and to release the molecule.
  • the AC waveform can have a frequency on the order of at least 10 microseconds, 1 millisecond (ms), 5 ms, 10 ms, 20 ms, 100 ms, 200 ms, 300 ms, 400 ms, 500 ms.
  • the waveform may aid in alternately and sequentially capturing molecules (e.g., the tag molecule) and releasing the molecule, or otherwise moving the molecule in multiple directions (e.g., opposing directions), which may increase the overall time period in which the molecule is associated with the nanopore. This balancing of charging and discharging can permit the generation of a longer signal from a nanopore electrode and/or a given molecule.
  • an AC waveform is applied to repeatedly direct at least a portion of a molecule (e.g., tag associated with a tagged nucleotide (e.g., incorporated tagged nucleotide)) into a nanopore and direct at least a portion of the molecule out of the nanopore.
  • a molecule e.g., tag associated with a tagged nucleotide (e.g., incorporated tagged nucleotide)
  • the molecule may be held by an enzyme (e.g., polymerase). This repetitive loading and expulsion of a single molecule held by the enzyme may advantageously provide more opportunities to detect the molecule.
  • the nanopore may be used to read the molecule approximately 4 times. Multiple reads may enable correction for errors, such as errors associated with the molecule threading into and/or out of a nanopore.
  • the waveform can have any suitable shape including either regular shapes (e.g., that repeat over a period of time) and irregular shapes (e.g., that do not repeat over any suitably long period of time such as 1 hour, 1 day or 1 week).
  • FIG. 29 shows some suitable (regular) waveforms. Examples of waveforms include triangular waves, (panel A) sine waves (panel B), sawtooth waves, square waves, and the like.
  • the electrode can be depleted during detection of the molecules in some cases. Reversal of the polarity (i.e., positive to negative or negative to positive) of the voltage across the nanopore, such as upon the application of an alternating current (AC) waveform, can recharge the electrode.
  • FIG. 29C shows a horizontal dashed line at zero potential difference across the nanopore with positive voltage extending upward in proportion to magnitude and negative voltage extending downward in proportion to magnitude. No matter the shape of the waveform, the combined area under the curve of a voltage versus time plot in the positive direction 3100 can equal the combined area under the curve in the negative direction 3101 .
  • the electrode is neither charged nor depleted over a suitably long period of time (e.g., one hour, one day or one week), for example when the positive 3100 and negative 3101 areas are equal.
  • a first current is measured, and upon the application of a negative potential (e.g., of equal absolute magnitude to the positive potential) across the nanopore, a second current is measured.
  • the first current may be equal to the second current, though in some cases the first current and the second current may be different. For example, the first current may be less than the second current.
  • the nanopore detects tagged nucleotides for relatively long periods of time at a relatively low magnitude voltage (e.g., FIG. 29 , indication 3100 ) and re-charges the electrode for relatively short periods of time at a relatively large magnitude voltage (e.g., FIG. 29 , indication 3101 ).
  • the time period for detection is at least 2, at least 3, at least 4, at least 5, at least 6, at least 8, at least 10, at least 15, at least 20, or at least 50 times longer than the time period for electrode recharge.
  • the waveform is altered in response to an input.
  • the input is the level of depletion of the electrode.
  • the polarity and/or magnitude of the voltage is varied at least in part based on the depletion of the electrode and the waveform is irregular.
  • the ability to repeatedly detect and re-charge the electrodes over short time periods allows for the use of smaller electrodes relative to electrodes that may maintain a constant direct current (DC) potential and DC current and are used to sequence polynucleotides that are threaded through the nanopore.
  • Smaller electrodes can allow for a high number of detection sites (e.g., comprising an electrode, a sensing circuit, a nanopore and a polymerase) on a surface.
  • the surface comprises any suitable density of discrete sites (e.g., a density suitable for sequencing a nucleic acid sample in a given amount of time or for a given cost).
  • the surface has a density of discrete sites greater than or equal to about 500 sites per 1 mm 2 .
  • the surface has a density of discrete sites of about 100, about 200, about 300, about 400, about 500, about 600, about 700, about 800, about 900, about 1000, about 2000, about 3000, about 4000, about 5000, about 6000, about 7000, about 8000, about 9000, about 10000, about 20000, about 40000, about 60000, about 80000, about 100000, or about 500000 sites per 1 mm 2 .
  • the surface has a density of discrete sites of at least about 200, at least about 300, at least about 400, at least about 500, at least about 600, at least about 700, at least about 800, at least about 900, at least about 1000, at least about 2000, at least about 3000, at least about 4000, at least about 5000, at least about 6000, at least about 7000, at least about 8000, at least about 9000, at least about 10000, at least about 20000, at least about 40000, at least about 60000, at least about 80000, at least about 100000, or at least about 500000 sites per 1 mm 2 .
  • the electrode can be re-charged prior to, between or during, or after detections (e.g., of nucleotide incorporation events). In some cases, the electrode is re-charged in about 20 milliseconds (ms), about 40 ms, about 60 ms, about 80 ms, about 100 ms, about 120 ms, about 140 ms, about 160 ms, about 180 ms, or about 200 ms.
  • ms milliseconds
  • the electrode is re-charged in less than about 20 milliseconds (ms), less than about 40 ms, less than about 60 ms, less than about 80 ms, less than about 100 ms, less than about 120 ms, less than about 140 ms, less than about 160 ms, less than about 180 ms, about 200 ms, less than about 500 ms, or less than about 1 second.
  • ms milliseconds
  • FIG. 4 An example of cell circuitry is shown in FIG. 4 .
  • An applied voltage Va is applied to an opamp 1200 ahead of a MOSFET current conveyor gate 401 . Also shown here are an electrode 402 and the resistance of the nucleic acid and/or tag detected by the device 403 .
  • An applied voltage Va can drive the current conveyor gate 401 .
  • the resulting voltage on the electrode sis then Va-Vt where Vt is the threshold voltage of the MOSFET.
  • Vt is the threshold voltage of the MOSFET.
  • this results in limited control of the actual voltage applied to the electrode as a MOSFET threshold voltage can vary considerably over process, voltage, temperature, and even between devices within a chip.
  • This Vt variation can be greater at low current levels where sub-threshold leakage effects can come into play. Therefore, in order to provide better control of the applied voltage, an opamp can be used in a follower feedback configuration with the current conveyor device. This ensures that the voltage applied to the electrode is Va, independent of variation of the MOSFET threshold voltage.
  • FIG. 5 Another example of cell circuitry is shown in FIG. 5 and includes an integrator, comparator, and digital logic to shift in control bits and simultaneously shift out the state of the comparator output.
  • the cell circuitry may be adapted for use with systems and methods provided herein.
  • the B0 through B1 lines may come out of the shift register.
  • the analog signals are shared by all cells within a bank while digital lines may be daisy-chained from cell to cell.
  • the cell digital logics comprises the 5 bit data shift register (DSR), 5 bit parallel load registers (PLR), control logic, and analog integrator circuit. Using the LIN signal, the control data shifted into the DSR is parallel loaded into the PLR. These 5 bits control digital “break-before-make”timing logic which controls the switches in the cell. In addition the digital logic has a set-reset (SR) latch to record the switching of the comparator output.
  • DSR 5 bit data shift register
  • PLR parallel load registers
  • control logic Using the LIN signal, the control data shifted into the DSR is parallel loaded into the PLR.
  • These 5 bits control digital “break-before-make”timing logic which controls the switches in the cell.
  • the digital logic has a set-reset (SR) latch to record the switching of the comparator output.
  • SR set-reset
  • the architecture delivers a variable sample rate that is proportional to the individual cell current.
  • a higher current may result in more samples per second than a lower current.
  • the resolution of the current measurement is related to the current being measured.
  • a small current may be measured with finer resolution than a large current, which may be a benefit over fixed resolution measurement systems.
  • There is an analog input which allows the user to adjust sample rates by changing the voltage swing of the integrator. It may be possible to increase the sample rate in order to analyze biologically fast processes or to slow the sample rate (and thereby gain precision) in order to analyze biologically slow processes.
  • the output of the integrator is initialized to the voltage LVB (low voltage bias) and integrates up to the voltage CMP. A sample is generated every time the integrator output swings between these two levels. Thus the greater the current the faster the integrator output swings and therefore the faster the sample rate. Similarly if CMP voltage is reduced the output swing of the integrator needed to generate a new sample is reduced and therefore the sample rate is increased. Thus simply reducing the voltage difference between LVB and CMP provides a mechanism to increase the sample rate.
  • a nanopore based sequencing chip may incorporate a large number of autonomously operating or individually addressable cells configured as an array. For example an array of one million cells could be constructed of 1000 rows of cells by 1000 columns of cells. This array enables the parallel sequencing of nucleic acid molecules by measuring the conductance difference when tags released upon nucleotide incorporation events are detected by the nanopore for example. Moreover this circuitry implementation allows the conductance characteristics of the pore-molecular complex to be determined which may be valuable in distinguishing between tags.
  • the integrated nanopore/bilayer electronic cell structures may apply appropriate voltages in order to perform current measurements. For example, it may be necessary to both (a) control electrode voltage potential and (b) monitor electrode current simultaneously in order to perform correctly.
  • the independent control of a cell may be required in order to manage a large number of cells that may be in different physical states.
  • Precise control of the piecewise linear voltage waveform stimulus applied to the electrode may be used to transition between the physical states of the cell.
  • the appropriate voltage may be applied to a cell and then the current measured to determine whether a bilayer has formed.
  • the cells are divided into two groups: (a) those which have had a bilayer form and no longer need to have the voltage applied. These cells may have a 0V bias applied in order to effect the null operation (NOP)—that is stay in the same state and (b) those which do not have a bilayer formed. These cells will again have the bilayer formation electric voltage applied.
  • NOP null operation
  • a substantial simplification and circuit size reduction may be achieved by constraining the allowable applied voltages to two and iteratively transitioning cells in batches between the physical states. For example, a reduction by at least a factor of 1.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, or 100 may be achieved by constraining the allowable applied voltages.
  • each nanopore location (e.g., 601 ) comprises a nanopore, optionally attached to a polymerase enzyme and/or phosphatase enzymes.
  • a sensor at each array location as described herein.
  • an array of nanopores attached to a nucleic acid polymerase is provided, and tagged nucleotides are incorporated with the polymerase.
  • a tag is detected by the nanopore (e.g., by releasing and passing into or through the nanopore, or by being presented to the nanopore).
  • the array of nanopores may have any suitable number of nanopores.
  • the array comprises about 200, about 400, about 600, about 800, about 1000, about 1500, about 2000, about 3000, about 4000, about 5000, about 10000, about 15000, about 20000, about 40000, about 60000, about 80000, about 100000, about 200000, about 400000, about 600000, about 800000, about 1000000, and the like nanopores.
  • the array comprises at least 200, at least 400, at least 600, at least 800, at least 1000, at least 1500, at least 2000, at least 3000, at least 4000, at least 5000, at least 10000, at least 15000, at least 20000, at least 40000, at least 60000, at least 80000, at least 100000, at least 200000, at least 400000, at least 600000, at least 800000, or at least 1000000 nanopores.
  • the array of nanopore detectors may have a high density of discrete sites. For example, a relatively large number of sites per unit area (i.e., density) allows for the construction of smaller devices, which are portable, low-cost, or have other advantageous features.
  • An individual site in the array can be an individually addressable site.
  • a large number of sites comprising a nanopore and a sensing circuit may allow for a relatively large number of nucleic acid molecules to be sequenced at once, such as, for example, through parallel sequencing. Such a system may increase the through-put and/or decrease the cost of sequencing a nucleic acid sample.
  • the surface comprises any suitable density of discrete sites (e.g., a density suitable for sequencing a nucleic acid sample in a given amount of time or for a given cost). Each discrete site can include a sensor.
  • the surface may have a density of discrete sites greater than or equal to about 500 sites per 1 mm 2 . In some embodiments, the surface has a density of discrete sites of about 200, about 300, about 400, about 500, about 600, about 700, about 800, about 900, about 1000, about 2000, about 3000, about 4000, about 5000, about 6000, about 7000, about 8000, about 9000, about 10000, about 20000, about 40000, about 60000, about 80000, about 100000, or about 500000 sites per 1 mm 2 .
  • the surface has a density of discrete sites of at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 900, at least 1000, at least 2000, at least 3000, at least 4000, at least 5000, at least 6000, at least 7000, at least 8000, at least 9000, at least 10000, at least 20000, at least 40000, at least 60000, at least 80000, at least 100000, or at least 500000 sites per 1 mm 2 .
  • a test chip includes an array of 264 sensors arranged in four separate groups (aka banks) of 66 sensor cells each. Each group is in turn divided into three “columns” with 22 sensors “cells” in each column.
  • the “cell” name is apropos given that ideally a virtual cell comprising a bi-lipid layer and inserted nanopore is formed above each of the 264 sensors in the array (although the device may operate successfully with only a fraction of the sensor cells so populated).
  • each of the 264 cells in the array may be controlled individually. Values are applied separately to a group of 66 cells.
  • the mode of each of the 66 cells in a group is controlled by serially shifting in 330 (66*5 bits/cell) digital values into a DataShiftRegister (DSR). These values are shifted into the array using the KIN (clock), and DIN (dat in) pins with a separate pin pair for each group of 66 cells.
  • DSR DataShiftRegister
  • 330 clocks are used to shift 330 bits into the DSR shift register.
  • a second 330 bit Parallel Load Register (PLR) is parallel loaded from this shift register when the corresponding LIN ⁇ i> (Load Input) is asserted high.
  • PLR Parallel Load Register
  • a complete operation may include 330 clocks to shift in 330 data bits into the DSR, a single clock cycle with LIN signal asserted high, followed by 330 clock cycles to read the captured status data shifted out of the DSR.
  • the operation is pipelined so that a new 330 bits may be shifted into the DSR simultaneously while the 330 bits are being read out of the array.
  • FIG. 8 shows a system 800 comprising a computer system 801 coupled to a nanopore detection and/or nucleic acid sequencing system 802 .
  • the computer system 801 may be a server or a plurality of servers.
  • the computer system 801 may be programmed to regulate sample preparation and processing, and nucleic acid sequencing by the sequencing system 802 .
  • the nanopore detection and/or sequencing system 802 may be a nanopore-based sequencer (or detector), as described herein.
  • the computer system may be programmed to implement the methods of the disclosure.
  • the computer system 801 includes a central processing unit (CPU, also “processor” herein) 805 , which can be a single core or multi core processor, or a plurality of processors for parallel processing.
  • the processor 805 can be part of a circuit, such as an integrated circuit. In some examples, the processor 805 can be integrated in an application specific integrated circuit (ASIC).
  • ASIC application specific integrated circuit
  • the computer system 801 also includes memory 810 (e.g., random-access memory, read-only memory, flash memory), electronic storage unit 815 (e.g., hard disk), communications interface 820 (e.g., network adapter) for communicating with one or more other systems, and peripheral devices 825 , such as cache, other memory, data storage and/or electronic display adapters.
  • the memory 810 , storage unit 815 , interface 820 and peripheral devices 825 are in communication with the CPU 805 through a communications bus (solid lines), such as a motherboard.
  • the storage unit 815 can be a data storage unit (or data repository) for storing data.
  • the computer system 801 may be operatively coupled to a computer network (“network”) with the aid of the communications interface 820 .
  • the network can be the Internet, an internet and/or extranet, or an intranet and/or extranet that is in communication with the Internet.
  • the network can include one or more computer servers, which can enable distributed computing.
  • the computer system 801 includes a field-programmable gate array (FPGA).
  • the processor 805 in such a case may be excluded.
  • Methods of the disclosure can be implemented by way of machine (or computer processor) executable code (or software) stored on an electronic storage location of the computer system 801 , such as, for example, on the memory 810 or electronic storage unit 815 .
  • the code can be executed by the processor 805 .
  • the code can be retrieved from the storage unit 815 and stored on the memory 810 for ready access by the processor 805 .
  • the electronic storage unit 815 can be precluded, and machine-executable instructions are stored on memory 810 .
  • the code can be pre-compiled and configured for use with a machine have a processer adapted to execute the code, or can be compiled during runtime.
  • the code can be supplied in a programming language that can be selected to enable the code to execute in a pre-compiled or as-compiled fashion.
  • the computer system 801 can be adapted to store user profile information, such as, for example, a name, physical address, email address, telephone number, instant messaging (IM) handle, educational information, work information, social likes and/or dislikes, and other information of potential relevance to the user or other users.
  • user profile information such as, for example, a name, physical address, email address, telephone number, instant messaging (IM) handle, educational information, work information, social likes and/or dislikes, and other information of potential relevance to the user or other users.
  • IM instant messaging
  • aspects of the systems and methods provided herein can be embodied in programming.
  • Various aspects of the technology may be thought of as “products” or “articles of manufacture” typically in the form of machine (or processor) executable code and/or associated data that is carried on or embodied in a type of machine readable medium.
  • Machine-executable code can be stored on an electronic storage unit, such memory (e.g., ROM, RAM) or a hard disk.
  • “Storage” type media can include any or all of the tangible memory of the computers, processors or the like, or associated modules thereof, such as various semiconductor memories, tape drives, disk drives and the like, which may provide non-transitory storage at any time for the software programming.
  • All or portions of the software may at times be communicated through the Internet or various other telecommunication networks. Such communications, for example, may enable loading of the software from one computer or processor into another, for example, from a management server or host computer into the computer platform of an application server.
  • another type of media that may bear the software elements includes optical, electrical and electromagnetic waves, such as used across physical interfaces between local devices, through wired and optical landline networks and over various air-links.
  • the physical elements that carry such waves, such as wired or wireless links, optical links or the like, also may be considered as media bearing the software.
  • terms such as computer or machine “readable medium” refer to any medium that participates in providing instructions to a processor for execution.
  • a machine readable medium such as computer-executable code
  • a tangible storage medium such as computer-executable code
  • Non-volatile storage media include, for example, optical or magnetic disks, such as any of the storage devices in any computer(s) or the like, such as may be used to implement the databases, etc. shown in the drawings.
  • Volatile storage media include dynamic memory, such as main memory of such a computer platform.
  • Tangible transmission media include coaxial cables; copper wire and fiber optics, including the wires that comprise a bus within a computer system.
  • Carrier-wave transmission media may take the form of electric or electromagnetic signals, or acoustic or light waves such as those generated during radio frequency (RF) and infrared (IR) data communications.
  • RF radio frequency
  • IR infrared
  • Common forms of computer-readable media therefore include for example: a floppy disk, a flexible disk, hard disk, magnetic tape, any other magnetic medium, a CD-ROM, DVD or DVD-ROM, any other optical medium, punch cards paper tape, any other physical storage medium with patterns of holes, a RAM, a ROM, a PROM and EPROM, a FLASH-EPROM, any other memory chip or cartridge, a carrier wave transporting data or instructions, cables or links transporting such a carrier wave, or any other medium from which a computer may read programming code and/or data.
  • Many of these forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to a processor for execution.
  • Methods for sequencing nucleic acids may include retrieving a biological sample having the nucleic acid to be sequenced, extracting or otherwise isolating the nucleic acid sample from the biological sample, and in some cases preparing the nucleic acid sample for sequencing.
  • FIG. 9 schematically illustrates a method for sequencing a nucleic acid sample.
  • the method comprises isolating the nucleic acid molecule from a biological sample (e.g., tissue sample, fluid sample), and preparing the nucleic acid sample for sequencing. Sequencing can involve determining a base makeup, including order, of individual nucleic acid bases of the nucleic acid sample.
  • the nucleic acid sample is extracted from a cell. Examples of techniques for extracting nucleic acids are using lysozyme, sonication, extraction, high pressures or any combination thereof.
  • the nucleic acid is cell-free nucleic acid in some cases and does not require extraction from a cell.
  • a nucleic acid sample may be prepared for sequencing by a process that involves removing proteins, cell wall debris and other components from the nucleic acid sample.
  • a process that involves removing proteins, cell wall debris and other components from the nucleic acid sample.
  • spin columns There are many commercial products available for accomplishing this, such as, for example, spin columns. Ethanol precipitation and centrifugation may also be used.
  • the nucleic acid sample may be partitioned (or fractured) into a plurality of fragments, which may facilitate nucleic acid sequencing, such as with the aid of a device that includes a plurality of nanopores in an array.
  • fracturing the nucleic acid molecule(s) to be sequenced may not be necessary.
  • any suitable length of nucleic acid sequence may be determined. For instance, at least about 5, about 10, about 20, about 30, about 40, about 50, about 100, about 200, about 300, about 400, about 500, about 600, about 700, about 800, about 800, about 1000, about 1500, about 2000, about 2500, about 3000, about 3500, about 4000, about 4500, about 5000, about 6000, about 7000, about 8000, about 9000, about 10000, about 20000, about 40000, about 60000, about 80000, or about 100000, and the like bases may be sequenced.
  • At least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 800, at least 1000, at least 1500, at least 2000, at least 2500, at least 3000, at least 3500, at least 4000, at least 4500, at least 5000, at least 6000, at least 7000, at least 8000, at least 9000, at least 10000, at least 20000, at least 40000, at least 60000, at least 80000, at least 100000, and the like bases are sequenced. In some instances the sequenced bases are contiguous. In some instances, the sequenced bases are not contiguous.
  • a given number of bases can be sequenced in a row.
  • one or more sequenced bases may be separated by one or more blocks in which sequence information is not determined and/or available.
  • a template can be sequenced multiple times (e.g., using a circular nucleic acid template), optionally generating redundant sequence information.
  • software is used to provide the sequence.
  • the nucleic acid sample may be partitioned prior to sequencing.
  • the nucleic acid sample strand may be processed so that a given duplex DNA or RNA/DNA region is made circular such that the corresponding sense and antisense portions of the duplex DNA or RNA/DNA region are included in the circular DNA or circular DNA/RNA molecule.
  • the sequenced bases from such a molecule may allow easier data assembly and checking of base position readings.
  • Systems and methods of the disclosure may be used to sequence various types of biological samples, such as nucleic acids (e.g., DNA, RNA) and proteins.
  • nucleic acids e.g., DNA, RNA
  • the methods, devices and systems described herein can be used to sort biological samples (e.g., proteins or nucleic acids).
  • the sorted samples and/or molecules can be directed to various bins for further analysis.
  • Nucleic acid molecules can be sequenced directly (e.g., by passing the nucleic acid through a nanopore as shown in FIG. 2B ) or indirectly (e.g., by detection of released tag molecules as shown in FIG. 2C ).
  • the one or more nanopores may be in a membrane (e.g., lipid bi-layer) that is disposed adjacent or in sensing proximity to an electrode that is part of, or coupled to, an integrated circuit.
  • a membrane e.g., lipid bi-layer
  • a nanopore device includes a single nanopore in a membrane that is adjacent or sensing proximity to an electrode.
  • a nanopore device includes at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 1000, or 10,000 nanopores in proximity to a sensor circuit or sensing electrodes.
  • the one or more nanopore may be associated with an individual electrode and sensing integrated circuit or a plurality of electrodes and sensing integrated circuits.
  • a system may include a reaction chamber that includes one or more nanopore devices.
  • a nanopore device may be an individually addressable nanopore device (e.g., a device that is capable of detecting a signal and providing an output independent of other nanopore devices in the system).
  • An individually addressable nanopore can be individually readable.
  • an individually addressable nanopore can be individually writable.
  • an individually addressable nanopore can be individually readable and individually writable.
  • the system can include one or more computer processors for facilitating sample preparation and various operations of the disclosure, such as nucleic acid sequencing.
  • the processor can be coupled to nanopore device.
  • a nanopore device may include a plurality of individually addressable sensing electrodes.
  • Each sensing electrode can include a membrane adjacent to the electrode, and one or more nanopores in the membrane.
  • nucleic acid bases may detect nucleic acid bases as a nucleic acid molecule passes through the nanopore.
  • the nucleic acid molecule can be modified to more readily differentiate between the various bases as they pass through the nanopore as described in PCT Patent Publication No. WO2007/146158, which is incorporated by reference in its entirety.
  • Systems and methods for polynucleotide sequencing are provided herein.
  • the presently disclosed systems and methods optimize control, speed, movement, and/or translocation of a molecule (e.g., a polynucleotide) within, through, or at least partially through a nanopore (or some type of protein or mutant protein).
  • a molecule e.g., a polynucleotide
  • the rate of passage is sufficiently slow or stopped for sufficient amounts of time in order to accumulate sufficient current blocking information to identify the molecule and/or sequence contiguous nucleotides in a single-stranded area of a polynucleotide.
  • speed bumps e.g., oligonucleotide n-mers
  • oligonucleotide n-mers can be bound to a target polynucleotide so that these double-stranded portions are “stuck” within a portion of the nanopore for an amount of time while a single-stranded portion (“ss”) of the target is interrogated and genetic analysis is generated and detected. After an amount of time, the “stuck” oligonucleotide can be melted away and the sample can be translocated through the nanopore.
  • the oligonucleotide n-mers can be selected such that each oligonucleotide n-mer melts away or is removed at a uniform rate such that the sample moves through the nanopore at a controlled and/or constant rate.
  • speed bump molecules is described in PCT Patent Publication No. WO2012/088339, and PCT Patent Publication No. WO2012/088341 which are incorporated by reference in its entirety.
  • the rate at which the nucleic acid passes through the nanopore can be controlled using speed bumps that comprise ribonucleic acid (RNA).
  • the speed bumps can comprise universal bases, optionally located along an RNA backbone.
  • Nucleic acid molecules can be sequenced by passing the molecule through a nanopore as described herein, but the rate of nucleic acid passage is often too rapid to determine the nucleic acid sequence accurately and/or to resolve individual nucleic acid positions.
  • RNA speed bumps can effectively reduce the rate of and/or control the speed at which a nucleic acid molecule passes through a nanopore.
  • a method for sequencing a nucleic acid molecule comprises providing a chip comprising at least one nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the electrode can be adapted to detect the nucleic acid molecule or a portion thereof.
  • the method can further include directing the nucleic acid molecule through the nanopore. Progression of the nucleic acid molecule through the nanopore can be stopped or stalled with the aid of at least one ribonucleic acid (RNA) speed-bump molecule associated with the nucleic acid molecule.
  • the method can further include sequencing the nucleic acid molecule or a portion thereof as the nucleic acid molecule passes through the nanopore.
  • a method for obtaining sequence information of a nucleic acid molecule comprises forming a duplex segment containing at least one ribonucleic acid (RNA) speed bump molecule associated with the nucleic acid molecule and flowing the nucleic acid molecule through a nanopore in a membrane.
  • the membrane is disposed adjacent to or in proximity to an electrode, and upon flowing the nucleic molecule through the nanopore, the duplex segment is directed towards the nanopore.
  • the method can further include obtaining electrical signals from the electrode upon the flow of the nucleic acid molecule through the nanopore. The electrical signals can be associated with the interaction of one or more bases of the nucleic acid molecule and the nanopore and the flow of the nucleic acid molecule can be reduced with the aid of the duplex segment.
  • the RNA speed-bump molecule is non-covalently associated with the nucleic acid molecule (e.g., forms non-covalent bonds such as base pair interactions between the speed-bump and the nucleic acid).
  • the RNA speed-bump molecule can comprises an oligonucleotide containing a sequence of one or more oligonucleotide bases.
  • the speed-bump molecule can have any length, including up to 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or more oligonucleotide bases.
  • the RNA speed-bump molecule has universal bases, morpholinos, glycol nucleotides, abasic nucleotides, methylated nucleobases, modified bases, non-binding base mimics, peptide nucleic acids (PNA), locked nucleic acids, or any combination thereof.
  • PNA peptide nucleic acids
  • Speed bump molecules can associate with the nucleic acid on one or more sides of the membrane.
  • the RNA speed-bump molecule is associated with the nucleic acid molecule on a cis side of the membrane (e.g., the side farther from the electrode).
  • the RNA speed-bump molecule is associated with the nucleic acid molecule on a trans side of the membrane (e.g., the side nearer to the electrode).
  • the RNA speed-bump molecule is associated with the nucleic acid molecule on a cis side of the membrane and on a trans side of the membrane.
  • the RNA speed-bump molecule may dissociate from the nucleic acid molecule as the nucleic acid molecule passes through the nanopore.
  • the method further comprises dissociating the RNA speed bump molecule from the nucleic acid molecule prior to flowing a portion of the nucleic molecule included in the duplex segment through the nanopore.
  • the nucleic acid molecule can be single-stranded.
  • the progression of the nucleic acid molecule through the nanopore can be slowed, stopped or stalled with the aid of a plurality of RNA speed-bump molecules associated with the nucleic acid molecule.
  • the flow can be reduced upon the interaction of the RNA speed bump molecule with the nanopore (e.g., the nanopore contains a constriction that restricts the flow of the nucleic acid molecule through the nanopore).
  • Any suitable number of bases can be identified (e.g., sequenced by the nanopore) when the progression of the nucleic acid molecule through the nanopore is stopped or stalled.
  • a single base of the nucleic acid molecule is identified.
  • up to 2, 3, 4, 5, 6, 7, 8, 9, 10, or more bases of the nucleic acid molecule is identified (e.g., as a group).
  • the method further comprises trapping the nucleic acid molecule in the nanopore.
  • the nucleic acid molecule can be trapped in the nanopore with the aid of bulky structures formed at one or more end portions of the nucleic acid molecule.
  • the nucleic acid molecule is trapped in the nanopore with the aid of bulky structures affixed (e.g., ligated) to one or more end portions of the nucleic acid molecule.
  • the method further comprises reversing a direction of flow of the nucleic acid molecule.
  • the nucleic acid molecule or a portion thereof can be re-sequenced by reversing the direction of flow of the nucleic acid molecule.
  • the present invention is directed to a method for detecting and/or identifying a sequence in a test polynucleotide using a nanopore detector.
  • the polynucleotide sequence can be trapped in the nanopore by one or two bulky structures formed at the end(s) of the polynucleotide sequence, so that the same test polynucleotide can be read multiple times by the same nanopore detector.
  • each bulky structure can be bound to the 5′ end or the 3′ end to thread the sample polynucleotide into the pore in a known direction.
  • Known speed bumps can be used to bind to known sequences in the test polynucleotide for the detection/identification of the known sequences.
  • This method can be used without limitation to detect whether the test polynucleotide has correctly threaded into the nanopore, which sample source the test polynucleotide is from, and individually identify the test polynucleotide trapped in the nanopore.
  • the test polynucleotide may further comprise a reference signal indicator to generate electrical signals that can be used as reference of calibration for other electrical signals obtained from the same nanopore.
  • multiple test polynucleotides can be analyzed by multiple nanopores at the same time for simultaneous sequencings and/or molecular characterizations.
  • the multiple nanopores can be individually addressable and/or have an individually applied electric potential.
  • multiple test polynucleotides can be analyzed simultaneously, optionally first to identify the polynucleotides having one or more desired known sequences.
  • the polynucleotides that do not have the desired known sequence can be released without further characterizations.
  • the polynucleotides having the desired known sequences can be further characterized, and optionally isolated and concentrated as described herein.
  • a random speed bump pool can be used to bind to the test polynucleotide or a fragment thereof in a random fashion.
  • each nucleotide of the test polynucleotide or the fragment thereof may be stalled in the nanopore for a time long enough to collect the nucleotide sequence information.
  • the nucleotide sequence of the test polynucleotide or the fragment thereof can be identified by taking all the sequence information obtained together.
  • the test polynucleotide may further comprise known structures such as direction identifiers, reference signal identifiers, sample source identifiers, sample identifiers to provide information (e.g., formation of the bulky structures), source of the test polynucleotide, and identification of the test polynucleotide.
  • the test polynucleotide may further comprise an isolation tag to isolate and concentrate the test polynucleotide.
  • multiple test polynucleotides are detected/identified by multiple nanopores (e.g. in a nanopore array). The method described herein can be applied to each test polynucleotide detected/identified.
  • the nanopores can be individually addressed and controlled to selectively detect/identify/collect/concentrate test polynucleotide(s) therein.
  • a single-stranded (ss) polynucleotide molecule can go through a nanopore under an applied electric potential.
  • the ss polynucleotide may be a test polynucleotide.
  • a set of electrical signals corresponding to the blockages of ion flow through the nanopore by the ss polynucleotide molecule can be detected as the ss polynucleotide molecule is threaded through the nanopore.
  • the ss polynucleotide molecule may encounter little resistance and travels through the nanopore too quickly for electrical signals to be reliably recorded for sequencing of the ss polynucleotide.
  • the ss polynucleotide is directed through the nanopore from a cis side of the membrane (i.e., side of the membrane disposed away from a sensing electrode) to a trans side of the membrane (i.e., side of the membrane disposed towards the sensing electrode).
  • FIG. 11 illustrates a trailing end BS used to stop the passage of a ss test polynucleotide molecule through a nanopore.
  • the BS can be a hairpin structure formed at one end of the ss test polynucleotide by wrapping the trailing end of the ss test polynucleotide upon itself.
  • the ss test polynucleotide can be threaded through the nanopore under an applied electric potential until the bulky hairpin structure reaches the entrance of the nanopore.
  • the ss test polynucleotide Since the hairpin structure is larger than the diameter of the nanopore, the ss test polynucleotide is stalled in the nanopore long enough to obtain a set of electrical signals of the ss test polynucleotide.
  • the electrical signals obtained may reflect the structure of only a portion of the polynucleotide that is in front of the hairpin or in front of the specific duplex region and therefore in or near the constriction area of the nanopore.
  • FIG. 12 illustrates a ss test polynucleotide trapped in a nanopore by two bulky structures.
  • the nanopore detection is carried out at a working temperature that may be lower than room temperature and/or the temperature at which the bulky structures form so that one or more shorter polynucleotide duplex sections can be formed between speed bumps and the ss test polynucleotide (speed bump-test polynucleotide duplex segments).
  • the speed bump-test polynucleotide duplex segment can slow or stall the ss test polynucleotide for a sufficient dwelling time to obtain sequence information of the ss test polynucleotide segment in front of the speed bump-test polynucleotide duplex segment and the first basepair of the speed bump-test polynucleotide duplex segment in the flow direction of the ss test polynucleotide.
  • the speed bump-test polynucleotide duplex segment may dissociate and the ss test polynucleotide can move forward through the nanopore until stalled by another speed bump-test polynucleotide duplex segment or stalled, slowed or stopped by a bulky structure on one end of the ss test polynucleotide.
  • the electric potential can be optionally reversed in polarity to move the ss test polynucleotide in a reversed direction and repeat the process as desired.
  • a random speed bump pool can be constructed to bind to random sections of the ss test polynucleotide.
  • the binding patterns achieved by contacting a ss test polynucleotide with a random speed bump pool each time can be random (e.g., FIG. 13 ).
  • the segments whose sequence information is obtained are also random for each run (e.g., FIG. 14 ).
  • repeating the process as described allows each and every nucleotide of the unknown sequence to be identified by the nanopore detector.
  • the whole unknown sequence can be constructed by overlapping the obtained sequence information of random sections of the ss test polynucleotide.
  • the method described herein can also be used to detect the presence of one or more identifiers and/or to identify a sequence on the ss test polynucleotide that is in front of the identifier in the flow direction of the ss test polynucleotide.
  • the ss test polynucleotide can have BS on only one end ( FIG. 15 ) or both ends.
  • the nanopore detector is operated at a working temperature, optionally lower than room temperature.
  • a speed bump pool comprises speed bumps that can bind specifically to the identifier (e.g. identifier 1, FIG.
  • the speed bump-identifier duplex segment can stall the ss test polynucleotide and a set of electrical signals can be obtained. These signals can be characterized to show presence of the identifier or to identify the sequence of the segment before the identifier in the flow direction of the ss test polynucleotide. An example of such electrical signals is shown in FIG. 16 .
  • a sample polynucleotide is linked with various functional moieties to facilitate nanopore sequencing and/or identifications.
  • functional moieties include, without limitation, pre-bulky structures and identifiers as described herein, and isolation tags to facilitate isolation and enrichment of the sample polynucleotide.
  • the functional moieties optionally comprise one or more nucleotides.
  • the sample polynucleotide may be a synthetic polynucleotide or a polynucleotide obtained from a biological sample.
  • the sample polynucleotide has 1 to about 100,000 bases, 1 to about 10,000 bases, 1 to about 1,000 bases, 1 to about 500 bases, 1 to about 300 bases, 1 to about 200 bases, 1 to about 100 bases, about 5 to about 100,000 bases, about 5 to about 10,000 bases, about 5 to about 1,000 bases, about 5 to about 500 bases, about 5 to about 300 bases, about 5 to about 200 bases, about 5 to about 100 bases, about 10 to about 100,000 bases, about 10 to about 10,000 bases, about 10 to about 1,000 bases, about 10 to about 500 bases, about 10 to about 300 bases, about 10 to about 200 bases, about 10 to about 100 bases, about 20 to about 100,000 bases, about 20 to about 10,000 bases, about 20 to about 1,000 bases, about 20 to about 500 bases, about 20 to about 300 bases, about 20 to about 200 bases, about 20 to about 100 bases, about 30 to about 100,000 bases, about 30 to about 10,000 bases,
  • a ss test polynucleotide comprises a first pre-bulky structure (PB 1) on a first end that can form a first bulky structure (BS1) under a first condition and a second pre-bulky structure (PB2) on a second end that can form a second bulky structure (BS2) under a second condition.
  • PB1 comprises ss polynucleotide segments that can form BS1 under the first condition.
  • a first condition can be a first temperature T1, which can be about room temperature to 70° C., about 40° C. or higher, about 30° C. or higher, about 25° C. or higher, about 20° C. or higher, or about 15° C. or higher.
  • the first condition can be T1 and the presence of a first ligand that can bind to PB1 to form BS1.
  • the first ligand include, without limitation, antisense oligonucleotide to PB1, other compounds to facilitate formation of BS1 (e.g. compounds that can form a binding-pair with a ligand, wherein the ligand is attached to PB1).
  • biding-pairs include, without limitation, antibody-antigen, and biotin-streptavidin system, and combinations thereof through covalent and/or noncovalent interactions.
  • BS1 is a polynucleotide 2-D or 3-D structure (e.g.
  • the melting temperature of BS 1 (Tm1) is 15° C. or above, about 20° C. or above, about 25° C. or above, about 30° C. or above, about 35° C. or above, about 40° C. or above, or about 50° C. or above.
  • PB2 forms BS2 under a second condition.
  • PB2 is a ss polynucleotide segment that can form BS2 (e.g., polynucleotide duplex, hairpin structure, multi-hairpin structure and multi-arm structure) under the second condition.
  • a second condition can be a second temperature T2, it is about ⁇ 5 to about 50° C., about 40° C. or higher, about 30° C. or higher, about 25° C. or higher, about 20° C. or higher, about 15° C. or higher, about 10° C. or higher, or about 5° C. or higher.
  • T2 is about at least 5° C. lower, preferably at least about 10° C.
  • the second condition can be T2 and the presence of a second ligand that can bind to PB2 to form BS2.
  • the second ligand include, without limitation, antisense oligonucleotide to PB2, other compounds to facilitate formation of BS2, (e.g., compounds that can form a binding-pair with a ligand, wherein the ligand is attached to PB2).
  • biding-pairs include, without limitation, antibody-antigen, and biotin-streptavidin system, and combinations thereof through covalent and/or noncovalent interactions.
  • BS2 is a polynucleotide 2-D or 3-D structure (e.g.
  • the melting temperature of BS2 is about 5 to about 10° C., about 10 to about 20° C., about 20 to about 30° C., or about 20 to about 50° C.
  • PB1 and/or PB2 comprise(s) structures that are non-binding to speed bumps in the speed bump pool.
  • structures include, without limitation, nucleotide analogs comprising non-binding bases such as IsodG, IsodC and abasic site.
  • a ss test polynucleotide further comprise(s) functional moieties such as identifiers and isolation tags.
  • identifier and isolation tags are constructed such that they will not be bound by the random speed bump pool.
  • an identifier segment can have isodG and isodC bases which preferably bind to each other. If speed bumps of the random speed bump pool do not have isodG or isodC base, speed bumps from the random speed bump pool will more preferably bind to sections of the ss test polynucleotide that is outside of the identifier segments. Thus, fewer electrical signals will be collected relating to the sequence information of the identifier, which makes the collected electrical signals easier to characterize.
  • identifiers include, without limitation, direction identifiers, reference signal identifiers, sample source identifiers and sample identifiers.
  • a ss test polynucleotide may have only one bulky structure on one end (e.g., FIG. 15 ), or two bulky structures on both ends (e.g., FIG. 17 ).
  • One direction identifier may be positioned closely (e.g., 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, . . . or 50 bases) to each bulky structure in the ss test polynucleotide.
  • the direction identifiers for different bulky structures can be the same or different.
  • ss test polynucleotide has two bulky structures and two direction identifiers
  • other identifiers can be positioned between the two direction identifiers.
  • other identifiers can be positioned further away from the bulky structure compared to the direction identifier.
  • identifiers include, without limitation, reference signal identifier serves as a reference or calibration read to base line other electrical signals obtained in the same nanopore; sample source identifiers used to identify the source of the sample polynucleotide; and sample identifiers used to identify individual sample polynucleotides.
  • an identifier can be detected and/or identified by contacting an identifier-specific speed bump with the ss test polynucleotide. If the ss test polynucleotide comprises the identifier of interest, an identifier-specific speed bump duplex section will be formed, which will stall the ss test polynucleotide in the nanopore. A set of electrical signals may be obtained while the ss test polynucleotide is stalled in the nanopore, which can be used to indicate the formation of the speed bump-identifier duplex section (identifier, FIG.
  • FIG. 18 shows the situation in a ss test polynucleotide having only one bulky structure. The same method can be used when the ss test polynucleotide has bulky structures on both ends.
  • the identifiers and/or identifier-specific speed bumps and/or the sequence in front of the identifier in the flow direction of the ss test polynucleotide molecule can comprise one or more nucleotides or structures that provide distinctive electrical signals that are readily identified.
  • nucleotides and structures include, without limitation, nucleotides comprising isodG or isodC, abasic nucleotides, methylated nucleotides, etc.
  • An isolation tag is a structure that can form a binding-pair with a ligand, wherein the ligand is further modified to facilitate concentration or isolation thereof.
  • biding-pairs include, without limitation, antibody-antigen, and the biotin-streptavidin system.
  • further modifications to facilitate concentration or isolation include, without limitation, attachment of the ligand to a magnetic bead that can be readily concentrated and/or isolated.
  • more than one functional moieties may overlap with each other or serve for more than one function.
  • FIG. 19 An example of a ss test polynucleotide comprising multiple functional moieties (segments A, B, C, D, F, G, H, and I, FIG. 19 ) and a sample polynucleotide is shown in FIG. 19 .
  • Segment I may serve as a pre-bulky structure and forms a bulky structure with a complementary strand thereof or by self-folding into a structure (e.g., polynucleotide hairpin structures, multi-hairpin structures and multi-arm structures), and segment H or a fragment thereof can serve as a direction identifier.
  • segment I can form a hairpin with segment H under certain conditions.
  • a pre-bulky structure is segments I and H.
  • Segment G or a fragment thereof can serve as a direction identifier.
  • Segment F, G, and H, or a fragment thereof can be a reference signal identifier, a sample identifier, a sample source identifier.
  • segments F, G and H together can be an identifier, or any fragment thereof can also serve as an identifier described herein. Similar situations apply to segments A, B, C and D on the 3′ end.
  • An Isolation Tag can be placed on the 3′ end or on the 5′ end, and it can be linked to the 3′ terminal or 5′ terminal nucleotide, or to any nucleotide on segments A, B, C, D, F, G, H and I, as long as it does not interfere with the binding of speed bump to the ss test polynucleotide, function of nanopore, or formation of bulky structure.
  • test polynucleotide comprising sample polynucleotide and one or more functional moieties is constructed by ligating the sample polynucleotide with other segments as desired using conventional organic and/or biological methods.
  • the ss test polynucleotide shown in FIG. 19 can be formed by linking multiple functional moieties to a sample polynucleotide using conventional ligation methods (e.g., formation of covalent bonds (e.g., ligase assisted ligation or other covalent bonds, wherein the ligation can be accomplished by paired end sequencing chemistry, blunt-ended polynucleotide ligation, and/or sticky-end ligation) or non-covalent interactions).
  • covalent bonds e.g., ligase assisted ligation or other covalent bonds, wherein the ligation can be accomplished by paired end sequencing chemistry, blunt-ended polynucleotide ligation, and/or sticky-end ligation
  • non-covalent interactions e.g., formation of covalent bonds (e.g., ligase assisted ligation or other covalent bonds, wherein the ligation can be accomplished by paired end sequencing chemistry, blunt-ended polynucleotide
  • sample polynucleotide obtained is a double-stranded (ds) sample polynucleotide.
  • the ds sample polynucleotide can be ligated with one or more ds functional moieties (e.g. ds PB1 (Segments I&H-Segments A′&B′, FIG. 20 ), ds PB2 (Segments B&A-Segments H′&I, FIG. 20 ), ds identifiers (e.g. (Segments G&F-Segments C′&D′, and Segments D&C-Segments F′&G′, FIG.
  • ds functional moieties e.g. ds PB1 (Segments I&H-Segments A′&B′, FIG. 20 ), ds PB2 (Segments B&A-Segments H′&I, FIG. 20 ), ds identifiers
  • the functional moieties can be ligated to the sample polynucleotide all in one step, or sequentially, or all functional moieties on one end of the sample polynucleotide are constructed together first and then ligated to the end of the sample polynucleotide.
  • the conventional ligation methods includes, without limitation, ligase assisted ligation following blunt end, dangling end, and/or linker ligation; paired end sequencing protocols; mate-paired and end-paired protocols.
  • the obtained ds polynucleotide is then denatured to provide ss test polynucleotide using conventional methods (e.g. heated to denature the ds polynucleotide).
  • the sample polynucleotide obtained is a ds sample polynucleotide, and is linked to one or more ds functional moieties (e.g. ds PB1, ds PB2, ds identifiers etc.) via covalent bonds other than the phosphodiester bonds.
  • ds functional moieties e.g. ds PB1, ds PB2, ds identifiers etc.
  • linkage include, without limitation, the linkage in glycol nucleotides, morpholinos, and locked nucleotides.
  • the sample polynucleotide obtained is a ss sample polynucleotide (DNA or RNA), and its complementary strand (DNA or RNA) can be created to anneal with the ss sample polynucleotide to form a ds sample polynucleotide (ds DNA, ds RNA or DNA-RNA hybrid) using conventional methods, and then ligate to one or more ds functional moieties as described herein.
  • DNA or RNA ss sample polynucleotide
  • DNA or RNA complementary strand
  • a ss sample polynucleotide is linked to one or more ss functional moieties (e.g., ss PB1, ss PB2, ss identifiers etc.) using ligase assisted ligation.
  • a ss sample polynucleotide is linked to one or more ss functional moieties via covalent bonds other than the phosphodiester bonds. Examples of such linkage include, without limitation, the linkage in glycol nucleotides, morpholinos, and locked nucleotides.
  • the sample polynucleotide obtained is a ds sample polynucleotide and can be denatured to provide a ss sample polynucleotide to be linked to one or more ss functional moieties as described herein.
  • the functional moieties are linked by cleavable bonds such that one or more individual functional moieties can be cleaved from the ss test polynucleotide.
  • a bulky structure can be removed from a ss test polynucleotide by cleaving a functional moieties positioned between the sample polynucleotide and the bulky structure. Then, the ss test polynucleotide can be released from the nanopore it is in by applying an electric potential to move the ss test polynucleotide through the nanopore in the direction at which it is no longer stalled, slowed or stopped by the cleaved bulky structure.
  • desired functional moieties are linked at a desired end (3′ or 5′) of the sample polynucleotide, such that the test polynucleotide obtained thereof can be threaded into the nanopore at a desired direction (e.g., from 3′ end or from 5′ end).
  • One aspect of the disclosure relates to a method of identifying a sample polynucleotide sequence comprising:
  • the ss polynucleotide is a ss test polynucleotide comprising a sample polynucleotide as described herein.
  • Speed bumps comprise one or more nucleotides as defined herein.
  • the ss sample polynucleotide comprises a DNA oligonucleotide, a RNA oligonucleotide, or a combination thereof.
  • the ds sample polynucleotide can be a ds DNA, ds RNA or a DNA-RNA hybrid.
  • a random speed bump pool comprises a collection of speed bumps of a given length that can bind to all sections of the ss test polynucleotide or a fragment thereof (e.g., a sample polynucleotide). Such a given length can be 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferred 10 or less, 8 or less, 6 or less and 4 or less.
  • the random speed bump pool comprise speed bumps composed of one or more nucleotides selected from the group consisting of universal nucleotides, locked nucleotides, primary nucleotides, modifications thereof, and combinations thereof.
  • Modifications of universal nucleotides, and primary nucleotides include modifications at the nucleobase structures, the backbone structures (e.g., glycol nucleotides, morpholinos, and locked nucleotides) and combinations thereof.
  • the random speed bump pool comprises oligonucleotides having universal nucleobases which base-pair with all primary nucleobases (A, T, C, G, and U).
  • the random speed bump pool comprises oligonucleotides having all possible combinations of primary nucleobases.
  • the random speed bump pool comprises oligonucleotides having all possible combinations of primary nucleobases and universal nucleobases.
  • the random speed bump pool comprises oligonucleotides having universal nucleotides at designated positions and all combinations of primary nucleobases at the other positions.
  • the backbone structures of the speed bumps in the random speed bump pool are modified (e.g., glycol nucleotides, morpholinos, and locked nucleotides) at designated position(s), random positions or combinations thereof.
  • the speed bumps in the random speed bump pool comprise DNA oligonucleotides, RNA oligonucleotidies, or combinations thereof.
  • the speed bumps may comprise universal nucleobases at designated positions and random primary nucleobases at other positions to lower the total number of possible combinations of primary nucleobases.
  • the speed bumps may be partially or completely in the nanopore and influence the electrical signals obtained, it is preferred to construct the speed bumps to have a universal nucleotide at the 5′ and/or 3′ end to normalize the contribution of the first base pair of the speed bump-test polynucleotide duplex segment and makes the signals easier to analyze.
  • the concentrations of one or more speed bumps of a random speed bump pool may be further adjusted to as desired.
  • the concentrations may be about the same for each type of speed bump; and be adjusted such that sufficient ss speed bumps exist to contact the ss test polynucleotide.
  • polyG and polyC speed bumps will have higher concentrations than speed bumps having other sequences to provide sufficient ss polyG and ss polyC to contact the ss test polynucleotide.
  • the concentrations of speed bumps and/or nucleotides used to make the speed bumps are adjusted such that each speed bump has about the same affinity to form speed bump-test polynucleotide complex, and no specific speed bumps are significantly more favored than others. In some embodiments, the concentrations of speed bumps and/or nucleotides used to make the speed bumps are adjusted such that one or more specific speed bumps are significantly more favored than others.
  • the speed bump pool can be constructed to be substantially free of speed bumps that can bind to known segments in the ss test polynucleotide. Therefore, more sequence information obtained will be about the unknown segments and not the known segments in the ss test polynucleotide.
  • step (B5) forms a speed bump-test polynucleotide complex having at least one speed bump-test polynucleotide duplex segment, wherein the speed bump forms a duplex with the ss test polynucleotide segment that is up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 basepairs, and is threaded in the nanopore at a first working condition.
  • a working condition includes parameters such as a working temperature (Tw), exposure time, concentration of speed bump and ss test polynucleotide, pH, salt concentration, and other additives and concentration thereof that can affect the formation of speed bump-test polynucleotide complex.
  • Tw can be about ⁇ 10 to about 25° C., about ⁇ 10 to about 20° C., about ⁇ 10 to about 15° C., about ⁇ 10 to about 10° C., about ⁇ 10 to about 5° C., about ⁇ 10 to about 0° C., about ⁇ 10 to about ⁇ 5° C., about ⁇ 5 to about 25° C., about ⁇ 5 to about 20° C., about ⁇ 5 to about 15° C., about ⁇ 5 to about 10° C., about ⁇ 5 to about 5° C., or about ⁇ 5 to about 0° C., to allow association of relatively short speed bumps (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 bases) to the ss test polynucleotide.
  • relatively short speed bumps (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 bases
  • Tw is about at least 10° C. lower, preferably at least about 20° C. lower than T2.
  • at Tw at least about 50% of PB1 and PB2 are in the forms of BS1 and BS2, respectively.
  • at Tw at least about 70% of PB1 and PB2 are in the forms of BS1 and BS2, respectively.
  • at Tw at least about 90% of PB1 and PB2 are in the forms of BS1 and BS2, respectively.
  • Exposure time of ss test polynucleotide to speed bumps is about 1 ns or longer, about 10 ns or longer, about 1 ⁇ s or longer, about 10 is or longer, about 1 ms or longer, about 10 ms or longer, about 1 s or longer, or about 5 s or longer to allow sufficient speed bump-test polynucleotide complex to form.
  • Concentrations of the speed bumps are preferably about 100,000 times, 10,000 times, 1,000 times, 300 times, about 200 times, about 100 times, about 50 times, or about 20 times of the concentration of the ss test polynucleotide, or the concentration of the speed bumps is about the same as that of the ss test polynucleotide.
  • the concentrations of the speed bumps are preferably about 1 nM to about 100 mM, about 1 nM to about 10 mM, about 1 nM to about 1 mM, about 10 nM to about 100 mM, about 10 nM to about 10 mM, about 10 nM to about 1 mM, about 1 mM to about 10 mM, or about 10 mM to 100 mM.
  • the concentration of ss test polynucleotide is about 1 nM to about 100 mM, about 1 nM to about 10 mM, about 1 nM to about 1 mM, about 10 nM to about 100 mM, about 10 nM to about 10 mM, or about 10 nM to about 1 mM.
  • pH is preferably about 6 to about 8, or about 7.
  • Salt (e.g., KCl, NaCl, phosphate) concentration is about 1 mM to about 10 M, about 1 mM to about 1 M, about 10 mM to about 10 M, about 10 mM to about 1 M, about 100 mM to about 10 M, or about 100 mM to about 1 M.
  • speed bump-test polynucleotide complex additives that may affect the formation of speed bump-test polynucleotide complex include, without limitation, dextran sulfate and glycerol. Their concentrations may be adjusted to optimize formation of speed bump-test polynucleotide complex.
  • a working condition further comprises an electric potential of about 0 mV to about 320 mV at a desired polarity.
  • the working condition can be continuously adjusted through the process based on the characteristics of the speed bump binding (e.g., length, nucleotide components, and binding affinity), the nanopore characteristics and the ss test polynucleotide property (e.g., GC content or secondary structure thereof), to optimize the signal quality.
  • the electric potential can continuously change from for example, ⁇ 320 mV to +320 mV.
  • Steps (B4) to (B9) can be carried out at a first working condition as described herein.
  • the electric potential applied to each step of steps (B4) to (B9) may be the same or different or continuously changing.
  • the electric potential for step (B8) may be adjusted to facilitate the dissociation of the speed bump-test polynucleotide duplex segment.
  • the electric potential for step (B8) may be applied to move the ss test polynucleotide at a reversed direction compared to the ss test polynucleotide flow direction in step (B6) (forward direction) to move the speed bump-test polynucleotide duplex segment from the constriction area of the nanopore before applying another electric potential to move the polynucleotide at the forward direction to dissociate the speed bump-test polynucleotide duplex segment.
  • a dwelling time is provided for a polynucleotide duplex segment to stall inside the nanopore so that a nanopore detector can collect and read relevant sequence information.
  • the dwelling time typically depends on the nanopore detector and the working condition.
  • the dwelling time is at least about 10 ⁇ s, at least about 1 ms, at least about 10 ms, at least about 200 ms, at least about 500 ms, at least about 1 s, at least about 2 s, or at about least 5 s.
  • the longer the dwelling time is, the better the signal quality, and the more sequence information can be obtained.
  • a sequence of a small number of bases (less than 20 bases) anywhere within up to 100 bases (preferably up to 50 bases) in front of the stopping point can be read at one time when a polynucleotide duplex segment is stalled inside the nanopore for a dwelling time.
  • 1, 2, 3, 4, or 5 bases are read at a time within a larger polynucleotide sequence up to 50 bases at any nucleotide position 1-50 (e.g., at position 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, . . . 50 from the speed bump-ss test polynucleotide duplex segment).
  • a ss test polynucleotide comprising bulky structures formed on both ends is locked in a nanopore (steps (B1) to (B4)) and forms speed bump-test polynucleotide complex with multiple speed bumps (step (B5)).
  • a set of electrical signals of the ss test polynucleotide may be obtained each time the ss test polynucleotide is stalled by a speed bump-test polynucleotide duplex segment in the nanopore for a dwelling time, and then the speed bump-test polynucleotide duplex segment dissociates and the ss test polynucleotide moves forward until stalled by the next speed bump-test polynucleotide duplex segment (in FIG. 12 , the ss test polynucleotide is illustrated to move from cis side to trans side).
  • This stall-detect-disassociate-stall process is repeated until the ss test polynucleotide is stalled, slowed or stopped by the bulky structure of one end.
  • An example of electrical signals obtained is shown in FIG. 16 .
  • a random speed bump pool is present mainly on one side of the nanopore (e.g., C is side as shown in FIG. 13 ), and the method further comprising:
  • Step (B10) can be carried out under a working condition described herein.
  • the electric potential applied can be at a reduced value or a reverse polarity compared to the electric potential applied in step (B4) to (B9) to reverse the flow of the test polynucleotide.
  • the electric potential applied in each step can be the same or different or continuously changing.
  • a random speed bump pool is present in both sides of the nanopore and speed bumps bind to the ss test polynucleotide at the segment exposed to the speed bump pool in both sides of the nanopore (Cis and Trans sides as shown in FIG. 21 ).
  • the method of identifying a nucleotide sequence of a sample polynucleotide in a ss test polynucleotide described herein further comprising:
  • the second working condition can be a working condition as described herein.
  • the second working condition can have the same or different parameters compared to the first working condition.
  • the electric potential applied in step (1) can be at a reduced value or a reverse polarity compared to the electric potential applied in step (B9).
  • the electric potential applied in each step can be the same as applied in the earlier step, or different compared to the earlier step, or continuously changing.
  • a random speed bump pool comprises speed bumps that can bind to random sections of the ss test polynucleotide, each time when the ss test polynucleotide goes from one end stalled, slowed or stopped by BS1/BS2 to the other end according to the process described herein, speed bumps may bind to different combinations of ss test polynucleotide duplex segments ( FIG. 13 ), and can provide sequence information of different segments in the ss test polynucleotide ( FIG. 14 ).
  • step (B8) and/or step (B9) are/is repeated such that sequence information of each and every nucleotide of the sample polynucleotide in the ss test polynucleotide has been obtained
  • the sample polynucleotide can be constructed by overlapping the collected nucleotide sequence information.
  • more than one speed bump is linked by a non-biding linker (e.g. abasic oligonucleotide) to form speed bump train ( FIG. 22 ) such that the dissociation of each speed bump-test polynucleotide duplex segment will not cause the dissociation of the whole speed bump train from the ss test polynucleotide.
  • the non-binding linker is designed to be spaced by about 1 base, about 2 bases, about 3 bases, about 4 bases or about 5 bases.
  • the gap between known segments shown in FIG. 14 will be more likely to be the same as the length of the linker (e.g., about 1 base, about 2 bases, about 3 bases, about 4 bases or about 5 bases). It will be easier to construct the nucleic acid sequence of the sample polynucleotide in this case.
  • step (B2) further comprises:
  • a method as described herein is carried out according to a flowchart shown in FIG. 23 .
  • a ss test polynucleotide comprising PB1, PB2, DI1, DI2 and a sample polynucleotide has been constructed and placed on nanopore array (Block 10 , FIG. 23 ). Then BS1 is formed from PB1 on one end of the ss test polynucleotide at T1 (Block 20 , FIG. 23 ).
  • a first electric potential is applied to thread the ss test polynucleotide through a nanopore until the ss test polynucleotide is stalled, slowed or stopped by BS 1 wherein a set of electrical signals characterizing DI1 are collected (Block 30 , FIG. 23 ).
  • the temperature is then lowered to T2 to form BS2 from PB2 (Block 40 , FIG. 23 ).
  • a second electric potential that is lower than the first electric potential or opposite in polarity to the first electric potential is applied until the ss test polynucleotide is stalled, slowed or stopped by BS2 wherein a set of electrical signals characterizing DI2 are collected (Block 50 , FIG. 23 ).
  • the temperature is further lowered to Tw (Block 60 , FIG. 23 ), then contact a random speed bump pool with the ss test polynucleotide under a first working condition as described herein to form randomly bound speed bump-test polynucleotide complex (Block 70 , FIG. 23 ).
  • a third electric potential is applied, moving the speed bump-test polynucleotide complex through the nanopore until the ss test polynucleotide is stalled by a first speed bump-test polynucleotide duplex segment.
  • the ss test polynucleotide is stalled for a dwelling time during which a set of electrical signals are obtained, which will be used to characterize the sequence in front of the first speed bump-test polynucleotide duplex segment and the first base pair of the speed bump-test polynucleotide duplex segment in the flow direction of the ss test polynucleotide. Then the first speed bump-test polynucleotide duplex segment is dissociated and the ss test polynucleotide continues through the nanopore until stalled, slowed or stopped by the next speed bump-test polynucleotide duplex segment or BS 1.
  • a set of electrical signals designated to DI1 are collected when the ss test polynucleotide is stalled, slowed or stopped by BS1 in the nanopore (Block 80 , FIG. 23 ). Then a fourth electric potential that is at a reduced value or a reverse polarity to the third electric potential is applied until the ss test polynucleotide is stalled, slowed or stopped by BS2 wherein a set of electrical signals characterizing D12 are collected (Block 90 , FIG. 23 ). Then the steps in Blocks 70 to 90 are repeated until sufficient sequence information has been collected to characterize the sequence of the sample polynucleotide.
  • Another aspect of the disclosure relates to a method of obtaining sequence information of a ss test polynucleotide molecule as described herein.
  • the method comprises:
  • the test polynucleotide molecule is a ss test polynucleotide comprising one or more nucleotides as described herein, and the speed bumps comprise one or more nucleotides as described herein.
  • the ss test polynucleotide comprises PB1 as described herein.
  • step (C1) forms a speed bump-test polynucleotide complex having at least one speed bump-test polynucleotide duplex segment, wherein the speed bump forms a duplex with the test polynucleotide duplex segment that is up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 basepairs.
  • Steps (Cl) to (C5) can be carried out at a working condition as described herein.
  • a dwelling time for a nanopore detector to collect relevant sequence information is the same as described herein.
  • a speed bump pool comprises a first speed bump ( FIG.
  • a ss test polynucleotide comprising identifier 1 contacts the first speed bump, a first speed bump-identifier 1 duplex segment is formed to form a first speed bump-test polynucleotide complex.
  • the first speed bump-test polynucleotide complex goes through a nanopore until stalled by the first speed bump-identifier 1 duplex segment.
  • the nanopore detector obtains a first set of electrical signals.
  • the first speed bump-test polynucleotide complex dissociates and the ss test polynucleotide goes through the nanopore until stalled, slowed or stopped by BS 1 at the first end (i.e., in step (C4), the ss test polynucleotide flow through the nanopore smoothly until stalled, slowed or stopped by BS 1 without being stalled again in the nanopore).
  • the nanopore detector will obtain another set of electrical signals when the ss test polynucleotide is stalled, slowed or stopped by the BS 1 structure.
  • the ss test polynucleotide that comprises identifier 1 sequence provides two sets of electrical signals showing that it is stalled twice in the nanopore, while the ss test polynucleotide that does not comprise identifier 1 sequence provides one set of electrical signals showing it is stalled once in the nanopore (by BS1).
  • the ss test polynucleotide and/or the speed bumps can be constructed such that the first set of electrical signal obtained in step (C3) is distinctive from a set of electrical signals obtained when a primary nucleotide sequence is detected by the nanopore.
  • the known identifier sequence can comprise one or more nucleotide analogs having isodG and/or IsodC. In front of this identifier sequence is a known reading sequence that would be in the constriction zone of a pore if a speed bump was hybridized to the identifier sequence and stalled, slowed or stopped in the pore.
  • the reading sequence could comprise IsodC, IsodG and/or abasic positions that do not bind to natural nucleotides. Additionally, both the identifier sequence and the specific antisense speed bump sequence to the identifier would contain appropriate IsodG and IsodC so that only the specific speed bump to the identifier would hybridize to that location. Natural nucleotide speed bumps would not interfere or bind to the IsodG, IsodC-containing identifier sequence and natural nucleotide speed bumps would not interfere with the reading sequence. The resulting identification of the strand in the pore would occur independent of the presence of other natural or man-made nucleotide speed bumps.
  • the speed bump pool does not have to be substantially free of other speed bumps that can form complex with the ss test polynucleotide.
  • the first set of electrical signal obtained while the first speed bump-test polynucleotide duplex segment is stalled in the nanopore is distinctive from the other set of electrical signal obtained while the other speed bump-test polynucleotide duplex segments are stalled in the nanopore.
  • the presence of other speed bumps that can form complex with the ss test polynucleotide does not interfere with the detection of the distinctive signals generated from binding of the first speed bump with identifier 1 of the ss test polynucleotide.
  • the ss test polynucleotide and/or the speed bumps can be further constructed such that no other speed bumps binds to the identifier 1 segment as described herein.
  • other speed bumps that do not comprise isodG or isodC bases will not bind to the identifier 1 segment.
  • the ss test polynucleotide comprises more than one identifier
  • the speed bump pool comprises the speed bumps specific for the identifier(s) that is (are) to be detected, and optionally include speed bumps for other identifiers and/or other speed bumps that can bind to the ss test polynucleotide.
  • the identifier that binds to the identifier-specific speed bump and the sequence in front of the identifier in the flow direction of the ss test polynucleotide are both known.
  • the set of electrical signals obtained in step C3 can also be used to identify the sequence in front of the identifier in the flow direction of the ss test polynucleotide, which can in turn be used to identify of the identifier.
  • the method further comprises applying a first electric potential to flow the ss test polynucleotide through a nanopore, and forming a second bulky structure (BS2) on a second end of the ss test polynucleotide under a second condition as described herein.
  • the temperature of the first condition (T1) is higher than the temperature of the second condition (T2), which is higher than the working temperature Tw.
  • the temperature of the first condition (T1) is at least 10° C. higher or at least 20° C. higher than the temperature of the second condition (T2), which is at least about 1° C. higher, at least about 5° C. higher, at least about 10° C. higher, at least about 15° C. higher, at least about 20° C. higher, or at least about 25° C. higher than the working temperature Tw.
  • This method may comprise the following steps:
  • Such knowledge may facilitate identification/sequencing of the rest of the unknown sequence of the sample polynucleotide using the method described herein (e.g., using a random speed bump pool). Furthermore, the same process can be used to identify a sequence of the sample polynucleotide from another end. Thus, up to 30 bases of an unknown sample polynucleotide can be identified, which will provide a good reference in further identification/sequencing of the whole sequence of the sample polynucleotide.
  • Another aspect of the disclosure relates to a method of isolating a sample polynucleotide comprising:
  • the ss test polynucleotide further comprises an isolation tag as described herein, and the method further comprises step (D3) after Step (D2):
  • step (D3) further comprising:
  • the method further comprising step (D4) after step (D3):
  • step (D5) further comprises cleaving PB1 and PB2 using endonucleases. In some embodiments, step (D5) further comprises cleaving PB1 and PB2 at a cleavable site.
  • step (D1) further comprises:
  • Another aspect of the disclosure relates to a method of sequencing, identifying, concentrating and isolating of sample polynucleotides using multiple nanopore detectors.
  • the same method as described herein regarding single nanopore detector can be used to multiple nanopore detectors.
  • the multiple nanopores are individually addressable, wherein the electric potential of each nanopore can be individually controlled.
  • the temperature of the nanopore may also be controlled.
  • the ss test polynucleotide molecules detected in a nanopore can be individually released by carrying out steps (D1) to (D3) on selected nanopores.
  • each nanopore has a ss test polynucleotide trapped according to the method described herein, and the individual polynucleotide is numbered polynucleotide 1, polynucleotide 2, . . . polynucleotide 10 in the corresponding nanopores N1, N2, . . . N10. If only polynucleotide 1 and polynucleotide 3 are desired to be collected, nanopores N1, N2, . . .
  • N10 can be individually controlled such that only polynucleotide 1 and polynucleotide 3 are collected (e.g., by applying an electric potential to move polynucleotide 1 and polynucleotide 3 from nanopores N1 and N3 respectively).
  • BS2s of polynucleotide 1, polynucleotide 2, . . . polynucleotide 10 are converted to a structure that can go through the nanopores (e.g., PB2s at a temperature about or higher than the second temperature while lower than the first temperature, or cleaved to leave ss structure that can go through the nanopores, respectively).
  • nanopores N2, N4 to N10 are individually controlled such that polynucleotide 2, polynucleotide 4 to polynucleotide 10 are released from the nanopores respectively, while polynucleotide 1 and polynucleotide 3 are still trapped in nanopores N1 and N3, respectively. Then nanopores N1 and N3 are individually controlled to release polynucleotide 1 and polynucleotide 3, respectively to be collected, concentrated and/or isolated.
  • Nanopores may be used to sequence nucleic acid molecules indirectly, optionally with electrical detection.
  • Indirect sequencing may be any method where an incorporated nucleotide in a growing strand does not pass through the nanopore.
  • the nucleic acid molecule may pass within any suitable distance from and/or proximity to the nanopore, optionally within a distance such that tags released from nucleotide incorporation events are detected in the nanopore (e.g., as shown in FIG. 2C and FIG. 2D ).
  • the tag is pre-loaded into the nanopore before it is released (as shown in FIG. 2D ).
  • An example of sequencing of nucleic acid molecules with tags is described in PCT Patent Publication No. WO2012/083249, which is incorporated by reference in its entirety.
  • nucleotide incorporation events are the incorporation of a nucleotide into a growing polynucleotide chain. A byproduct may be correlated with the incorporation of a given type nucleotide.
  • the nucleotide incorporation events are generally catalyzed by an enzyme, such as DNA polymerase, and use base pair interactions with a template molecule to choose amongst the available nucleotides for incorporation at each location.
  • a nucleic acid sample may be sequenced using tagged nucleotides or nucleotide analogs.
  • a method for sequencing a nucleic acid molecule comprises (a) incorporating (e.g., polymerizing) tagged nucleotides, wherein a tag associated with an individual nucleotide is released upon incorporation, and (b) detecting the released tag with the aid of a nanopore.
  • the method further comprises directing the tag attached to or released from an individual nucleotide through the nanopore.
  • the released or attached tag may be directed by any suitable technique, in some cases with the aid of an enzyme (or molecular motor) and/or a voltage difference across the pore.
  • the released or attached tag may be directed through the nanopore without the use of an enzyme.
  • the tag may be directed by a voltage difference across the nanopore as described herein.
  • Methods, devices and systems of the disclosure may detect individual nucleotide incorporation events, such as upon the incorporation of a nucleotide into a growing strand that is complementary to a template.
  • An enzyme e.g., DNA polymerase, RNA polymerase, ligase
  • Enzymes e.g., polymerases
  • the added nucleotide can be complimentary to the corresponding template nucleic acid strand which is hybridized to the growing strand (e.g., polymerase chain reaction (PCR)).
  • a nucleotide can include a tag (or tag species) that is coupled to any location of the nucleotide including, but not limited to a phosphate (e.g., gamma phosphate), sugar or nitrogenous base moiety of the nucleotide.
  • tags are detected while tags are associated with a polymerase during the incorporation of nucleotide tags. The tag may continue to be detected until the tag translocates through the nanopore after nucleotide incorporation and subsequent cleavage and/or release of the tag.
  • nucleotide incorporation events release tags from the nucleotides which pass through a nanopore and are detected.
  • the tag can be released by the polymerase, or cleaved/released in any suitable manner including without limitation cleavage by an enzyme located near the polymerase.
  • the incorporated base may be identified (i.e., A, C, G, T or U) because a unique tag is released from each type of nucleotide (i.e., adenine, cytosine, guanine, thymine or uracil).
  • nucleotide incorporation events do not release tags.
  • a tag coupled to an incorporated nucleotide is detected with the aid of a nanopore.
  • the tag can move through or in proximity to the nanopore and be detected with the aid of the nanopore.
  • Methods and systems of the disclosure can enable the detection of nucleic acid incorporation events, such as at a resolution of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 100, 500, 1000, 5000, 10000, 50000, or 100000 nucleic acid bases (“bases”) within a given time period.
  • a nanopore device is used to detect individual nucleic acid incorporation events, with each event being associated with an individual nucleic acid base.
  • a nanopore device is used to detect an event that is associated with a plurality of bases.
  • a signal sensed by the nanopore device can be a combined signal from at least 2, 3, 4, or 5 bases.
  • the tags do not pass through the nanopore.
  • the tags can be detected by the nanopore and exit the nanopore without passing through the nanopore (e.g., exit from the inverse direction from which the tag entered the nanopore).
  • the chip can be configured to actively expel the tags from the nanopore.
  • the tags are not released upon nucleotide incorporation events.
  • nucleotide incorporation events “present” tags to the nanopore (i.e., without releasing the tags).
  • the tags can be detected by the nanopore without being released.
  • the tags may be attached to the nucleotides by a linker of sufficient length to present the tag to the nanopore for detection.
  • Nucleotide incorporation events may be detected in real-time (i.e., as they occur) and with the aid of a nanopore.
  • an enzyme e.g., DNA polymerase
  • a nucleotide incorporation event, or the incorporation of a plurality of nucleotides, may release or present one or more tag species (also “tags” herein), which may be detected by a nanopore. Detection can occur as the tags flow through or adjacent to the nanopore, as the tags reside in the nanopore and/or as the tags are presented to the nanopore.
  • an enzyme attached to or in proximity to the nanopore may aid in detecting tags upon the incorporation of one or more nucleotides.
  • Tags of the disclosure may be atoms or molecules, or a collection of atoms or molecules.
  • a tag may provide an optical, electrochemical, magnetic, or electrostatic (e.g., inductive, capacitive) signature, which signature may be detected with the aid of a nanopore.
  • Methods described herein may be single-molecule methods. That is, the signal that is detected is generated by a single molecule (i.e., single nucleotide incorporation) and is not generated from a plurality of clonal molecules. The method may not require DNA amplification.
  • Nucleotide incorporation events may occur from a mixture comprising a plurality of nucleotides (e.g., deoxyribonucleotide triphosphate (dNTP where N is adenosine (A), cytidine (C), thymidine (T), guanosine (G), or uridine (U)). Nucleotide incorporation events do not necessarily occur from a solution comprising a single type of nucleotide (e.g., dATP).
  • dNTP deoxyribonucleotide triphosphate
  • A adenosine
  • C cytidine
  • T thymidine
  • G guanosine
  • U uridine
  • Nucleotide incorporation events do not necessarily occur from alternating solutions of a plurality of nucleotides (e.g., dATP, followed by dCTP, followed by dGTP, followed by dTTP, followed by dATP).
  • a plurality of nucleotides e.g., dimers of AA, AG, AC, AT, GA, GG, GG, GC, GT, CA, etc. . . . .
  • a ligase are incorporated by a ligase.
  • a tagged nucleotide comprises a tag capable of being cleaved in a nucleotide incorporation event and detected with the aid of a nanopore.
  • the tag may be attached to the 5′-phosphate of the nucleotide.
  • the tag is not a fluorophore.
  • the tag may be detectable by its charge, shape, size, or any combination thereof. Examples of tags include various polymers.
  • Each type of nucleotide i.e., A, C, G, T
  • Each type of nucleotide i.e., A, C, G, T
  • Each type of nucleotide i.e., A, C, G, T
  • FIG. 25 provides an example of a tagged nucleotide.
  • R 1 is generally OH and R 2 is H (i.e., for DNA) or OH (i.e., for RNA), although other modifications are acceptable.
  • X is any suitable linker.
  • the linker is cleavable. Examples of linkers include without limitation, O, NH, S or CH 2 . Examples of suitable chemical groups for the position Z include O, S, or BH 3 .
  • the base is any base suitable for incorporation into a nucleic acid including adenine, guanine, cytosine, thymine, uracil, or a derivative thereof. Universal bases are also acceptable in some cases.
  • the number of phosphates (n) is any suitable integer value (e.g., a number of phosphates such that the nucleotide may be incorporated into a nucleic acid molecule).
  • a suitable integer value e.g., a number of phosphates such that the nucleotide may be incorporated into a nucleic acid molecule.
  • all types of tagged nucleotides have the same number of phosphates, but this is not required.
  • nucleotide e.g., A, C, T, G or U
  • the ability to distinguish one nucleotide from another is determined at least in part by the number of phosphates (with various types of nucleotides having a different value for n).
  • the value for n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or greater.
  • Suitable tags are described herein.
  • the tag has a charge which is reverse in sign relative to the charge on the rest of the compound.
  • the charge on the overall compound may be neutral. Release of the tag may result in two molecules, a charged tag and a charged nucleotide. The charged tag passes through a nanopore and is detected in some cases.
  • FIG. 26 More examples of suitable tagged nucleotides are shown in FIG. 26 .
  • the tag may be attached to the sugar molecule, the base molecule, or any combination thereof.
  • Y is a tag and X is a linker (optionally cleavable).
  • R 1 if present, is generally OH, —OCH 2 N 3 or —O-2-nitrobenzyl
  • R 2 if present, is generally H.
  • Z is generally O, S or BH 3
  • n is any integer including 1, 2, 3, or 4.
  • the A is O, S, CH2, CHF, CFF, or NH.
  • the type of base on each dNPP analogue is generally different from the type of base on each of the other three dNPP analogues
  • the type of tag on each dNPP analogue is generally different from the type of tag on each of the other three dNPP analogues.
  • Suitable bases include, but are not limited to adenine, guanine, cytosine, uracil or thymine, or a derivative of each thereof. In some cases, the base is one of 7-deazaguanine, 7-deazaadenine or 5-methylcytosine.
  • the methods optionally further comprise treating the incorporated dNPP analogue so as to remove the —CH 2 N 3 and result in an OH group attached to the 3′ position thereby permitting incorporation of a further dNPP analogue.
  • the methods optionally further comprise treating the incorporated nucleotide analogue so as to remove the ⁇ 2-nitrobenzyl and result in an OH group attached to the 3′ position thereby permitting incorporation of a further dNPP analogue.
  • a tag may be any chemical group or molecule that is capable of being detected in a nanopore.
  • a tag comprises one or more of ethylene glycol, an amino acid, a carbohydrate, a peptide, a dye, a chemilluminiscent compound, a mononucleotide, a dinucleotide, a trinucleotide, a tetranucleotide, a pentanucleotide, a hexanucleotide, an aliphatic acid, an aromatic acid, an alcohol, a thiol group, a cyano group, a nitro group, an alkyl group, an alkenyl group, an alkynyl group, an azido group, or a combination thereof.
  • the tag further comprises appropriate number of lysines or arginines to balance the number of phosphates in the compound.
  • the tag is a polymer.
  • Polyethylene glycol (PEG) is an example of a polymer and has the structure as follows:
  • W is an integer between 0 and 100. In some cases, the number of ethylene glycol units is different for each type of nucleotide. In an embodiment, the four types of nucleotides comprise tags having 16, 20, 24 or 36 ethylene glycol units. In some cases, the tag further comprises an additional identifiable moiety, such as a coumarin based dye. In some cases, the polymer is charged. In some instances, the polymer is not charged and the tag is detected in a high concentration of salt (e.g., 3-4 M).
  • a high concentration of salt e.g., 3-4 M.
  • alkyl includes both branched and straight-chain saturated aliphatic hydrocarbon groups having the specified number of carbon atoms and may be unsubstituted or substituted.
  • alkenyl refers to a non-aromatic hydrocarbon radical, straight or branched, containing at least 1 carbon to carbon double bond, and up to the maximum possible number of non-aromatic carbon-carbon double bonds may be present, and may be unsubstituted or substituted.
  • alkynyl refers to a hydrocarbon radical straight or branched, containing at least 1 carbon to carbon triple bond, and up to the maximum possible number of non-aromatic carbon-carbon triple bonds may be present, and may be unsubstituted or substituted.
  • substituted refers to a functional group as described above such as an alkyl, or a hydrocarbyl, in which at least one bond to a hydrogen atom contained therein is replaced by a bond to non-hydrogen or non-carbon atom, provided that normal valencies are maintained and that the substitution(s) result(s) in a stable compound.
  • Substituted groups also include groups in which one or more bonds to a carbon(s) or hydrogen(s) atom are replaced by one or more bonds, including double or triple bonds, to a heteroatom.
  • tags may be attached to the terminal phosphate by (a) contacting a nucleotide triphosphate with dicyclohexylcarbodiimide/dimethylformamide under conditions permitting production of a cyclic trimetaphosphate; (b) contacting the product resulting from step a) with a nucleophile so as to form an —OH or —NH 2 functionalized compound; and (c) reacting the product of step b) with a tag having a —COR group attached thereto under conditions permitting the tag to bond indirectly to a terminal phosphate thereby forming the nucleotide triphosphate analogue.
  • the nucleophile is H 2 N—R—OH, H 2 N—R—NH 2 , R′S—R—OH, R′S—R—NH 2 , or
  • the method comprises, in step b), contacting the product resulting from step a) with a compound having the structure:
  • step b) may then be reacted with a tag having a —COR group attached thereto under conditions permitting the tag to bond indirectly to a terminal phosphate thereby forming the nucleotide triphosphate analogue having the structure:
  • R 1 is OH
  • R 2 is H or OH
  • the base is adenine, guanine, cytosine, thymine, uracil, a 7-deazapurine or a 5-methylpyrimidine.
  • a tag may be released in any manner.
  • the tag is attached to polyphosphate (e.g., FIG. 25 ) and incorporation of the nucleotide into a nucleic acid molecule results in release of a polyphosphate having the tag attached thereto.
  • the incorporation may be catalyzed by at least one polymerase, optionally attached to the nanopore.
  • at least one phosphatase enzyme is also attached to the pore.
  • the phosphatase enzyme may cleave the tag from the polyphosphate to release the tag.
  • the phosphatase enzymes are positioned such that pyrophosphate produced by the polymerase in a polymerase reaction interacts with the phosphatase enzymes before entering the pore.
  • the tag is not attached to polyphosphate (see, e.g., FIG. 26 ).
  • the tag is attached by a linker (X), which is optionally cleavable.
  • linker Methods for production of cleavably capped and/or cleavably linked nucleotide analogues are disclosed in U.S. Pat. No. 6,664,079, which is entirely incorporated herein by reference. The linker need not be cleavable.
  • the linker may be any suitable linker and optionally cleaved in any suitable manner.
  • the linkers may be photocleavable.
  • UV light is used to photochemically cleave the photochemically cleavable linkers and moieties.
  • the photocleavable linker is a 2-nitrobenzyl moiety.
  • the —CH 2 N 3 group may be treated with TCEP (tris(2-carboxyethyl)phosphine) so as to remove it from the 3′ O atom of a dNPP analogue, or rNPP analogue, thereby creating a 3′ OH group.
  • TCEP tris(2-carboxyethyl)phosphine
  • a polymerase draws from a pool of tagged nucleotides comprising a plurality of different bases (e.g., A, C, G, T, and/or U). It is also possible to iteratively contact the polymerase with the various types of tagged bases. In this case, it may not be necessary that each type of nucleotide have a unique base, but the cycling between different base types adds cost and complexity to the process in some cases, nevertheless this embodiment is encompassed in the present invention.
  • bases e.g., A, C, G, T, and/or U.
  • FIG. 27 shows that incorporation of the tagged nucleotide into a nucleic acid molecule (e.g., using a polymerase to extend a primer base paired to a template) can release a detectable TAG-polyphosphate in some embodiments.
  • the TAG-polyphosphate is detected as it passes through the nanopore. In some embodiments, the TAG-polyphosphate is detected as it resides in the nanopore.
  • the method distinguishes the nucleotide based on the number of phosphates comprising the polyphosphate (e.g., even when the TAGs are identical). Nevertheless, each type of nucleotide generally has a unique tag.
  • the TAG-polyphosphate compound may be treated with phosphatase (e.g., alkaline phosphatase) before passing the tag into and/or through a nanopore and measuring the ionic current.
  • phosphatase e.g., alkaline phosphatase
  • Tags may flow through a nanopore after they are released from the nucleotide.
  • a voltage is applied to pull the tags through the nanopore.
  • At least about 85%, at least 90%, at least 95%, at least 99%, at least 99.9 or at least 99.99% of the released tags may translocate through the nanopore.
  • the tags reside in the nanopore for a period of time where they are detected. In some instances, a voltage is applied to pull the tags into the nanopore, detect the tags, expel the tags from the nanopore, or any combination thereof. The tags can be released or remain bound to the nucleotide upon nucleotide incorporation events.
  • the tag may be detected in the nanopore (at least in part) because of its charge.
  • the tag compound is an alternatively charged compound which has a first net charge and, after a chemical, physical or biological reaction, a different second net charge.
  • the magnitude of the charge on the tag is the same as the magnitude of the charge on the rest of the compound.
  • the tag has a positive charge and removal of the tag changes the charge of the compound.
  • the tag may generate an electronic change.
  • the electronic change is a change in current amplitude, a change in conductance of the nanopore, or any combination thereof.
  • the nanopore may be biological or synthetic. It is also contemplated that the pore is proteinaceous, for example wherein the pore is an alpha hemolysin protein.
  • An example of a synthetic nanopore is a solid-state pore or graphene.
  • polymerase enzymes and/or phosphatase enzymes are attached to the nanopore.
  • Fusion proteins or disulfide crosslinks are example of methods for attaching to a proteinaceous nanopore.
  • the attachment to the surface near the nanopore may be via biotin-streptavidin linkages.
  • the DNA polymerase is attached to a solid surface via gold surface modified with an alkanethiol self-assembled monolayer functionalized with amino groups, wherein the amino groups are modified to NHS esters for attachment to amino groups on the DNA polymerase.
  • the method may be performed at any suitable temperature.
  • the temperature is between 4° C. and 10° C. In some embodiments, the temperature is ambient temperature.
  • the method may be performed in any suitable solution and/or buffer.
  • the buffer is 300 mM KCl buffered to pH 7.0 to 8.0 with 20 mM HEPES.
  • the buffer does not comprise divalent cations. In some cases, the method is unaffected by the presence of divalent cations.
  • Double stranded nucleic acid molecules may have a sense strand and an anti-sense strand that hybridize (e.g., bind to each other) according to well known base pair interactions (e.g., A with T and G with C).
  • the sense strand and anti-sense strand wrap around each other in a well known alpha-helical configuration.
  • the sense strand is the strand that encodes an amino acid according to well known codons used by most organisms (e.g., from the 5′ to 3′ direction, TCA generally encodes for the amino acid serine, etc. . . . ).
  • the designation of which strand is the sense strand and which is the anti-sense strand can be arbitrary. Not all nucleic acids encode for proteins.
  • nucleic acid sequence of the anti-sense strand can be used to determine and/or verify the sequence of the sense strand (e.g., from the 5′ to 3′ direction) (e.g., because of the known base pair interactions). Furthermore, sequencing both the sense strand and the anti-sense strand to determine the sequence of a double stranded nucleic acid molecule may have certain advantages.
  • sequence of either the sense strand or the anti-sense strand may be easier to determine the sequence of either the sense strand or the anti-sense strand (e.g., for any reason or an unknown reason—examples include but are not limited to (a) one strand may form secondary structures not formed by the other strand or (b) the signal from one strand is relatively stronger and/or more well resolved than the signal from the other strand).
  • the sequence signals and/or information obtained from one strand can be complimentary to the sequence signals and/or information obtained from the other strand (e.g., a base that is not readily resolved on one strand may be readily resolved on the other strand).
  • Nucleic acid molecules can have various types of mutations and/or mismatches.
  • a base pair mismatch may be present where any number of base positions (e.g., 1, 2, 3, 4, 5, 6, 7, or more) are not complimentary between the two strands (e.g., an A on the sense strand and a G on the anti-sense strand).
  • one strand can have an insertion or deletion of base positions relative to the other strand (e.g., the sense strand has a sequence ACCTCGAT that is not base paired with the anti-sense strand).
  • the sense strand and the anti-sense strand can be base paired in the 5′ direction from the deletion and/or insertion, in the 3′ direction from the deletion and/or insertion, or in both directions.
  • the double stranded nucleic acid molecule may contain information (e.g., epigenetic markers such as methylated bases) that is only found on one of the strands. In this case, one can sequence both the sense strand and the anti-sense strand to detect the epigenetic information (e.g., methylated bases).
  • the ends of the sense strand and the anti-sense strand can be ligated together to form a single-stranded nucleic acid molecule to be sequenced that contains both the sense strand and the anti-sense strand.
  • the single stranded nucleic acid molecule can be sequenced by passing it through a nanopore (e.g., as shown in FIG. 2B ) or passing it adjacent to a nanopore where tag molecules are detected (e.g., as shown in FIG. 2C and FIG. 2D ).
  • a method for sequencing a nucleic acid molecule or portion thereof comprises (a) providing a double stranded nucleic acid molecule comprising a sense strand and an anti-sense strand; (b) ligating a first nucleic acid segment on a first end of the double stranded nucleic acid molecule that links the sense strand with the anti-sense strand; (c) dissociating the double stranded nucleic acid to provide a single stranded nucleic acid molecule comprising a sense portion of said sense strand and an anti-sense portion of said anti-sense strand; (d) passing the single stranded nucleic acid molecule through or in proximity to a nanopore in a membrane that is disposed adjacent or in proximity to an electrode, (e) using the electrode, obtaining current measurements while passing the single stranded nucleic acid molecule through or in proximity to the nanopore; and (f) determining the sequence of the double stranded nucleic acid from the
  • the first nucleic acid segment can have a nucleic acid hairpin (e.g., Linker Section in FIG. 28 ).
  • the hairpin can have a non-base paired hairpin structure located between two segments of a hairpin duplex (HD) comprising base paired (double stranded) nucleic acid.
  • the first nucleic acid segment can further comprise a first identifier. The first identifier can identify from which sample the double stranded nucleic acid molecule is derived.
  • the method further comprises ligating a second nucleic acid segment onto the second end of the double stranded nucleic acid (e.g., Pre-bulky Section in FIG. 28 ).
  • the second nucleic acid segment comprises a portion capable of trapping the single stranded nucleic acid molecule in the nanopore (e.g., first and/or second pre-bulky structure).
  • the second nucleic acid segment is capable of trapping the single stranded nucleic acid molecule in the nanopore below a certain temperature (e.g., when the temperature is below about 60° C., below about 50° C., below about 40° C., below about 30° C., below about 20° C., below about 10° C., below about 0° C., or below about ⁇ 10° C.).
  • the second nucleic acid segment comprises a second identifier (e.g., capable of being used to determine whether the single stranded nucleic acid molecule is passing through the nanopore in a first direction or in a second direction).
  • the rate of passage of the single stranded nucleic acid molecule through or in proximity to the nanopore is slowed with the aid of one or more speed bump molecules as described herein.
  • Current measurements can be obtained when the rate of passage of the single stranded nucleic acid molecule is slowed.
  • current measurements are made at a plurality of voltages applied across the nanopore and/or across the membrane.
  • an individual speed bump molecule of said one or more speed bump molecules comprises ribonucleic acid.
  • the present invention is directed to a method for obtaining sequence and/or structure information of a sample polynucleotide using a nanopore detector and a test polynucleotide comprising both the sample polynucleotide structure and the antisense polynucleotide thereof.
  • the test polynucleotide can be trapped in the nanopore by a stopper-test polynucleotide segment for a dwelling time. During this dwelling time, a constant electric potential or a varied electric potential profile comprising electric potentials having more than one voltage are applied to the electrodes of the nanopore detector and a set of electrical signals are obtained.
  • the electrical potential can be varied according to a waveform (e.g., the waveforms shown in FIG. 29 ).
  • the electrical signals collected under the constant or varied electric potential profile may provide information of the sequence and/or structure that is in front of the stopper-test polynucleotide segment in the flow direction of the test polynucleotide.
  • the electrical signals collected from different sequences and/or structures of the sample polynucleotide may be difficult to resolve with high confidence.
  • taking the electrical signals collected from the sample polynucleotide and the corresponding antisense polynucleotide together may improve the confidence in resolving the sequences and/or structures in the sample polynucleotide.
  • Characterizing the sample polynucleotide and the corresponding antisense polynucleotide in the same nanopore may also lower the systematic error by collecting singnals from the same nanopore at about the same time. Previous methods analyze only the sample polynucleotide. Thus, the electrical signals collected from reading the sample polynucleotide and the antisense polynucleotide thereof may provide a more reliable and accurate determination of the sample polynucleotide sequence and/or structure than the currently available methods.
  • One aspect of the present invention relates to a method of obtaining structure information of a sample, comprising,
  • both the first and second pre-bulky structures are polynucleotide/oligonucleotide pre-bulky structures.
  • the first pre-bulky structure forms the corresponding first bulky structure at a first temperature.
  • the second pre-bulky structure forms the corresponding second bulky structure at a second temperature. And the first temperature is higher than the second temperature.
  • the first pre-bulky structure is a polynucleotide and/or oligonucleotide pre-bulky structure that forms the first bulky structure via interaction with a ligand specific to the first pre-bulky structure.
  • the formation of the first bulky structure is temperature-independent.
  • the second pre-bulky structure can be such that the conversion between the pre-bulky structure and the corresponding bulky structure is temperature-dependent.
  • the first pre-bulky structure comprising a biotin modified polynucleotide and/or oligonucleotide forms the first bulky structure via binding to streptavidin via biotin/streptavidin interaction.
  • the formation of the first bulky structure can be temperature independent.
  • a ds test polynucleotide described herein comprises a sample polynucleotide, an antisense polynucleotide of the sample polynucleotide
  • antisense polynucleotide a linker linking the sample polynucleotide and the antisense polynucleotide thereof (sections I3-HD-hairpin-HD′-I3′), a first pre-bulky structure, a second pre-bulky structure, a first direction identifier (DI1) to indicate the proper formation of the first bulky structure ( FIG. 28 ).
  • Each of the sections I2, I13, I2′ and I3′ optionally comprises one or more identifiers described herein.
  • HD1 and HD l′ together are a polynucleotide duplex.
  • Section DI-1 comprises a first direction identifier and optionally one or more other identifiers.
  • Section LI comprises a low temperature direction identifier and optionally one or more other identifiers.
  • Sections 12-HI may or may not be completely complementary to sections 12′-LI, but at least a portion thereof forms a duplex structure.
  • the duplex section between sections 12-HI and 12′-LI can be in close proximity, and more preferably adjacent, to the end of the ds sample polynucleotide section ( FIG. 28 ).
  • the ds test polynucleotide can be converted into a ss test polynucleotide by conventional denaturing technique well known in the art (e.g. by heat).
  • the sample polynucleotide can be a DNA or RNA polynucleotide; and the antisense polynucleotide is a DNA or RNA polynucleotide that is complementary to the sample polynucleotide.
  • the linker section linking the sample polynucleotide and the antisense sample polynucleotide on the first end of the sample duplex section by: (a) linking the 3′ end of the sample polynucleotide and the 5′ end of the antisense sample polynucleotide, and/or (b) linking the 5′ end of the sample polynucleotide and the 3′ end of the antisense sample polynucleotide.
  • the test polynucleotide has 1 to about 10,000 bases, 1 to about 1,000 bases, 1 to about 500 bases, 1 to about 300 bases, 1 to about 200 bases, 1 to about 100 bases, about 5 to about 10,000 bases, about 5 to about 1,000 bases, about 5 to about 500 bases, about 5 to about 300 bases, 5 to about 200 bases, 5 to about 100 bases, 10 to about 10,000 bases, 10 to about 1,000 bases, 10 to about 500 bases, 10 to about 300 bases, 10 to about 200 bases, 10 to about 100 bases, 20 to about 10,000 bases, 20 to about 1,000 bases, 20 to about 500 bases, 20 to about 300 bases, 20 to about 200 bases, 20 to about 100 bases, 30 to about 10,000 bases, 30 to about 1,000 bases, 30 to about 500 bases, 30 to about 300 bases, 30 to about 200 bases, 30 to about 100 bases, 30 to about 50 bases, 50 to about 10,000 bases, 50 to about 1,000 bases, 50 to about 500 bases, 50 to about 300 bases, 50 to about 200 bases, or 50 to about 100 bases.
  • the stopper can be a speed bump (e.g., oligonucleotide) described herein, and the ss test polynucleotide can comprise a section of ss polynucleotide that is to be bound by the speed bump in a method described herein.
  • the test polynucleotide is a test DNA or RNA
  • the speed bump is a DNA or RNA speed bump.
  • a speed bump can have a length of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferred 10 or less, 8 or less, 6 or less and 4 or less.
  • the speed bump may comprise one or more nucleotides selected from the group consisting of universal nucleotides, locked nucleotides, primary nucleotides, modifications thereof, and combinations thereof. Modifications of universal nucleotides, and primary nucleotides include modifications at the nucleobase structures, the backbone structures (e.g. glycol nucleotides, morpholinos, and locked nucleotides) and combinations thereof. In another preferred embodiment, the backbone structures of the speed bump is modified (e.g. glycol nucleotides, morpholinos, and locked nucleotides) at designated position(s), random positions or combinations thereof.
  • the first base pair of the speed bump-test polynucleotide segment may be partially or completely in the nanopore and contributes to the electrical signals obtained in step (G7).
  • step (G8) further comprises obtaining structure information of the first base pair of the speed bump-test polynucleotide segment in the flow direction of the ss test polynucleotide.
  • the speed bumps it is preferred to construct the speed bumps to have a universal nucleotide which base-pair with all primary nucleobases (A, T, C, G and U) at the 5′ and/or 3′ end to normalize the contribution of the first base pair of the speed bump-test polynucleotide segment and makes the signals easier to analyze.
  • the stopper can be an enzyme that binds to the ss test polynucleotide at a duplex section created by hybridization of the ss test polynucleotide and a primer, and optionally moves the ss test polynucleotide through the nanopore and causes the reading of the test polynucleotide either by staying associated with the test polynucleotide during the reading process in the pore, or by disassociating after a single nucleotide extension of the antisense strand of the test polynucleotide and subsequently inserting the newly created sample/antisense duplex into the pore to read one base different than the prior duplex sample strand read.
  • enzymes include, without limitation, Klenow-exo minus; Phi29 polymerase; Phi29-exo minus polymerase; T4 DNA polymerase; M-MuLV Reverase Transcriptase; and T7 Gp4a Helicase.
  • the stopper is an enzyme; the ss test polynucleotide further comprises an enzyme binding site for the enzyme to bind to the ss test polynucleotide.
  • enzyme binding site may exist in sections DI1, DI2, I2 or I2′, and preferably in DI1 or I2, to ensure that all sample polynucleotide and antisense polynucleotide can be characterized by the nanopore.
  • the first base pair of the stopper-test polynucleotide segment may be partially or completely in the nanopore, the electrical signals obtained in step (G7), step (G8) further comprising determining the first base pair of the stopper-test polynucleotide segment in the flow direction of the ss test polynucleotide.
  • the structure in front of the stopper-test polynucleotide segment determined in step (G8) is a 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 to 50 bases, 50 to 100 bases, 100 to 200 bases, 200 to 500 bases, or greater than a 500 base sequence.
  • the structure in front of the stopper-test polynucleotide segment determined in step (G8) is any nucleotide sequence at position 1-50, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30, or a combination thereof from the stopper-test polynucleotide segment.
  • the electric potential profile applied in step (G7) is a constant electric potential profile having a voltage of about 160 mV to about ⁇ 160 mV, about 160 mV to about 0 mV, about 160 mV to about 60 mV, about 100 mV to about 0 mV, 100 mV to about 80 mV, or 80 mV to about 70 mV.
  • the electric potential profile applied in step (G7) is a varied electric potential profile comprising electric potentials having two or more voltages each applied for a certain time.
  • the varied electric potential profile comprises one or more electric potentials resulted during step (G6) or after the stopper-test polynucleotide complex is stalled, slowed or stopped in the nanopore in step (G6).
  • At least two electric potentials of the two or more electric potentials applied have a difference of more than about 1 mV, 5 mV, 10 mV, or 30 mV.
  • the electric potentials have a voltage of about 160 mV to about ⁇ 160 mV, about 160 mV to about 0 mV, about 160 mV to about 60 mV, about 100 mV to about 0 mV, 100 mV to about 80 mV, or 80 mV to about 70 mV.
  • the time for each electric potential can be at least about 5 ⁇ s, at least about 10 ⁇ s, at least about 50 ⁇ s, at least about 100 ⁇ s, at least about 500 ⁇ s, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 50 ms, at least about 100 ms, at least about 500 ms, at least about 1 s, or at least about 2 s.
  • the varied electric potential profile applied in step (G7) comprises an electric potential ramp changing from a first electric potential to a second electric potential over a certain time period.
  • the varied electric potential profile can comprise one or more electric potentials resulted during step (G6) or after the stopper-test polynucleotide complex is stalled, slowed or stopped in the nanopore in step (G6).
  • the first electric potential of the varied electric potential profile can be an electric potential resulted during step (G6) or after the stopper-test polynucleotide complex is stalled, slowed or stopped in the nanopore in step (G6).
  • the difference between the highest electric potential and the lowest electric potential of the varied electric potential profile is more than about 1 mV, 5 mV, 10 mV, 20 mV, or 30 mV.
  • the first electric potential is about 160 mV and the second electric potential is about ⁇ 160 mV.
  • the first electric potential is about 160 mV and the second electric potential is about 60 mV.
  • the first electric potential is about 100 mV and the second electric potential is about 0 mV.
  • the first electric potential is about 160 mV
  • the second electric potential is about 0 mV.
  • the first electric potential is about 100 mV and the second electric potential is about 80 mV.
  • the first electric potential is about 100 mV and the second electric potential is about 90 mV. In another embodiment, the first electric potential is about 90 mV and the second electric potential is about 85 mV.
  • the predetermined time period is at least about 5 ⁇ s, at least about 10 ⁇ s, at least about 50 ⁇ s, at least about 100 ⁇ s, at least about 500 ⁇ s, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 50 ms, at least about 100 ms, at least about 500 ms, at least about 1 s, or at least about 2 s.
  • the varied electric potential profile applied in step (G7) comprises an electric potential waveform changing from a first electric potential to a second electric potential to a third electric potential and so on to a plurality of electric potentials that in total form a varied applied electric potential waveform.
  • step (G7) is performed in a solution having at least 0.1M salt.
  • the salt is selected from the group consisting of chloride, phosphate, nitrate and sulfate.
  • step (G7) is performed in a solution having a pH of about 6.5 to about 8.5 or from about 7 to about 8.
  • Any buffer that can provide such pH can be used. Examples include, without limitation, HEPES buffer.
  • the nanopore is an alpha hemolysin nanopore or a MspA nanopore.
  • the nanopore detector comprises at least one metal electrode embedded in an isolation surface.
  • the materials the metal electrode comprises include, without limitation, silver, sliver chloride, platinum, gold, ruthenium and nickel.
  • the materials the isolation surface comprises include, without limitation, a plastic material (e.g. Teflon), a glass, or a semiconductor material (e.g. silicon, germanium, and gallium).
  • the isolation surface is further modified to be hydrophobic and lipophilic using methods known in the art to facilitate attachment of biological molecules to the isolation surfaces. For example, further silanization with silane molecules containing 6 to 20 carbon-long chains (e.g.
  • octadecyl-trichlorosilane, octadecyl-trimethoxysilane, or octadecyl-triethoxysilane) or DMOCs can be done on silicon dioxide surface on a silicon surface.
  • the structure that is in front of the stopper-test polynucleotide segment in the flow direction of the test polynucleotide in step (G7) can be determined according to the information gathered from the sample polynucleotide and the corresponding complementary structure in the antisense polynucleotide thereof.
  • the reliability and accuracy of the reading is improved by gathering information from both the sample polynucleotide and the antisense polynucleotide.
  • certain structures providing similar signals in step (G7) can be further differentiated from each other by the corresponding complementary structure in the antisense polynucleotide.
  • a single nucleotide difference of the structure that is in front of the stopper-test polynucleotide segment in the flow direction of the test polynucleotide can be characterized in step (G7).
  • C and T can be determined with high confidence (>about 97%, >about 99% and preferably >99.5% confidence).
  • G and A can be characterized with a lower confidence (about 90 to 95% confidence).
  • the complementary structures of G and A are C and T, respectively.
  • determining the C's and T's in both the sample DNA and the antisense strand provides the structure of the sample DNA with a higher confidence (>99%, preferably >99.5% confidence) than determining all four nucleotides A, C, T and G from information collected from the sample DNA only (about 95% confidence).
  • the nanopore is an alpha hemolysin nanopore
  • the polynucleotide characterized is a DNA or RNA
  • the electric potential(s) applied in steps (G6 to G7), either in a constant profile or a varied profile is at least about 10 mV, at least about 50 mV, at least about 60 mV, about 60 mV to about 160 mV, preferably at least about 90 mV, at least about 100 mV, more preferably about 100 mV to about 160 mV.
  • a single nucleotide difference of the structure that is in front of the stopper-test polynucleotide segment in the flow direction of the test polynucleotide can be characterized in step (G7).
  • C and A can be determined with high confidence (>about 98%, preferably >99.5% confidence).
  • G and T can be characterized with a lower confidence (about 95% confidence).
  • the complementary structures of G and T are C and A, respectively.
  • the nanopore is an alpha hemolysin nanopore
  • the polynucleotide characterized is a DNA or RNA
  • the electric potential(s) applied in steps (G6 to G7), either in a constant profile or a varied profile is less than about 140 mV, less than about 80 mV, about 0 mV to about 140 mV, preferably less than about 100 mV, less than about 70 mV, more preferably about 0 mV to about 70 mV.
  • a two-nucleotide dimer of the structure that is in front of the stopper-test polynucleotide segment in the flow direction of the test polynucleotide can be determined in step (G7). Characterizing the dimers in both the sample DNA and the antisense strand provides the structure of the sample DNA with a higher confidence (> about 97%, or >about 99%, preferably >99.5% confidence) than determining all dimers from the sample DNA only (>about 90%, or >about 95% confidence).
  • such two-nucleotide dimer is suspending in the constriction site of an alpha hemolysin pore in step (G7).
  • Another aspect of the present invention relates to a method of obtaining sequence information of multiple single-stranded (ss) test polynucleotides in an array format.
  • “Multiple” refers to more than 1, preferably more than 10, 100, 1,000, 100,000, 1 million, 10 millions, or 100 millions.
  • the method comprises:
  • the method can comprise providing a chip comprising at least one nanopore in a membrane that is disposed adjacent or in proximity to an electrode.
  • the electrode can be adapted to detect a current passing through the nanopore.
  • the method can include inserting a molecule or portion thereof into the nanopore and applying a voltage applied across the nanopore and/or across the membrane.
  • the molecule or portion thereof can affect (and be identified by) the current. It is recognized herein that the current measured at a single voltage may be inadequate to identify the molecule or portion thereof.
  • the methods described herein comprise measuring measuring the current at a plurality of voltages to identify the molecule or portion thereof.
  • the current at a plurality of voltages comprises an electronic signature and further comprises comparing the electronic signature to a plurality of reference electronic signatures to identify the molecule or portion thereof.
  • the portions of the polymer molecule are identified in the sequence at which they are along the length of the polymer molecule and/or the molecules are identified in the order at which the nucleotides are incorporated into the growing nucleic acid chain.
  • the methods described herein involving measuring current at a plurality of voltages can be used with nanopores in any application.
  • molecules can be identified as shown in FIG. 2A .
  • the molecule is a polymer molecule (e.g., a nucleic acid molecule, protein, carbohydrate) and portions of the polymer are identified, optionally in the sequence in which they appear on the polymer (e.g., the polymer is sequenced).
  • the polymer flows through the nanopore as shown in FIG. 2B .
  • the polymer is a nucleic acid molecule and the polymer does not flow through the nanopore.
  • a nucleic acid molecule can be sequenced by passing it adjacent to a nanopore where tag molecules are detected (e.g., as shown in FIG. 2C and FIG. 2D ).
  • the voltage is varied according to a voltage waveform.
  • the voltage waveform can be any waveform including a square wave, a sinusoidal wave, a triangular wave, a saw-tooth wave, or an irregular wave.
  • FIG. 29 shows some suitable waveforms.
  • the voltage is varied by applying an alternating current (AC) waveform to the nanopore and/or membrane.
  • the AC waveform can have any suitable frequency.
  • the frequency is about 0.1 hertz (Hz), about 0.5 Hz, about 1 Hz, about 5 Hz, about 10 Hz, about 50 Hz, about 100 Hz, about 500 Hz, about 1000 Hz, about 5000 Hz, about 10000 Hz, about 50000 Hz, about 100000 Hz, about 500000 Hz, or about 1000000 Hz.
  • the frequency is at least about 0.1 hertz (Hz), at least about 0.5 Hz, at least about 1 Hz, at least about 5 Hz, at least about 10 Hz, at least about 50 Hz, at least about 100 Hz, at least about 500 Hz, at least about 1000 Hz, at least about 5000 Hz, at least about 10000 Hz, at least about 50000 Hz, at least about 100000 Hz, at least about 500000 Hz, or at least about 1000000 Hz.
  • Hz hertz
  • the frequency is at most about 0.1 hertz (Hz), at most about 0.5 Hz, at most about 1 Hz, at most about 5 Hz, at most about 10 Hz, at most about 50 Hz, at most about 100 Hz, at most about 500 Hz, at most about 1000 Hz, at most about 5000 Hz, at most about 10000 Hz, at most about 50000 Hz, at most about 100000 Hz, at most about 500000 Hz, or at most about 1000000 Hz.
  • Hz hertz
  • the voltage is varied such that the molecule or portion thereof is identified with high statistical confidence. In some instances, the molecule or portion thereof is identified with a statistical confidence of about 90%, about 95%, about 99%, about 99.9%, about 99.99%, or about 99.999%. In some instances, the molecule or portion thereof is identified with a statistical confidence of at least about 90%, at least about 95%, at least about 99%, at least about 99.9%, at least about 99.99%, or at least about 99.999%.
  • the chip comprises a plurality of nanopores adjacent or in proximity to a plurality of electrodes and the electrodes (i) are individually addressed, (ii) the voltage applied is individually controlled, or (ii) both (i) and (ii).
  • the voltage can be varied over any suitable range including from about 120 mV to about 150 mV or from about 40 mV to about 150 mV.
  • the molecule can be a double stranded nucleic acid molecule, in which case the molecule can be dissociated to form one or more single-stranded nucleic acid molecules, and the one or more single-stranded nucleic acid molecules can be passed through the nanopore to determine the sequence of the double stranded nucleic acid molecule.
  • nanopores include the alpha hemolysin nanopore and the Mycobacterium smegmatis (MspA) nanopore.
  • the rate of passage of the polymer molecule through the nanopore is slowed with the aid of one or more speed bump molecules where portions of the polymer molecule are identified when the rate of passage of the polymer molecule is slowed.
  • an individual speed bump molecule comprises ribonucleic acid.
  • the polymer molecule is trapped in the nanopore (e.g., the polymer molecule is a single stranded nucleic acid molecule and the molecule is trapped in the nanopore by bulky structures formed on either side of the nanopore).
  • the polymer molecule can be threaded back and forth through the nanopore to identify portions of the polymer molecule a plurality of times (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, or more times).
  • the present invention is directed to a method for obtaining sequence and/or structure information of a test polymer using a nanopore detector.
  • the test polymer can be trapped in or reside in the nanopore for a dwelling time (optionally by a stopper-test polymer segment).
  • a varied electric potential profile comprising electric potentials having more than one voltage can be applied to the electrodes of the nanopore detector and a set of electrical signals may be obtained.
  • the electrical signals collected under the varied electric potential profile may provide more distinctive information of the sequence and/or structure (e.g., that is in front of the stopper-test polymer segment in the flow direction of the test polymer) compared to the electrical signals collected under a constant electric potential.
  • the electrical signals collected under the varied electric potential profile may provide a more reliable and accurate determination of the test polymer sequence and/or structure than previous methods that use a constant electric potential.
  • One aspect of the present invention relates to a method of obtaining sequence and/or structure information of a test polymer, comprising:
  • the test polymer is a test polynucleotide
  • the building blocks are nucleotides as described herein.
  • the test polynucleotide has 1 to about 10,000 bases, 1 to about 1,000 bases, 1 to about 500 bases, 1 to about 300 bases, 1 to about 200 bases, 1 to about 100 bases, about 5 to about 10,000 bases, about 5 to about 1,000 bases, about 5 to about 500 bases, about 5 to about 300 bases, 5 to about 200 bases, 5 to about 100 bases, 10 to about 10,000 bases, 10 to about 1,000 bases, 10 to about 500 bases, 10 to about 300 bases, 10 to about 200 bases, 10 to about 100 bases, 20 to about 10,000 bases, 20 to about 1,000 bases, 20 to about 500 bases, 20 to about 300 bases, 20 to about 200 bases, 20 to about 100 bases, 30 to about 10,000 bases, 30 to about 1,000 bases, 30 to about 500 bases, 30 to about 300 bases, 30 to about 200 bases, 30 to about 100 bases, 30 to about 50 bases, 50 to about 10,000 bases, 50 to about 1,000 bases, 50 to about 500
  • the stopper can be an oligonucleotide speed bump, and the ss test polynucleotide can comprise a section of ss polynucleotide that is to be bound by the speed bump in a method described herein.
  • the test polynucleotide is a test DNA or RNA
  • the speed bump is a DNA or RNA speed bump.
  • a speed bump can have a length of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 bases. In some cases the speed bump has 10 or less, 8 or less, 6 or less, or 4 or less bases.
  • the speed bump may comprise one or more nucleotides selected from the group consisting of universal nucleotides, locked nucleotides, primary nucleotides, modifications thereof, and combinations thereof. Modifications of universal nucleotides, and primary nucleotides include modifications at the nucleobase structures, the backbone structures (e.g. glycol nucleotides, morpholinos, and locked nucleotides) and combinations thereof. In another preferred embodiment, the backbone structures of the speed bump is modified (e.g. glycol nucleotides, morpholinos, and locked nucleotides) at designated position(s), random positions or combinations thereof.
  • the first base pair of the speed bump-test polynucleotide segment may be partially or completely in the nanopore and contributes to the electrical signals obtained in step (J2).
  • step (J3) further comprises obtaining sequence and/or structure information of the first base pair of the speed bump-test polynucleotide segment in the flow direction of the ss test polynucleotide.
  • the stopper can be an enzyme that binds to the ss test polynucleotide and optionally moves the ss test polynucleotide through the nanopore.
  • enzymes include, without limitation, Klenow, exo minus; Phi29 polymerase; Phi29, exo minus polymerase; T4 DNA polymerase; M-MuLV Rever Transcriptase; and T7 Gp4a Helicase.
  • the stopper can be a part of the test polynucleotide that can form a 2-D or 3-D structures such as polynucleotide hairpin structures, multi-hairpin structures and multi-arm structures.
  • the first base pair of the stopper-test polynucleotide segment may be partially or completely in the nanopore, the electrical signals obtained in step (J2), step (J3) further comprising determining the first base pair of the stopper-test polynucleotide segment in the flow direction of the ss test polynucleotide.
  • the structure in front of the stopper-test polynucleotide segment determined in step (J3) is a 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 to 50 bases, 50 to 100 bases, 100 to 200 bases, 200 to 500 bases, or greater than a 500 base sequence.
  • the structure in front of the stopper-test polynucleotide segment determined in step (J3) is any nucleotide sequence at position 1-50, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30, or a combination thereof from the stopper-test polynucleotide segment.
  • the varied electric potential profile applied in step (J2) comprises electric potentials having two or more voltages each applied for a time.
  • the varied electric potential profile comprises one or more electric potentials resulted during step (J1) or after the stopper-test polymer complex is stalled, slowed or stopped in the nanopore in step (J1). At least two electric potentials of the two or more electric potentials applied have a difference of more than about 1 mV, 5 mV, 10 mV, or 30 mV.
  • the electric potentials have a voltage of about 160 mV to about ⁇ 160 mV, about 160 mV to about 0 mV, about 160 mV to about 60 mV, about 100 mV to about 0 mV, 100 mV to about 80 mV, or 80 mV to about 70 mV.
  • the time for each electric potential is at least about 5 ⁇ s, at least about 10 ⁇ s, at least about 50 ⁇ s, at least about 100 ⁇ s, at least about 500 ⁇ s, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 50 ms, at least about 100 ms, at least about 500 ms, at least about 1 s, or at least about 2 s.
  • the varied electric potential profile applied in step (J2) comprises an electric potential ramp changing from a first electric potential to a second electric potential over a time period.
  • the varied electric potential profile comprises one or more electric potentials resulted during step (J1) or after the stopper-test polymer complex is stalled, slowed or stopped in the nanopore in step (J1).
  • the first electric potential of the varied electric potential profile can be an electric potential resulted during step (J1) or after the stopper-test polymer complex is stalled, slowed or stopped in the nanopore in step (J1).
  • the first electric potential is about 100 mV and the second electric potential is about 90 mV. In another embodiment, the first electric potential is about 90 mV and the second electric potential is about 85 mV.
  • the predetermined time period is at least about 5 ⁇ s, at least about 10 ⁇ s, at least about 50 ⁇ s, at least about 100 ⁇ s, at least about 500 ⁇ s, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 50 ms, at least about 100 ms, at least about 500 ms, at least about 1 s, or at least about 2 seconds.
  • the varied electric potential profile applied in step (J2) comprises an electric potential waveform changing from a first electric potential to a second electric potential to a third electric potential and so on to a plurality of electric potentials that in total form a varying applied electric potential waveform.
  • step (J2) is performed in a solution having at least 0.1M salt.
  • the salt is selected from the group consisting of chloride, phosphate, nitrate and sulfate.
  • step (J2) is performed in a solution having a pH of about 6.5 to about 8.5 or from about 7 to about 8.
  • Any buffer that can provide such pH can be used. Examples include, without limitation, HEPES buffer.
  • the nanopore is an alpha hemolysin nanopore or a MspA nanopore.
  • the nanopore detector comprises at least one metal electrode embedded in an isolation surface.
  • the materials the metal electrode comprises include, without limitation, silver, sliver chloride, platinum, gold, ruthenium and nickel.
  • the materials the isolation surface comprises include, without limitation, a plastic material (e.g. Teflon), a glass, or a semiconductor material (e.g. silicon, germanium, and gallium).
  • the isolation surface is further modified to be hydrophobic and lipophilic using methods known in the art to facilitate attachment of biological molecules to the isolation surfaces. For example, further silanization with silane molecules containing 6 to 20 carbon-long chains (e.g.
  • octadecyl-trichlorosilane, octadecyl-trimethoxysilane, or octadecyl-triethoxysilane) or DMOCs can be done on silicon dioxide surface on a silicon surface.
  • Another aspect of the present invention relates to a method of obtaining sequence information of multiple single-stranded (ss) test polynucleotides in an array format.
  • “Multiple” refers to more than 1, preferably more than 10, 100, 1,000, 100,000, 1 million, 10 millions, or 100 millions.
  • the method comprises:
  • FIGS. 30-32 show the response to varied applied voltage for nucleotides.
  • the methods and concept of varied applied voltage and/or electronic signatures can be used to distinguish tag molecules (e.g., attached to tagged nucleotides).
  • FIG. 30 shows the extracted signal (DLC) versus applied voltage for the nucleotides adenine (A), cytosine (C), guanine (G) and thymine (T).
  • FIG. 31 shows the same information for a plurality of nucleotides (many experimental trials).
  • cytosine is relatively easy to distinguish from thymine at 120 mV, but difficult to distinguish from each other at 150 mV (e.g., because the extracted signal is approximately equal for C and T at 150 mV).
  • thymine is difficult to distinguish from adenine at 120 mV, but relatively easier to distinguish at 150 mV. Therefore, in some cases, the applied voltage can be changed (e.g., as part of a voltage sweep) from about 120 mV to 150 mV to distinguish each of the nucleotides A, C, G and T (or U).
  • FIG. 32 shows the percent relative conductive difference (% RCD) as a function of applied voltage for the nucleotides adenine (A), cytosine (C), guanine (G) and thymine (T). Plotting % RCD (which is essentially the difference in conductance of each molecule referenced to a 30T reference molecule) can remove off set and gain variation between experiments.
  • FIG. 32 includes individual DNA waveforms from the first block of 17/20 Trials. The % RCD of all single nucleotide DNA captures from number 50 to 200 for all 17 good Trials. Voltages where each of the nucleotides are distinguishable are indicated.
  • a ss test DNA having a BS2 on one end is captured in a nanopore at a temperature lower than T2 and released at a temperature higher than T2 ( FIG. 24 ).
  • the BS2 (BS2-1) is a DNA 5-base duplex hairpin structure formed from a PB2 having a sequence of 5′-CCCCC CCCCC TTATA CCCCT ATAA-3′ (SEQ ID NO. 1, PB2-1).
  • BS2-1 had melting temperature of about 15° C., and a ⁇ G of about ⁇ 0.96 kcal/mol at 5° C. according to the simulation using UNAFOLD program. This moderately low ⁇ G indicated that BS2-1 had a relatively low binding energy.
  • the solid line showed the change in temperature from 2° C. to 14° C.
  • the dots represented individual DNA captures, meaning that PB2-1 formed BS2-1 at the corresponding temperature and is captured in the nanopore.
  • the captures were present when the temperature is about or lower than T2 (about 5° C.), indicating that BS2-1 is formed from PB2-1 and the DNA is stalled in the nanopore.
  • the capture of the DNA disappeared when the temperature increased to about 5 to 10° C. over T2, indicating that BS2-1 melted and is no longer stalled in the nanopore.
  • PB2-1 formed BS2-1 which stalled, slowed or stopped the ss DNA in the pore at a temperatures about 10° C. lower than its melting temperature. This may be due to the relatively low ⁇ G BS2-1 had.
  • the DNA duplex structure in BS2-1 is relatively easy to dissociate in the nanopore.
  • a BS2 having a higher AG may be more difficult to destruct and may provide longer dwelling time at the nanopore at a temperature closer to the melting temperature of the BS2.
  • a PB1 forms a BS1 at a first temperature (T1) that is higher than the second temperature (T2) at which a BS2 is formed from a PB2.
  • T2 is higher than a working temperature (Tw).
  • Tw is below room temperature.
  • PB1 is designed to have a relative long DNA duplex segment (either in a DNA duplex with an anti-sense DNA segment, or in a hairpin structure) such that the desired melting temperature of the relative long DNA duplex segment is achieved.
  • a molly bolt or branched molecule has been designed to provide a BS2 having low T2 while not readily dissociated at the working condition.
  • PB1 has a sequence of 15 bases and a 4 base A loop; 5′-CGTCT AGCGT TGCCG AAAAC GGCAA CGCTA GACG-3′ (SEQ ID NO. 2, PB1-1). This sequence has a melt temperature of 91.4° C. in 1 M KCl, and 1 ⁇ M sequence concentration according to the simulation using UNAFOLD program.
  • PB2 has a sequence of 5′-GACCC TGCCC CCAGC TTTCC CCAAA CGTCA AAAAA-3′ (SEQ ID NO. 3, PB2-2) and the formed BS2-2 is a 3 stem, 3 duplex, 2 loop molecule as shown below according to the stimulation using UNAFOLD program:
  • a calculated melting curve of BS2-1 is obtained using nearest neighbor basis.
  • the melting curve illustrates that at above 30° C. about 90% of the structures are linear (PB2-2) and at below 20° C. about 90% of the structures form BS2-2.
  • Such a steep melting curve shows well controlled bulky structure formation of BS2-2, which is highly desired.
  • the AG of BS2-2 at 5° C. is ⁇ 4.5 kcal/mol, which indicates a stronger binding affinity than the 5 base hairpin molecule BS2-1 in Example 1.
  • This example illustrates a 4-base duplex segment stalled the ss test DNA in a nanopore for a dwelling time sufficient to obtain desired sequence information.
  • test DNAs were the following:
  • a test DNA is formed by self-hybridization of DNA-1: 5′-CCCCC CCCCC GCGC-3′ (SEQ ID NO. 4).
  • DNA-1 is dissolved in biology grade water, heated to 90° C. and then left to cool to room temperature for self-hybridization.
  • a DNA-1 molecule hybridize with another DNA-1 molecule to form a self-hybridized DNA-1 structure having a 4-base GCGC duplex segment at the 3′ ends and two overhanging ss 10-C tails at the 5′ ends thereof.
  • the self-hybridized DNA-1 structure entered a nanopore with one of the two overhanging ss 10-C tails, stalled in the nanopore by the 4-base duplex segment at the 3′ end for a dwelling time, and then when the 4-base duplex segment dissociated, the self-hybridized DNA-1 structure is converted to two ss DNA-1 molecules which went through the nanopore like ss test DNAs.
  • the self-hybridized DNA-1 structure simulated a ss test DNA having a 4-base duplex segment formed by a speed bump and the ss test DNA.
  • Another test DNA self-hybridized DNA-2 structure, is formed by self-hybridization of DNA-2: 5′-TTTTT TTTTT GCGC-3′ (SEQ ID NO. 5) using the same process described herein regarding the formation of the self-hybridized DNA-1.
  • the self-hybridized DNA-2 structure had a 4-base GCGC duplex at the 3′ ends and two overhanging ss 10-T tails at the 5′ ends.
  • streptavidin-DNA-3 complex formed by incubation of DNA-3: 5′-TTTTT TTTTT TTTTT TTTTT TTTTT TTTTT TTTTT TTTTT TTTTT-biotin-3′ (SEQ ID NO. 6) and streptavidin at a condition described below.
  • streptavidin-DNA-3 complex stalled in the nanopore until the electric potential is changed/reversed.
  • streptavidin-DNA-3 complex served as a positive control showing that the nanopore detector system is working properly.
  • the dwell time of this molecule is relatively long.
  • the working condition is 20 mM HEPEs buffer and 1 M KCl at 0° C.
  • the electric potential applied is about 128 mV.
  • the nanopores were created from 10 ng/mL alpha hemolysin deposited onto the surface of a bilayer at a final concentration of 0.2 ng/mL and with the application of electrical stimulus as described in U.S. Patent Application Publication No. 2011/0193570, which is entirely incorporated herein by reference.
  • the bilayers were created with the painting method from 10 mg/mL of DPhPC in Decane across the essentially planar AgCl electrode on a Teflon surface as described in U.S.
  • This example illustrates a 6-base random speed bump pool successfully bound to, stalled in a nanopore detector and dissociated from a test DNA.
  • the ss test DNA is ss female genomic DNA.
  • the random speed bump pool comprised hexamer DNA oligonucleotides having all combinations of the primary DNA nucleotides, which is purchased from Invitrogen.
  • the working condition is 20 mM HEPEs buffer and 1 M KCl at 0° C.
  • the electric potential applied is about 128 mV.
  • the nanopores are created from 10 ng/mL alpha hemolysin deposited onto the surface of a bilayer at a final concentration of 0.2 ng/mL and with the application of electrical stimulus as described in U.S. Patent Application Publication No. 2011/0193570, which is entirely incorporated herein by reference.
  • the bilayers are created with the painting method from 10 mg/mL of DPhPC in Decane across the essentially planar AgCl electrode on a Teflon surface as described in U.S. Patent Application Publication No. 2011/0193570, which is entirely incorporated herein by reference.
  • the ss test DNA (1 ⁇ M) is incubated with the 6-base random speed bump pool (100 ⁇ M) are incubated with multiple nanopores constructed as described herein for about 2 h at the working condition described herein in this example.
  • An electric potential of about 128 mV is applied to the nanopore and electrical signals are collected. The signals showed that the 6-base random speed bump pool is able to bind to the ss test DNA, stall the ss test DNA in the nanopore long enough to obtain relevant sequence information, and dissociate from the ss test DNA as described herein.
  • the Sample Polynucleotide is a ds Sample DNA
  • the double-stranded (ds) test polynucleotide can be formed by conventional DNA ligation techniques.
  • the ds sample polynucleotide can be ligated with the duplex section of Linker section and the duplex section of the Pre-bulky Section as shown in FIG. 28 .
  • the ds test polynucleotide can be denatured (e.g. heating) to provide the ss test polynucleotide ( FIG. 28 ).
  • the Sample Polynucleotide is a ss Sample DNA
  • a ds sample DNA can be prepared from the ss sample DNA using conventional methods well known in the art. Then the ds sample DNA can be further processed according to the method described herein with regard to ds sample DNA.
  • the Sample Polynucleotide is a ss Sample RNA
  • a ds sample DNA-RNA hybrid can be prepared from the ss sample RNA using conventional methods well known in the art. Then the ds sample DNA-RNA hybrid can be further processed according to the similar method described herein with regard to ds sample DNA.
  • the ds DNA can be denatured to provide ss sample DNA's to be used in this enzymatic approach:
  • the hook shaped primer comprises a hairpin structure, a section of 3′ overhang that can form a duplex section with the 3′ end of the ss sample polynucleotide.
  • the 3′ overhang of the hook primer can comprise a few universal nucleotides (e.g. 2, 3, 4, 5, 6, 7, or 8 nucleotides or more) that can interact with any oligonucleotide sequences.
  • the 5′ end of the hook primer may have a gap from the 3′ end of the ss sample polynucleotide, which can be ligated/filled in with an enzyme in single temperature extension reaction known in the art.
  • the polynucleotide obtained from step D2) has a hairpin structure on one end and a single strand section on the other end.
  • the single strand section is used as the template to elongate the polynucleotide from the 3′ end of the hook primer with an enzyme in single temperature extension reaction known in the art.
  • the polynucleotide has a blunt end at one end and a hairpin at the other end.
  • step D4) The polynucleotide obtained from step D3) is ligated with the pre-bulky section shown in FIG. 28 by blunt-end ligation. If the pre-bulky section has a biotin attachment, the obtained polynucleotide can be isolated by attachment of biotin to magnetic streptavidin beads. Other types of interactions can also be used, e.g. antibody-antigen interaction, to isolate the desired polynucleotides.
  • the method of using a specific hybridization sequence in the hairpin primer and using a biotin molecule attached to one or more of the pre-bulky structures blunt-end ligated to the newly created duplex sample provides a method to selectively enrich a sample for the specific sample fragments that are targeted by the hairpin primer.
  • a single hairpin primer or only a few variant hairpin primers can be used to create sense/antisense samples from all the strands in a sample. Such a method may lose information about the corresponding antisense structure at the 3′ end of the sample but it makes the creation of a prepared sample from a large collection of different nucleic acid molecules possible.
  • a ss sample polynucleotide is hybridized with a specific primer (adaptor) or a universal adaptor onto the 3′ end of the sample molecule so that a 5′ overhang exists on the hybridized adaptor.
  • a specific primer adaptor
  • a universal adaptor onto the 3′ end of the sample molecule so that a 5′ overhang exists on the hybridized adaptor.
  • To this overhang end of the adaptor is ligated another polynucleotide comprising a hairpin structure and constructed so that the 3′ end of the hairpin comes in contact with the 5′ end of the adaptor and the 5′ of the hairpin comes in contact with the 3′ end of the original ss sample polynucleotide.
  • the adaptor contains an overhang section that may contain nucleotides defined herein that bind specifically to a separate molecule that is fully or partially a hairpin nucleic acid strand.
  • the adaptor may also contain portions of specific sequence to a particular sample strand sequence, or it may contain a random sequence that when made into a library of adaptors can bind to any sample strand, or it may contain universal bases or combinations of normal bases and universal bases that allow the adaptor to bind to any sample strand.
  • These potential combinations of nucleotides are important because they allow enrichment of a sample for specific sequences in the case of using specific nucleotides in the adaptor or they allow universal creation of sense/antisense strands from all sample single stranded nucleic acids in a sample.
  • the overhang portion of the adaptor may be created to bind to man-made DNA but not natural DNA so that only the added hairpin molecule with its overhang and that has appropriate complementary nucleic acids or nucleic acid analogues will bind to the hairpin or partial hairpin molecule. This may be accomplished, for example, by the use of isodG and isodC nucleotides. The full hybridized complex can then be ligated together at the two locations above and the molecule is ready for antisense extension.
  • a ss sample polynucleotide may also be turned into a sense-antisense representation with select pre-bulky structures attached to the ends of the molecule by adapter and hairpin hybridization, sample strand and hairpin ligation, adaptor melt-off, extension, and blunt end ligation.
  • the adaptor will contain an overhang section that may contain natural or man-made nucleotides that will bind specifically to a separate molecule that is fully or partially a hairpin nucleic acid strand.
  • the adaptor may also contain portions of specific sequence to a particular sample strand sequence, or it may contain a random sequence that when made into a library of adaptors can bind to any sample strand, or it may contain universal bases or combinations of normal bases and universal bases that allow the adaptor to bind to any sample strand.
  • the overhang portion of the adaptor may be created to bind to man-made DNA but not natural DNA so that only the added hairpin molecule with its overhang and that has appropriate complementary nucleic acids or nucleic acid analogues will bind to the hairpin or partial hairpin molecule. This may be accomplished, for example, by the use of isodG and isodC nucleotides.
  • the adaptor molecule may also be created so that the 5′ end of the adaptor nucleic acid strand does not contain the needed tri-phosphate group for ligation to occur.
  • the adaptor will still serve its intended function of hybridizing to the ssDNA or ssRNA sample and hybridizing to the hairpin molecule and thus bringing the two molecules into close proximity for ligation to occur. Without the appropriate phosphate group however, the ligation of the adaptor and hairpin will not occur. Ligation will occur at the end of the sample molecule and the hairpin, but not between the hairpin and the adaptor.
  • the creation of a linked sense sample strand and a new antisense strand can also be accomplished by single stranded ligation of ss sample polynucleotide and a hairpin nucleic acid comprising an overhang that is single stranded.
  • T4 Ligase commercially available can link two separate single stranded portions of polynucleotides. Subsequent fill in and blunt end ligation of pre-bulky structures and denaturing (e.g. melting) will create a sense/antisense prepared molecule.
  • each electrode controlling an applied and read stimulus to a nanopore.
  • Multiple electrode/nanopore sensors can be combined into an array of individually controlled electrode/nanopore sensors on a planar or three dimensional surface such as may constructed on or in a semiconductor material using techniques familiar to the art in the semiconductor field.
  • the antisense strand is synthesized by a fill-in enzyme like Klenow from the polynucleotide obtained from step (E1) to provide a polynucleotide having a hairpin structure on one end and a blunt end on the other.
  • step E3 The polynucleotide obtained from step E2) is ligated with the pre-bulky section shown in FIG. 28 by blunt-end ligation. If one or more strands of the pre-bulky structure has a biotin attachment, the obtained polynucleotide can be isolated by attachment of biotin to magnetic streptavidin beads. Other types of interactions can also be used, e.g. antibody-antigen interaction, to isolate the desired polynucleotides.
  • DNA-TA (5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
  • Each type of DNA (DNA-TA, DNA-TT, DNA-TC, DNA-TG and DNA-TR) is mixed individually with Streptavidin to a working concentration of 100 ⁇ M of DNA and 25 ⁇ M of Streptavidin.
  • the obtained solutions are then further diluted to a final concentration of 4 ⁇ M of test DNA and 1.0 ⁇ M of Streptavidin as DNA stock solutions.
  • the tests are run on alpha hemolysin nanopore detectors.
  • the nanopore detectors had a pair of silver electrodes embedded in a planar Teflon surface.
  • Lipid bilayers are created by a bubble method or by sliding a pipette tip dipped in a small amount of lipid mix across the surface of the planar electrode using 1 ⁇ A of 15 mg/mL DPhPC lipid in Decane.
  • Nanopores are prepared with up to 1 ⁇ L of 1 ⁇ g/mL Alpha Hemolysin in 20% Glycerol and water buffered to pH 8.0 with 20 mM HEPES. Alternatively, the nanopores are prepared with 1 to 100 ng/mL of alpha hemolysin porin.
  • the electric potentials applied to the electrodes are changed linearly from 160 mV to 0 mV in 2 seconds.
  • a short negative potential pulse (approximately ⁇ 40 mV for 0.5 seconds) is applied to eject the test molecule from the pore and this is followed by a return to the capture voltage of +160 mV for another capture/read cycle.
  • a reference DNA (DNA-TR) is captured, the DNA captured is released from the pore when the electric potential applied is about 40 mV.
  • DNA-TA DNA-TA, DNA-TT, DNA-TC or DNA-TG
  • the DNA captured is released after the electric potential applied reached about 0 mV.
  • the DNA captured can be identified as the reference DNA or one of the test DNAs.
  • Each experiment is carried out for approximately 30 minutes on one nanopore. The same experiments are repeated on three nanopores for each test DNAs, thus 12 sets of data are provided.
  • the currents recorded by the nanopore detector when the reference DNA is captured in the nanopore are referred herein as the reference reads.
  • the currents recorded by the nanopore detector when the test DNA is captured in the nanopore are referred herein as the test reads.
  • the reference reads versus change of electric potential applied are fit into a quadratic line.
  • the median of the reference reads vs. the changes of the electric potential is obtained (hereinafter the reference medians).
  • the delta current between each test read and the reference medians are calculated for each electric potential applied and then divided by the derivative of the reference quadratic fit to obtain a ratio of the test reads to the reference reads.
  • the conductance of the delta current is then multiplied by 100 to turn into % reference conductance difference.
  • curves of the % reference conductance differences for the test reads versus electric potential applied (mV) are drafted and compiled.
  • the curves show that single substitution of A, T, C, or G in a polyT DNA captured in a nanopore can be identified with more than 95% confidence as described herein. It is assumed that none of the other nucleotides but the single substituted nucleotide (A, T, C, and G) affects the signals obtained by the nanopore detector.
  • steps (B6 to B7) either in a constant profile or a varied profile is (are) at least about 90 mV, preferably at least about 100 mV, more preferably about 100 mV to about 160 mV, C and T are determined with high confidence (>about 99%, preferably >99.5% confidence). G and A are characterized with a lower confidence (about 95% confidence). The complementary structures of G and A are C and T, respectively. Thus, determining the C's and T's in the antisense strand provided the determination of G's and A's in the sample DNA with a higher confidence (>99%, preferably >99.5% confidence) as well.
  • determining the C's and T's in both the sample DNA and the antisense strand can provide the structure of the sample DNA with a higher confidence (>99%, preferably >99.5% confidence) than determining all four nucleotides A, C, T and G from information collected from the sample DNA only (about 95% confidence).
  • determining the C's and A's in both the sample DNA and the antisense strand can provide the structure of the sample DNA with a higher confidence (>99%, preferably >99.5% confidence) than determining all four nucleotides A, C, T and G from information collected from the sample DNA only (about 95% confidence).
  • determining all four nucleotides A, C, T and G from information collected from the sample DNA only about 95% confidence.
  • the signals can be derived from a speed bump reading system as described earlier, from an enzyme extension system as described earlier, from an enzyme extension and disassociation of the enzyme from the sample reading system as described earlier, or from other enzyme/strand movement techniques including helicase enzyme strand movement as an example.
  • Helicase does not require base extension of an antisense strand to move the sample strand in a nanopore but unravels the DNA sample in a linear fashion through the nanopore for reading.
  • Example 6 The similar experiments as described in Example 6 are carried out for each test DNAs (DNA-AA, DNA-AT, DNA-AC, DNA-AG, DNA-CA, DNA-CT, DNA-CC, DNA-CG DNA-TA, DNA-TT, DNA-TC or DNA-TG) using DNA-CR as the reference DNA, except that the experiments are run at 0° C. instead of at room temperature.
  • Experiments for all test DNAs are performed once, and the data obtained are processed as described in Example 6.
  • the data complied shows that 2-base differences at positions 11 to 13 from the 3′ end of the tests DNAs; comprised of 3 different homopolymer backbone strands can be identified reliably by DNA nanopore detection using a varied electric potential profile described herein.
  • electric potential profile data is provided corresponding to DNAs having polyA-backbones, DNAs having polyC-backbones, and DNAs having polyT-backbones.
  • constriction zone in the upper portion of the alpha hemolysin pore barrel is the major constriction zone in the pore and accounts for the majority of the current decrease when DNA is suspended in the pore. Without the intention to be bound by any theory, it is estimated that when a DNA is suspended in the pore a total of 10 nucleotides fit in the full length of the barrel of an alpha-hemolysin pore.
  • the graph readings identified the 2 nucleotides in the constriction zone but data had not been taken on all possible combinations of the remaining 8 nucleotides in the pore.
  • the reading levels of electric potential profiles assumes that the eight remaining nucleotides in the pore at the time of measurement did not appreciably affect the current readings of the 2-nucleotide pairs.
  • the electric potential profiles show the following:
  • TG, TA and TT Signals of TG, TA and TT are mixed together.
  • the corresponding antisense dimers of TG, TA and TT are CA, TA and AA, respectively, which are easy to differentiate from each other.
  • the corresponding antisense dimers of AT, AA and AG are AT, TT and CT, respectively, which are easy to differentiate from each other.
  • CG, CA and CT Signals of CG, CA and CT are mixed together.
  • the corresponding antisense dimers of CG, CA and CT are CG, TG and AG, respectively, CG and CT are difficult to differentiate from each other under the electric potential(s) of about 130 mV or higher, but are easy to differentiate from each other when the electric potential(s) applied in steps (B6 to B7) is (are) lower (e.g. around 100 mV).
  • the electric potential(s) applied in steps (B6 to B7) either in a constant profile or a varied profile, is (are) about 80 mV to about 120 mV:
  • TG, TA and TT Signals of TG, TA and TT are mixed together.
  • the corresponding antisense dimers of TG, TA and TT are CA, TA and AA, respectively, which are easy to differentiate from each other.
  • the corresponding antisense dimers of AT, AA and AG are AT, TT and CT, respectively, which are easy to differentiate from each other.
  • the corresponding antisense dimers of CG, CA and CT are CG, TG and AG, respectively, which are easy to differentiate from each other.
  • the method described herein provide a more reliable and accurate characterization of a sample DNA by characterizing both the sample DNA and the antisense DNA thereof.
  • the methods of sample preparation described herein are easy and can be applied to any nucleic acid sample.
  • the methods of preparation described herein allow multiplexed samples on the same nanopore sensor.
  • the sense/antisense sample preparation and reading techniques described herein may be ideal or otherwise suited for use on a nanopore sequencer or detector comprising an array individually controlled nanopore sensors.
  • the ability to read the sense and antisense strand of the same region of sample DNA or RNA at nearly the same time and in the same nanopore lowers the systematic error, and improves the ability to correctly read and sequence the sample.
  • the number of nanopore sensors in one array can be large and is limited only by semiconductor process technology.
  • DNA-TA (5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
  • Each type of DNA (DNA-TA, DNA-TT, DNA-TC, DNA-TG and DNA-TR) is mixed individually with Streptavidin to a working concentration of 100 ⁇ M of DNA and 25 ⁇ M of Streptavidin.
  • the obtained solutions are then further diluted to a final concentration of 4 ⁇ M of test DNA and 1.0 ⁇ M of Streptavidin as DNA stock solutions.
  • the tests are run on alpha hemolysin nanopore detectors.
  • the nanopore detectors had a pair of silver electrodes embedded in a planar Teflon surface.
  • Lipid bilayers are created by a bubble method or by sliding a pipette tip dipped in a small amount of lipid mix across the surface of the planar electrode using 1 ⁇ L of 15 mg/mL DPhPC lipid in Decane.
  • Nanopores are prepared with up to 1 ⁇ L of 1 ⁇ g/mL Alpha Hemolysin in 20% Glycerol and water buffered to pH 8.0 with 20 mM HEPES. Alternatively, the nanopores are prepared with 1 to 100 ng/mL of alpha hemolysin porin.
  • the electric potential applied to the electrodes are changed linearly from 160 mV to 0 mV in 2 seconds. After the current recorded showed that the DNA captured is released from the nanopore, the electric potential applied to the nanopore detector is restored to 160 mV until the next DNA capture happened.
  • a reference DNA DNA-TR
  • the DNA captured is released when the electric potential applied is about 40 mV.
  • a test DNA DNA-TA, DNA-TT, DNA-TC or DNA-TG
  • the DNA captured can be identified as the reference DNA or one of the test DNAs.
  • the experiment is carried out for 30 minutes on one nanopore.
  • the same experiments are repeated on three nanopores for each test DNAs, thus provided 12 sets of data
  • the currents recorded by the nanopore detector when the reference DNA is captured in the nanopore may be referred to herein as the reference reads.
  • the currents recorded by the nanopore detector when the test DNA is captured in the nanopore are referred herein as the test reads.
  • the reference reads versus change of electric potential applied are fit into a quadratic line.
  • the median of the reference reads vs. the changes of the electric potential is obtained (hereinafter the reference medians).
  • the delta current between each test read and the reference medians are calculated for each electric potential applied and then divided by the derivative of the reference quadratic fit to obtain a ratio of the test reads to the reference reads.
  • the conductance of the delta current is calculated and multiplied by 100 to turn into % reference conductance difference. Then curves of the % reference conductance differences for the test reads versus electric potential applied (mV) are drafted and complied to provide an electric potential profile (graph).
  • a first set of curves show data obtained from DNA-TA
  • a second set of curves show data obtained from DNA-TG
  • a third set of curves show data obtained from DNA-TT
  • a fourth set of curves show data obtained from DNA-TC.
  • the electric potential profile shows that single substitution of A, T, C, or G in a polyT DNA captured in a nanopore can be identified with more than 95% confidence as described herein.
  • Example 8 The similar experiments as described in Example 8 are carried out for each test DNAs (DNA-AA, DNA-AT, DNA-AC, DNA-AG, DNA-CA, DNA-CT, DNA-CC, DNA-CG DNA-TA, DNA-TT, DNA-TC or DNA-TG) using DNA-CR as the reference DNA, except that the experiments are run at 0° C. instead of at room temperature.
  • Experiments for all test DNAs are performed once, and the data obtained are processed as described in Example 8.
  • the data complied showed that 2-base differences at positions 11 to 13 from the 3′ end of the tests DNAs; comprised of 3 different homopolymer backbone strands could be identified reliably by DNA nanopore detection using a varied electric potential profile described herein.
  • data for DNAs having polyA-backbones, data for DNAs having polyC-backbones, and data for DNAs having polyT-backbones is provided.
  • a first set of curves is from data for DNA-AA, DNA-CA and DNA-TA;
  • a second set of curves is from data for DNA-AC, DNA-CC and DNA-TC;
  • a third set of curves is from data for DNA-AT, DNA-CT and DNA-TT;
  • a fourth set of curves is from data for DNA-AG, DNA-CG and DNA-TG.
  • Data obtained from experiments of 39A1Ns described is used to generate an electric potential profile showing percent reference conductance difference as a function of voltage (V).
  • a first set of curves is generated from data for DNA-AA; a second set of curves is generated from data for DNA-AC; a third set of curves is generated from data for DNA-AT; and a fourth set of curves is generated from data for DNA-AG.
  • Data obtained from experiments of 39C1Ns described herein is used to generate an electric potential profile showing percent reference conductance difference as a function of voltage (V).
  • a first set of curves is generated from data for DNA-CA; a second set of curves is generated from data for DNA-CC; a third set of curves is generated from data for DNA-CT; and a fourth set of curves is generated from data for DNA-CG.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nanotechnology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
US13/745,688 2012-01-20 2013-01-18 Nanopore Based Molecular Detection and Sequencing Abandoned US20130244340A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/745,688 US20130244340A1 (en) 2012-01-20 2013-01-18 Nanopore Based Molecular Detection and Sequencing
US15/703,909 US10662471B2 (en) 2012-01-20 2017-09-13 Nanopore based molecular detection and sequencing
US16/851,884 US11965210B2 (en) 2012-01-20 2020-04-17 Nanopore based molecular detection and sequencing

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261589196P 2012-01-20 2012-01-20
US201261589719P 2012-01-23 2012-01-23
US201261600227P 2012-02-17 2012-02-17
US13/745,688 US20130244340A1 (en) 2012-01-20 2013-01-18 Nanopore Based Molecular Detection and Sequencing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/703,909 Continuation US10662471B2 (en) 2012-01-20 2017-09-13 Nanopore based molecular detection and sequencing

Publications (1)

Publication Number Publication Date
US20130244340A1 true US20130244340A1 (en) 2013-09-19

Family

ID=48799710

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/745,688 Abandoned US20130244340A1 (en) 2012-01-20 2013-01-18 Nanopore Based Molecular Detection and Sequencing
US15/703,909 Active US10662471B2 (en) 2012-01-20 2017-09-13 Nanopore based molecular detection and sequencing
US16/851,884 Active 2034-05-01 US11965210B2 (en) 2012-01-20 2020-04-17 Nanopore based molecular detection and sequencing

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/703,909 Active US10662471B2 (en) 2012-01-20 2017-09-13 Nanopore based molecular detection and sequencing
US16/851,884 Active 2034-05-01 US11965210B2 (en) 2012-01-20 2020-04-17 Nanopore based molecular detection and sequencing

Country Status (6)

Country Link
US (3) US20130244340A1 (ja)
EP (2) EP3415901A1 (ja)
JP (2) JP6333179B2 (ja)
CN (2) CN107828877A (ja)
CA (1) CA2861457A1 (ja)
WO (1) WO2013109970A1 (ja)

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845880B2 (en) 2010-12-22 2014-09-30 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps
US20150041315A1 (en) * 2013-08-07 2015-02-12 Xagenic Inc. Microchip structure and treatments for electrochemical detection
US8962242B2 (en) 2011-01-24 2015-02-24 Genia Technologies, Inc. System for detecting electrical properties of a molecular complex
US8986629B2 (en) 2012-02-27 2015-03-24 Genia Technologies, Inc. Sensor circuit for controlling, detecting, and measuring a molecular complex
WO2015061509A1 (en) * 2013-10-23 2015-04-30 Genia Technologies, Inc. High speed molecular sensing with nanopores
US9041420B2 (en) 2010-02-08 2015-05-26 Genia Technologies, Inc. Systems and methods for characterizing a molecule
US9110478B2 (en) 2011-01-27 2015-08-18 Genia Technologies, Inc. Temperature regulation of measurement arrays
WO2015167972A1 (en) * 2014-04-28 2015-11-05 Tsavachidou Dimitra Methods for nucleic acid base determination
WO2015183836A1 (en) 2014-05-27 2015-12-03 Brian Haynes Compositions, methods, and uses related to ntrk2-tert fusions
WO2015183837A1 (en) 2014-05-27 2015-12-03 Brian Haynes Compositions, methods, and uses related to ntrk2-tert fusions
WO2015200756A1 (en) * 2014-06-26 2015-12-30 President And Fellows Of Harvard College Pore-based bubble chamber
US9322062B2 (en) 2013-10-23 2016-04-26 Genia Technologies, Inc. Process for biosensor well formation
WO2016085992A1 (en) 2014-11-24 2016-06-02 Ppg Industries Ohio, Inc. Methods for reactive three-dimensional printing by extrusion
WO2016099673A1 (en) * 2014-12-19 2016-06-23 Genia Technologies, Inc. Nanopore-based sequencing with varying voltage stimulus
US9494554B2 (en) 2012-06-15 2016-11-15 Genia Technologies, Inc. Chip set-up and high-accuracy nucleic acid sequencing
US9551697B2 (en) 2013-10-17 2017-01-24 Genia Technologies, Inc. Non-faradaic, capacitively coupled measurement in a nanopore cell array
US9605307B2 (en) 2010-02-08 2017-03-28 Genia Technologies, Inc. Systems and methods for forming a nanopore in a lipid bilayer
US9605309B2 (en) 2012-11-09 2017-03-28 Genia Technologies, Inc. Nucleic acid sequencing using tags
US9678055B2 (en) 2010-02-08 2017-06-13 Genia Technologies, Inc. Methods for forming a nanopore in a lipid bilayer
US9759711B2 (en) 2013-02-05 2017-09-12 Genia Technologies, Inc. Nanopore arrays
WO2017162828A1 (en) 2016-03-24 2017-09-28 Genia Technologies, Inc. Site-specific bio-conjugation methods and compositions useful for nanopore systems
WO2017203059A1 (en) 2016-05-27 2017-11-30 F. Hoffmann-La Roche Ag Tagged multi-nucleotides useful for nucleic acid sequencing
US9863904B2 (en) 2014-12-19 2018-01-09 Genia Technologies, Inc. Nanopore-based sequencing with varying voltage stimulus
US20180030506A1 (en) * 2015-02-26 2018-02-01 Hitachi High Technologies Corporation Method for Constructing Nucleic Acid Molecule
WO2018037096A1 (en) 2016-08-26 2018-03-01 F. Hoffmann-La Roche Ag Tagged nucleotides useful for nanopore detection
WO2018069484A2 (en) 2016-10-13 2018-04-19 F. Hoffmann-La Roche Ag Molecular detection and counting using nanopores
US20180143178A1 (en) * 2015-05-11 2018-05-24 Oxford Nanopore Technologies Ltd. Apparatus and methods for measuring an electrical current
US10126262B2 (en) 2015-09-24 2018-11-13 Genia Technologies, Inc. Differential output of analog memories storing nanopore measurement samples
US20190033286A1 (en) * 2016-02-25 2019-01-31 Quantapore, Inc. Redundant polymer analysis by translocation reversals
WO2019035099A1 (en) 2017-08-18 2019-02-21 Ppg Industries Ohio, Inc. MANUFACTURE OF ADDITIVES USING REACTIVE COMPOSITIONS
US10240195B2 (en) 2014-03-24 2019-03-26 The Trustees Of Columbia University In The City Of New York Chemical methods for producing tagged nucleotides
US20190161795A1 (en) * 2015-08-05 2019-05-30 Genia Technologies, Inc. Use of titanium nitride as an electrode in non-faradaic electrochemical cell
CN109963949A (zh) * 2016-09-15 2019-07-02 豪夫迈·罗氏有限公司 使用具有杂合模式刺激的电压模式的基于纳米孔的测序
WO2019166457A1 (en) 2018-02-28 2019-09-06 F. Hoffmann-La Roche Ag Tagged nucleoside compounds useful for nanopore detection
US20190309008A1 (en) * 2012-04-09 2019-10-10 The Trustees Of Columbia University In The City Of New York Method of preparation of nanopore and uses thereof
WO2019226822A1 (en) * 2018-05-23 2019-11-28 The Regents Of The University Of California Methods of analyzing capped ribonucleic acids
WO2019228995A1 (en) 2018-05-28 2019-12-05 F. Hoffmann-La Roche Ag Enzymatic enrichment of dna-pore-polymerase complexes
WO2020002621A2 (en) 2018-06-29 2020-01-02 F. Hoffmann-La Roche Ag Detection of microsatellite instability
WO2020131759A1 (en) 2018-12-19 2020-06-25 Roche Diagnostics Gmbh 3' protected nucleotides
US10732183B2 (en) * 2013-03-15 2020-08-04 The Trustees Of Columbia University In The City Of New York Method for detecting multiple predetermined compounds in a sample
WO2020176301A1 (en) 2019-02-28 2020-09-03 Pacific Biosciences Of California, Inc. Improved alignment using homopolymer-collapsed sequencing reads
WO2020202153A1 (en) 2019-04-01 2020-10-08 Stratasys Ltd. Additive manufacturing of an object made of a polyurea material
WO2021013805A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Systems and methods for cell of origin determination from variant calling data
WO2021053008A1 (en) 2019-09-20 2021-03-25 F. Hoffmann-La Roche Ag Immune repertoire profiling by primer extension target enrichment
US10975426B2 (en) 2015-09-10 2021-04-13 Roche Sequencing Solutions, Inc. Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
CN112714869A (zh) * 2018-08-28 2021-04-27 豪夫迈·罗氏有限公司 含钌电极
WO2021099521A1 (en) 2019-11-21 2021-05-27 F. Hoffmann-La Roche Ag Systems and methods for contamination detection in next generation sequencing samples
WO2021156370A1 (en) 2020-02-06 2021-08-12 F. Hoffmann-La Roche Ag Compositions that reduce template threading into a nanopore
WO2021239834A1 (en) 2020-05-28 2021-12-02 F. Hoffmann-La Roche Ag Sequence alignment systems and methods to identify short motifs in high-error single-molecule reads
WO2021247137A2 (en) 2020-06-05 2021-12-09 Ppg Industries Ohio, Inc. Additive manufacturing compositions and methods including resin stabilized pigments
US11332787B2 (en) 2018-06-29 2022-05-17 Pacific Biosciences Of California, Inc. Methods and compositions for delivery of molecules and complexes to reaction sites
US11333655B2 (en) 2016-09-07 2022-05-17 The Board Of Trustees Of The University Of Illinois Nanopore-based system for trapping, controlled displacement, and sequencing of (bio)macromolecules
WO2022117625A1 (en) 2020-12-03 2022-06-09 F. Hoffmann-La Roche Ag Whole transcriptome analysis in single cells
WO2022171606A2 (en) 2021-02-09 2022-08-18 F. Hoffmann-La Roche Ag Methods for base-level detection of methylation in nucleic acids
WO2022184836A1 (en) 2021-03-03 2022-09-09 F. Hoffmann-La Roche Ag Devices and methods for electrophoretic extraction of nucleic acids from biological samples
WO2022217221A1 (en) 2021-04-06 2022-10-13 Ppg Industries Ohio, Inc. Structural modules produced by additive manufacturing
WO2022231694A2 (en) 2021-04-27 2022-11-03 Ppg Industries Ohio, Inc. Co-reactive additive manufacturing compositions and articles for use in investment casting
US11493499B1 (en) 2018-10-30 2022-11-08 Seagate Technology Llc Event timing detection for DNA sequencing
WO2022248237A1 (en) 2021-05-24 2022-12-01 F. Hoffmann-La Roche Ag Enhancer oligonucleotides for nucleic acid hybridization
WO2022263489A1 (en) 2021-06-17 2022-12-22 F. Hoffmann-La Roche Ag Nucleoside-5 -oligophosphates having a cationically-modified nucleobase
US11608523B2 (en) 2012-06-20 2023-03-21 The Trustees Of Columbia University In The City Of New York Nucleic acid sequencing by nanopore detection of tag molecules
WO2023107899A2 (en) 2021-12-07 2023-06-15 Caribou Biosciences, Inc. A method of capturing crispr endonuclease cleavage products
WO2023164445A1 (en) 2022-02-23 2023-08-31 Ppg Industries Ohio, Inc. Conductive articles and methods for additive manufacturing thereof
WO2023213766A1 (en) 2022-05-02 2023-11-09 F. Hoffmann-La Roche Ag Compositions and methods that reduce prussian blue formation during nanopore sequencing
WO2023242075A1 (en) 2022-06-14 2023-12-21 F. Hoffmann-La Roche Ag Detection of epigenetic cytosine modification
WO2024039924A1 (en) 2022-08-14 2024-02-22 Ppg Industries Ohio, Inc. Additive manufacturing using recycled materials
WO2024038069A1 (en) 2022-08-18 2024-02-22 F. Hoffmann-La Roche Ag Detection of epigenetic modifications
WO2024064900A1 (en) 2022-09-22 2024-03-28 Pacific Biosciences Of California, Inc. Systems and methods for tandem repeat mapping

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
US20160162634A1 (en) 2011-09-23 2016-06-09 Oxford Nanopore Technologies Limited Analysis of a polymer comprising polymer units
EP3415901A1 (en) * 2012-01-20 2018-12-19 Genia Technologies, Inc. Nanopore based molecular detection and sequencing
CN104321441B (zh) 2012-02-16 2016-10-19 牛津楠路珀尔科技有限公司 聚合物的测量的分析
BR112014025157B1 (pt) 2012-04-10 2022-02-08 Oxford Nanopore Technologies Limited Monômero de lisenina mutante, construto, poro, método para caracterizar um analito alvo, uso de um poro, e, kit
GB201222928D0 (en) 2012-12-19 2013-01-30 Oxford Nanopore Tech Ltd Analysis of a polynucleotide
WO2014135838A1 (en) 2013-03-08 2014-09-12 Oxford Nanopore Technologies Limited Enzyme stalling method
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
US20150037787A1 (en) * 2013-07-31 2015-02-05 International Business Machines Corporation Polynucleotide configuration for reliable electrical and optical sensing
WO2015110813A1 (en) 2014-01-22 2015-07-30 Oxford Nanopore Technologies Limited Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
WO2015166276A1 (en) 2014-05-02 2015-11-05 Oxford Nanopore Technologies Limited Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
CN117164682A (zh) 2014-09-01 2023-12-05 弗拉芒区生物技术研究所 突变csgg孔
CN115851894A (zh) 2014-10-16 2023-03-28 牛津楠路珀尔科技股份有限公司 聚合物的分析
JP6401588B2 (ja) * 2014-11-28 2018-10-10 株式会社アドバンテスト 電流測定装置および塩基配列解析装置、測定用チップ
WO2016106690A1 (en) * 2014-12-31 2016-07-07 Coyote Bioscience Co., Ltd. Detection of nucleic acid molecules using nanopores and complexing moieties
WO2016106689A1 (en) * 2014-12-31 2016-07-07 Coyote Bioscience Co., Ltd. Detection of nucleic acid molecules using nanopores and tags
GB201502810D0 (en) 2015-02-19 2015-04-08 Oxford Nanopore Tech Ltd Method
GB201502809D0 (en) 2015-02-19 2015-04-08 Oxford Nanopore Tech Ltd Mutant pore
CN104713932B (zh) * 2015-03-24 2017-03-29 清华大学 一种交流模式的多参数纳米孔单分子分析仪
US11169138B2 (en) 2015-04-14 2021-11-09 Katholieke Universiteit Leuven Nanopores with internal protein adaptors
CN115433769A (zh) * 2015-08-12 2022-12-06 香港中文大学 血浆dna的单分子测序
JP2017038539A (ja) * 2015-08-18 2017-02-23 日本電信電話株式会社 脂質二分子膜基板
CA3000561C (en) * 2015-09-24 2022-03-22 F. Hoffman-La Roche Ag Alpha-hemolysin variants
US10976300B2 (en) 2015-12-08 2021-04-13 Katholieke Universiteit Leuven Modified nanopores, compositions comprising the same, and uses thereof
RU2765308C2 (ru) * 2016-02-29 2022-01-28 Айридия, Инк. Способы, композиции и устройства для хранения информации
EP3423485B1 (en) 2016-03-02 2021-12-29 Oxford Nanopore Technologies plc Mutant pore
AU2017246690B2 (en) 2016-04-06 2022-03-24 Oxford Nanopore Technologies Plc Mutant pore
GB201609221D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
EP3526603B1 (en) * 2016-10-12 2022-07-20 F. Hoffmann-La Roche AG Nanopore voltage methods
GB201620450D0 (en) 2016-12-01 2017-01-18 Oxford Nanopore Tech Ltd Method
US11448638B2 (en) * 2017-01-10 2022-09-20 Hitachi High-Tech Corporation Current measurement device and current measurement method using nanopore
CN113755319A (zh) * 2017-02-14 2021-12-07 阿克斯比尔公司 用于大分子的连续诊断的设备和方法
GB201707140D0 (en) 2017-05-04 2017-06-21 Oxford Nanopore Tech Ltd Method
WO2018222853A1 (en) * 2017-05-31 2018-12-06 Molecular Assemblies, Inc. Homopolymer encoded nucleic acid memory
EP4273156A3 (en) 2017-06-30 2024-01-17 Vib Vzw Novel protein pores
WO2019040546A1 (en) * 2017-08-23 2019-02-28 Roche Sequencing Solutions, Inc ENZYME SCREENING METHODS
GB201809323D0 (en) * 2018-06-06 2018-07-25 Oxford Nanopore Tech Ltd Method
JP2020031557A (ja) * 2018-08-28 2020-03-05 株式会社日立ハイテクノロジーズ 生体分子分析装置
CN109266537B (zh) * 2018-09-14 2019-10-29 首度生物科技（苏州）有限公司 使用单分子多次通过纳米孔达到精密测序的基因测序仪
WO2020078595A1 (en) * 2018-10-19 2020-04-23 F. Hoffmann-La Roche Ag Electric field-assisted junctions for sequencing
CN109295187B (zh) * 2018-10-31 2021-02-09 南京大学 一种基于纳米孔对非天然核酸直接测序的错位测序方法
CN109358106B (zh) * 2018-11-05 2021-04-13 中国科学院重庆绿色智能技术研究院 一种基于固态纳米孔技术的多糖单分子结构解析方法
WO2020113581A1 (zh) * 2018-12-07 2020-06-11 深圳华大生命科学研究院 纳米孔测序方法
CN109680052B (zh) * 2019-01-14 2022-07-22 京东方科技集团股份有限公司 纳米孔薄膜、基因测序装置及纳米孔薄膜的制备方法
CN112147185B (zh) * 2019-06-29 2022-07-01 清华大学 一种控制多肽穿过纳米孔速度的方法及其应用
US20230220450A1 (en) * 2019-09-18 2023-07-13 Hitachi High-Tech Corporation Adapter molecule, biomolecule-adapter molecule complex composed of adapter molecule and biomolecule bound together, biomolecule analyzer and biomolecule analysis method
GB2602736A (en) * 2019-09-18 2022-07-13 Hitachi High Tech Corp Adapter molecule, biomolecule-adapter molecule complex in which said adapter molecule and biomolecule are bound, biomolecule analysis apparatus, and
CN113493735B (zh) * 2020-04-02 2023-06-16 成都今是科技有限公司 基因测序阵列结构和基因测序装置
US20230230636A1 (en) * 2020-05-15 2023-07-20 The Curator's of the University of Missouri Nanopore unzipping-sequencing for dna data storage
CN111879941B (zh) * 2020-06-29 2021-11-02 北京大学 基于自组装纳米孔的蛋白行为检测系统及其制备与使用方法
KR102579071B1 (ko) 2021-02-18 2023-09-15 고려대학교 산학협력단 포어 구조를 구비하는 핵산 검출용 미세 유동장치
CN113462544A (zh) * 2021-07-01 2021-10-01 南方科技大学 核酸序列的检测方法、装置、系统、控制设备
CN113718023A (zh) * 2021-08-23 2021-11-30 普瑞基准生物医药(苏州)有限公司 基于牛纳米孔测序技术的原核生物核糖核酸直接测序方法
CN115901907A (zh) * 2021-09-30 2023-04-04 成都今是科技有限公司 纳米孔测序电路单元及基因测序装置
CN115876866A (zh) * 2021-09-30 2023-03-31 成都今是科技有限公司 纳米孔测序电路单元及基因测序装置

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020094526A1 (en) * 2000-02-11 2002-07-18 Bayley Hagan P. Biosensor compositions and methods of use
US20080187915A1 (en) * 2007-02-02 2008-08-07 Stanislav Polonsky Systems and Methods for Controlling the Position of a Charged Polymer Inside a Nanopore
US20090298075A1 (en) * 2008-03-28 2009-12-03 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
US20110037486A1 (en) * 2009-08-13 2011-02-17 Ut-Battelle, Llc Nucleotide capacitance measurement for low cost dna sequencing
US8845880B2 (en) * 2010-12-22 2014-09-30 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362002B1 (en) * 1995-03-17 2002-03-26 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
NO986133D0 (no) * 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering
WO2002029003A2 (en) 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
AU2002239284A1 (en) * 2000-11-27 2002-06-03 The Regents Of The University Of California Methods and devices for characterizing duplex nucleic acid molecules
US7075161B2 (en) * 2003-10-23 2006-07-11 Agilent Technologies, Inc. Apparatus and method for making a low capacitance artificial nanopore
US7279337B2 (en) * 2004-03-10 2007-10-09 Agilent Technologies, Inc. Method and apparatus for sequencing polymers through tunneling conductance variation detection
US7972858B2 (en) * 2004-08-13 2011-07-05 President And Fellows Of Harvard College Ultra high-throughput opti-nanopore DNA readout platform
US20070020146A1 (en) * 2005-06-29 2007-01-25 Young James E Nanopore structure and method using an insulating substrate
CA2647786A1 (en) * 2006-03-14 2007-09-20 Genizon Biosciences Inc. Methods and means for nucleic acid sequencing
US20070298511A1 (en) * 2006-04-27 2007-12-27 The Texas A&M University System Nanopore sensor system
CN101495656B (zh) 2006-06-07 2017-02-08 纽约哥伦比亚大学理事会 采用带修饰的核苷酸通过纳米通道进行dna序列测定
CN100999764A (zh) * 2006-12-14 2007-07-18 上海交通大学 光学镊控制单链核酸穿孔速度的方法
KR101521990B1 (ko) * 2007-04-04 2015-05-20 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 나노포어 사용을 위한 조성물, 장치, 시스템 및 방법
WO2009045472A1 (en) * 2007-10-02 2009-04-09 President And Fellows Of Harvard College Capture, recapture, and trapping of molecules with a nanopore
US8283157B2 (en) * 2008-06-18 2012-10-09 Electronics Biosciences, Inc. System and method for increasing polymer/nanopore interactions
CN102203288A (zh) * 2008-09-03 2011-09-28 康特姆斯集团有限公司 核酸测序的方法和试剂盒
EP2391732B1 (en) * 2009-01-30 2015-05-27 Oxford Nanopore Technologies Limited Methods using adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) * 2009-03-25 2009-05-06 Isis Innovation Method
WO2010117470A2 (en) 2009-04-10 2010-10-14 Pacific Biosciences Of California, Inc. Nanopore sequencing devices and methods
CN101619353B (zh) * 2009-08-13 2011-07-27 上海交通大学 将单分子dna连接到单个磁珠上的方法
WO2011040996A1 (en) * 2009-09-30 2011-04-07 Quantapore, Inc. Ultrafast sequencing of biological polymers using a labeled nanopore
CN101654712A (zh) * 2009-10-10 2010-02-24 上海交通大学 核酸单分子测序方法
US8969090B2 (en) 2010-01-04 2015-03-03 Life Technologies Corporation DNA sequencing methods and detectors and systems for carrying out the same
US8324914B2 (en) * 2010-02-08 2012-12-04 Genia Technologies, Inc. Systems and methods for characterizing a molecule
EP2539707B1 (en) * 2010-02-23 2021-06-30 University Of Washington Artificial mycolic acid membranes
US20130256118A1 (en) * 2010-05-11 2013-10-03 Trustees Of Boston University Use of Nanopore Arrays For Multiplex Sequencing of Nucleic Acids
AU2011279083B2 (en) * 2010-07-14 2015-03-26 The Curators Of The University Of Missouri Nanopore-facilitated single molecule detection of nucleic acids
CN103282518B (zh) 2010-12-17 2016-11-16 纽约哥伦比亚大学理事会 使用经修饰的核苷酸和纳米孔检测的dna边合成边测序
EP3415901A1 (en) * 2012-01-20 2018-12-19 Genia Technologies, Inc. Nanopore based molecular detection and sequencing
EP3540077B1 (en) * 2012-02-16 2021-01-27 Genia Technologies, Inc. Methods for creating bilayers for use with nanopore sensors
EP2861768A4 (en) * 2012-06-15 2016-03-02 Genia Technologies Inc CHIP SETUP AND HIGH ACCURACY NUCLEIC ACID SEQUENCING

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020094526A1 (en) * 2000-02-11 2002-07-18 Bayley Hagan P. Biosensor compositions and methods of use
US20080187915A1 (en) * 2007-02-02 2008-08-07 Stanislav Polonsky Systems and Methods for Controlling the Position of a Charged Polymer Inside a Nanopore
US20090298075A1 (en) * 2008-03-28 2009-12-03 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
US20110037486A1 (en) * 2009-08-13 2011-02-17 Ut-Battelle, Llc Nucleotide capacitance measurement for low cost dna sequencing
US8845880B2 (en) * 2010-12-22 2014-09-30 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps

Cited By (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9678055B2 (en) 2010-02-08 2017-06-13 Genia Technologies, Inc. Methods for forming a nanopore in a lipid bilayer
US10343350B2 (en) 2010-02-08 2019-07-09 Genia Technologies, Inc. Systems and methods for forming a nanopore in a lipid bilayer
US9605307B2 (en) 2010-02-08 2017-03-28 Genia Technologies, Inc. Systems and methods for forming a nanopore in a lipid bilayer
US11027502B2 (en) 2010-02-08 2021-06-08 Roche Sequencing Solutions, Inc. Systems and methods for forming a nanopore in a lipid bilayer
US10926486B2 (en) 2010-02-08 2021-02-23 Roche Sequencing Solutions, Inc. Systems and methods for forming a nanopore in a lipid bilayer
US9041420B2 (en) 2010-02-08 2015-05-26 Genia Technologies, Inc. Systems and methods for characterizing a molecule
US10371692B2 (en) 2010-02-08 2019-08-06 Genia Technologies, Inc. Systems for forming a nanopore in a lipid bilayer
US9377437B2 (en) 2010-02-08 2016-06-28 Genia Technologies, Inc. Systems and methods for characterizing a molecule
US9121059B2 (en) 2010-12-22 2015-09-01 Genia Technologies, Inc. Nanopore-based single molecule characterization
US9617593B2 (en) 2010-12-22 2017-04-11 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps
US8845880B2 (en) 2010-12-22 2014-09-30 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps
US10920271B2 (en) 2010-12-22 2021-02-16 Roche Sequencing Solutions, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps
US10400278B2 (en) 2010-12-22 2019-09-03 Genia Technologies, Inc. Nanopore-based single DNA molecule characterization, identification and isolation using speed bumps
US8962242B2 (en) 2011-01-24 2015-02-24 Genia Technologies, Inc. System for detecting electrical properties of a molecular complex
US10156541B2 (en) 2011-01-24 2018-12-18 Genia Technologies, Inc. System for detecting electrical properties of a molecular complex
US9581563B2 (en) 2011-01-24 2017-02-28 Genia Technologies, Inc. System for communicating information from an array of sensors
US9110478B2 (en) 2011-01-27 2015-08-18 Genia Technologies, Inc. Temperature regulation of measurement arrays
US10010852B2 (en) 2011-01-27 2018-07-03 Genia Technologies, Inc. Temperature regulation of measurement arrays
US11275052B2 (en) 2012-02-27 2022-03-15 Roche Sequencing Solutions, Inc. Sensor circuit for controlling, detecting, and measuring a molecular complex
US8986629B2 (en) 2012-02-27 2015-03-24 Genia Technologies, Inc. Sensor circuit for controlling, detecting, and measuring a molecular complex
US11795191B2 (en) * 2012-04-09 2023-10-24 The Trustees Of Columbia University In The City Of New York Method of preparation of nanopore and uses thereof
US20190309008A1 (en) * 2012-04-09 2019-10-10 The Trustees Of Columbia University In The City Of New York Method of preparation of nanopore and uses thereof
US9494554B2 (en) 2012-06-15 2016-11-15 Genia Technologies, Inc. Chip set-up and high-accuracy nucleic acid sequencing
US11608523B2 (en) 2012-06-20 2023-03-21 The Trustees Of Columbia University In The City Of New York Nucleic acid sequencing by nanopore detection of tag molecules
US9605309B2 (en) 2012-11-09 2017-03-28 Genia Technologies, Inc. Nucleic acid sequencing using tags
US10526647B2 (en) 2012-11-09 2020-01-07 The Trustees Of Columbia University In The City Of New York Nucleic acid sequences using tags
US11674174B2 (en) 2012-11-09 2023-06-13 The Trustees Of Columbia University In The City Of New York Nucleic acid sequences using tags
US10822650B2 (en) 2012-11-09 2020-11-03 Roche Sequencing Solutions, Inc. Nucleic acid sequencing using tags
US9759711B2 (en) 2013-02-05 2017-09-12 Genia Technologies, Inc. Nanopore arrays
US10809244B2 (en) 2013-02-05 2020-10-20 Roche Sequencing Solutions, Inc. Nanopore arrays
US10012637B2 (en) 2013-02-05 2018-07-03 Genia Technologies, Inc. Nanopore arrays
US10732183B2 (en) * 2013-03-15 2020-08-04 The Trustees Of Columbia University In The City Of New York Method for detecting multiple predetermined compounds in a sample
US10416109B2 (en) * 2013-08-07 2019-09-17 General Atomics Microchip structure and treatments for electrochemical detection
US20150041315A1 (en) * 2013-08-07 2015-02-12 Xagenic Inc. Microchip structure and treatments for electrochemical detection
US9551697B2 (en) 2013-10-17 2017-01-24 Genia Technologies, Inc. Non-faradaic, capacitively coupled measurement in a nanopore cell array
US10393700B2 (en) 2013-10-17 2019-08-27 Roche Sequencing Solutions, Inc. Non-faradaic, capacitively coupled measurement in a nanopore cell array
US9567630B2 (en) 2013-10-23 2017-02-14 Genia Technologies, Inc. Methods for forming lipid bilayers on biochips
WO2015061509A1 (en) * 2013-10-23 2015-04-30 Genia Technologies, Inc. High speed molecular sensing with nanopores
CN105723222A (zh) * 2013-10-23 2016-06-29 吉尼亚科技公司 使用纳米孔的高速分子感测
CN109797199A (zh) * 2013-10-23 2019-05-24 吉尼亚科技公司 使用纳米孔的高速分子感测
EP3640349A3 (en) * 2013-10-23 2020-07-29 Roche Sequencing Solutions, Inc. High speed molecular sensing with nanopores
US11021745B2 (en) 2013-10-23 2021-06-01 Roche Sequencing Solutions, Inc. Methods for forming lipid bilayers on biochips
US10421995B2 (en) 2013-10-23 2019-09-24 Genia Technologies, Inc. High speed molecular sensing with nanopores
US9322062B2 (en) 2013-10-23 2016-04-26 Genia Technologies, Inc. Process for biosensor well formation
US10240195B2 (en) 2014-03-24 2019-03-26 The Trustees Of Columbia University In The City Of New York Chemical methods for producing tagged nucleotides
US11396677B2 (en) 2014-03-24 2022-07-26 The Trustees Of Columbia University In The City Of New York Chemical methods for producing tagged nucleotides
WO2015167972A1 (en) * 2014-04-28 2015-11-05 Tsavachidou Dimitra Methods for nucleic acid base determination
WO2015183837A1 (en) 2014-05-27 2015-12-03 Brian Haynes Compositions, methods, and uses related to ntrk2-tert fusions
WO2015183836A1 (en) 2014-05-27 2015-12-03 Brian Haynes Compositions, methods, and uses related to ntrk2-tert fusions
WO2015200756A1 (en) * 2014-06-26 2015-12-30 President And Fellows Of Harvard College Pore-based bubble chamber
WO2016085976A1 (en) 2014-11-24 2016-06-02 Ppg Industries Ohio, Inc. Methods for reactive three-dimensional printing by inkjet printing
US11028279B2 (en) 2014-11-24 2021-06-08 Ppg Industries Ohio, Inc. Coreactive materials and methods for three-dimensional printing
US10982105B2 (en) 2014-11-24 2021-04-20 Ppg Industries Ohio, Inc. Methods for reactive three-dimensional printing by extrusion
US11220610B2 (en) 2014-11-24 2022-01-11 Ppg Industries Ohio, Inc. Methods for reactive three-dimensional printing by inkjet printing
WO2016085992A1 (en) 2014-11-24 2016-06-02 Ppg Industries Ohio, Inc. Methods for reactive three-dimensional printing by extrusion
WO2016085914A1 (en) 2014-11-24 2016-06-02 Ppg Industries Ohio, Inc. Coreactive materials and methods for three-dimensional printing
US10253195B2 (en) 2014-11-24 2019-04-09 Ppg Industries Ohio, Inc. Coreactive materials and methods for three-dimensional printing
US10545112B2 (en) 2014-12-19 2020-01-28 Roche Sequencing Solutions, Inc. Nanopore-based sequencing with varying voltage stimulus
CN107533030A (zh) * 2014-12-19 2018-01-02 豪夫迈·罗氏有限公司 利用变化的电压刺激的基于纳米孔的测序
WO2016099673A1 (en) * 2014-12-19 2016-06-23 Genia Technologies, Inc. Nanopore-based sequencing with varying voltage stimulus
US9557294B2 (en) 2014-12-19 2017-01-31 Genia Technologies, Inc. Nanopore-based sequencing with varying voltage stimulus
US9863904B2 (en) 2014-12-19 2018-01-09 Genia Technologies, Inc. Nanopore-based sequencing with varying voltage stimulus
US20180030506A1 (en) * 2015-02-26 2018-02-01 Hitachi High Technologies Corporation Method for Constructing Nucleic Acid Molecule
US10612073B2 (en) * 2015-02-26 2020-04-07 Hitachi High-Technologies Corporation Method for constructing nucleic acid molecule
US20180143178A1 (en) * 2015-05-11 2018-05-24 Oxford Nanopore Technologies Ltd. Apparatus and methods for measuring an electrical current
US10962523B2 (en) * 2015-05-11 2021-03-30 Oxford Nanopore Technologies Ltd. Apparatus and methods for measuring an electrical current
US11098354B2 (en) * 2015-08-05 2021-08-24 Roche Sequencing Solutions, Inc. Use of titanium nitride as an electrode in non-faradaic electrochemical cell
US20190161795A1 (en) * 2015-08-05 2019-05-30 Genia Technologies, Inc. Use of titanium nitride as an electrode in non-faradaic electrochemical cell
US11739378B2 (en) 2015-09-10 2023-08-29 Roche Sequencing Solutions, Inc. Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
US10975426B2 (en) 2015-09-10 2021-04-13 Roche Sequencing Solutions, Inc. Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
EP4303314A2 (en) 2015-09-10 2024-01-10 F. Hoffmann-La Roche AG Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
US10126262B2 (en) 2015-09-24 2018-11-13 Genia Technologies, Inc. Differential output of analog memories storing nanopore measurement samples
US10670549B2 (en) 2015-09-24 2020-06-02 Roche Sequencing Solutions, Inc. Differential output of analog memories storing nanopore measurement samples
US20190033286A1 (en) * 2016-02-25 2019-01-31 Quantapore, Inc. Redundant polymer analysis by translocation reversals
JP2019509039A (ja) * 2016-02-25 2019-04-04 クアンタポール， インコーポレイテッド 移行反転による冗長ポリマー分析
US11001611B2 (en) 2016-03-24 2021-05-11 Roche Sequencing Solutions, Inc. Site-specific bio-conjugation methods and compositions useful for nanopore systems
US11866464B2 (en) 2016-03-24 2024-01-09 Roche Sequencing Solutions, Inc. Site-specific bio-conjugation methods and compositions useful for nanopore systems
WO2017162828A1 (en) 2016-03-24 2017-09-28 Genia Technologies, Inc. Site-specific bio-conjugation methods and compositions useful for nanopore systems
WO2017203059A1 (en) 2016-05-27 2017-11-30 F. Hoffmann-La Roche Ag Tagged multi-nucleotides useful for nucleic acid sequencing
WO2017202917A1 (en) 2016-05-27 2017-11-30 F. Hoffmann-La Roche Ag Tagged multi-nucleotides useful for nucleic acid sequencing
US10975432B2 (en) 2016-05-27 2021-04-13 Roche Sequencing Solutions, Inc. Tagged multi-nucleotides useful for nucleic acid sequencing
US10655174B2 (en) 2016-05-27 2020-05-19 Roche Sequencing Solutions, Inc. Tagged multi-nucleotides useful for nucleic acid sequencing
US11008613B2 (en) 2016-08-26 2021-05-18 Roche Sequencing Solutions, Inc. Tagged nucleotides useful for nanopore detection
WO2018037096A1 (en) 2016-08-26 2018-03-01 F. Hoffmann-La Roche Ag Tagged nucleotides useful for nanopore detection
US10669580B2 (en) 2016-08-26 2020-06-02 Roche Sequencing Solutions, Inc. Tagged nucleotides useful for nanopore detection
US11333655B2 (en) 2016-09-07 2022-05-17 The Board Of Trustees Of The University Of Illinois Nanopore-based system for trapping, controlled displacement, and sequencing of (bio)macromolecules
CN109963949A (zh) * 2016-09-15 2019-07-02 豪夫迈·罗氏有限公司 使用具有杂合模式刺激的电压模式的基于纳米孔的测序
US11029306B2 (en) * 2016-09-15 2021-06-08 Roche Sequencing Solutions, Inc. Nanopore-based sequencing using voltage mode with hybrid mode stimuli
WO2018069484A2 (en) 2016-10-13 2018-04-19 F. Hoffmann-La Roche Ag Molecular detection and counting using nanopores
US11041845B2 (en) 2016-10-13 2021-06-22 Roche Sequencing Solutions, Inc. Molecular detection and counting using nanopores
WO2019035099A1 (en) 2017-08-18 2019-02-21 Ppg Industries Ohio, Inc. MANUFACTURE OF ADDITIVES USING REACTIVE COMPOSITIONS
US10864673B2 (en) 2017-08-18 2020-12-15 Ppg Industries Ohio, Inc. Additive manufacturing using polyurea materials
US10434704B2 (en) 2017-08-18 2019-10-08 Ppg Industries Ohio, Inc. Additive manufacturing using polyurea materials
WO2019166457A1 (en) 2018-02-28 2019-09-06 F. Hoffmann-La Roche Ag Tagged nucleoside compounds useful for nanopore detection
WO2019226822A1 (en) * 2018-05-23 2019-11-28 The Regents Of The University Of California Methods of analyzing capped ribonucleic acids
WO2019228995A1 (en) 2018-05-28 2019-12-05 F. Hoffmann-La Roche Ag Enzymatic enrichment of dna-pore-polymerase complexes
WO2020002621A2 (en) 2018-06-29 2020-01-02 F. Hoffmann-La Roche Ag Detection of microsatellite instability
US11332787B2 (en) 2018-06-29 2022-05-17 Pacific Biosciences Of California, Inc. Methods and compositions for delivery of molecules and complexes to reaction sites
US20210311017A1 (en) * 2018-08-28 2021-10-07 Roche Sequencing Solutions, Inc. Nanopore sequencing device comprising ruthenium-containing electrodes
CN112714869A (zh) * 2018-08-28 2021-04-27 豪夫迈·罗氏有限公司 含钌电极
US11493499B1 (en) 2018-10-30 2022-11-08 Seagate Technology Llc Event timing detection for DNA sequencing
WO2020131759A1 (en) 2018-12-19 2020-06-25 Roche Diagnostics Gmbh 3' protected nucleotides
WO2020176301A1 (en) 2019-02-28 2020-09-03 Pacific Biosciences Of California, Inc. Improved alignment using homopolymer-collapsed sequencing reads
WO2020202153A1 (en) 2019-04-01 2020-10-08 Stratasys Ltd. Additive manufacturing of an object made of a polyurea material
WO2021013805A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Systems and methods for cell of origin determination from variant calling data
WO2021053008A1 (en) 2019-09-20 2021-03-25 F. Hoffmann-La Roche Ag Immune repertoire profiling by primer extension target enrichment
WO2021099521A1 (en) 2019-11-21 2021-05-27 F. Hoffmann-La Roche Ag Systems and methods for contamination detection in next generation sequencing samples
WO2021156370A1 (en) 2020-02-06 2021-08-12 F. Hoffmann-La Roche Ag Compositions that reduce template threading into a nanopore
WO2021239834A1 (en) 2020-05-28 2021-12-02 F. Hoffmann-La Roche Ag Sequence alignment systems and methods to identify short motifs in high-error single-molecule reads
WO2021247137A2 (en) 2020-06-05 2021-12-09 Ppg Industries Ohio, Inc. Additive manufacturing compositions and methods including resin stabilized pigments
WO2022117625A1 (en) 2020-12-03 2022-06-09 F. Hoffmann-La Roche Ag Whole transcriptome analysis in single cells
WO2022171606A2 (en) 2021-02-09 2022-08-18 F. Hoffmann-La Roche Ag Methods for base-level detection of methylation in nucleic acids
WO2022184836A1 (en) 2021-03-03 2022-09-09 F. Hoffmann-La Roche Ag Devices and methods for electrophoretic extraction of nucleic acids from biological samples
WO2022217221A1 (en) 2021-04-06 2022-10-13 Ppg Industries Ohio, Inc. Structural modules produced by additive manufacturing
WO2022231694A2 (en) 2021-04-27 2022-11-03 Ppg Industries Ohio, Inc. Co-reactive additive manufacturing compositions and articles for use in investment casting
WO2022248237A1 (en) 2021-05-24 2022-12-01 F. Hoffmann-La Roche Ag Enhancer oligonucleotides for nucleic acid hybridization
WO2022263489A1 (en) 2021-06-17 2022-12-22 F. Hoffmann-La Roche Ag Nucleoside-5 -oligophosphates having a cationically-modified nucleobase
WO2023107899A2 (en) 2021-12-07 2023-06-15 Caribou Biosciences, Inc. A method of capturing crispr endonuclease cleavage products
WO2023164445A1 (en) 2022-02-23 2023-08-31 Ppg Industries Ohio, Inc. Conductive articles and methods for additive manufacturing thereof
WO2023213766A1 (en) 2022-05-02 2023-11-09 F. Hoffmann-La Roche Ag Compositions and methods that reduce prussian blue formation during nanopore sequencing
WO2023242075A1 (en) 2022-06-14 2023-12-21 F. Hoffmann-La Roche Ag Detection of epigenetic cytosine modification
WO2024039924A1 (en) 2022-08-14 2024-02-22 Ppg Industries Ohio, Inc. Additive manufacturing using recycled materials
WO2024038069A1 (en) 2022-08-18 2024-02-22 F. Hoffmann-La Roche Ag Detection of epigenetic modifications
WO2024064900A1 (en) 2022-09-22 2024-03-28 Pacific Biosciences Of California, Inc. Systems and methods for tandem repeat mapping

Also Published As

Publication number Publication date
US20200308641A1 (en) 2020-10-01
EP2807476A1 (en) 2014-12-03
CA2861457A1 (en) 2013-07-25
WO2013109970A1 (en) 2013-07-25
US20180223351A1 (en) 2018-08-09
JP2015505458A (ja) 2015-02-23
CN107828877A (zh) 2018-03-23
JP2018072353A (ja) 2018-05-10
US11965210B2 (en) 2024-04-23
US10662471B2 (en) 2020-05-26
CN104254771B (zh) 2018-01-12
EP3415901A1 (en) 2018-12-19
CN104254771A (zh) 2014-12-31
JP6333179B2 (ja) 2018-05-30
JP6744852B2 (ja) 2020-08-19
EP2807476A4 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
US11965210B2 (en) Nanopore based molecular detection and sequencing
US11499190B2 (en) Nucleic acid sequencing using tags
US20220333187A1 (en) Methods for creating bilayers for use with nanopore sensors
US20200377944A1 (en) Compositions and methods for unidirectional nucleic acid sequencing

Legal Events

Date Code Title Description
AS Assignment

Owner name: GENIA TECHNOLOGIES, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DAVIS, RANDALL;CHEN, ROGER;REEL/FRAME:030410/0267

Effective date: 20130510

AS Assignment

Owner name: GLENVIEW INSTITUTIONAL PARTNERS, L.P., NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: DOBKIN, ROBERT, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: GLENVIEW CAPITAL MASTER FUND LTD, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: GLENVIEW CAPITAL PARTNERS LP, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: GLENVIEW CAPITAL OPPORTUNITY FUND, LP, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: LIFE TECHNOLOGIES CORPORATION, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: SHERMAN, LEN, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

Owner name: GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD., N

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:030423/0652

Effective date: 20130515

AS Assignment

Owner name: GLENVIEW CAPITAL MASTER FUND LTD., NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:032161/0007

Effective date: 20140131

Owner name: GLENVIEW CAPITAL OPPORTUNITY FUND, LP, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:032161/0007

Effective date: 20140131

Owner name: GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD., N

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:032161/0007

Effective date: 20140131

Owner name: GLENVIEW INSTITUTIONAL PARTNERS, L.P., NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:032161/0007

Effective date: 20140131

Owner name: GLENVIEW CAPITAL PARTNERS LP, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:GENIA TECHNOLOGIES, INC.;REEL/FRAME:032161/0007

Effective date: 20140131

AS Assignment

Owner name: GENIA TECHNOLOGIES, INC, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNORS:GLENVIEW CAPITAL PARTNERS, L.P.;GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD;GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.;AND OTHERS;REEL/FRAME:033083/0203

Effective date: 20140529

Owner name: GENIA TECHNOLOGIES, INC, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNORS:GLENVIEW CAPITAL PARTNERS, L.P.;GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.;GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.;AND OTHERS;REEL/FRAME:033083/0170

Effective date: 20140529

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION